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ABSTRACT 
 
 
Comparison of Circadian Gene Expression among Different Oscillator Models: 
Identification of Critical Output Signals of the SCN Pacemaker.  
 (May 2007) 
Gus John Menger III, B.S., Southwest Texas State University 
 
Chair of Advisory Committee: Dr. David Earnest 
 
 
 
Diverse forms of life have evolved 24-hour or circadian timekeeping systems 
serving to coordinate internal biological events with the daily solar cycle. The generation 
of circadian rhythms by this timekeeping system ensures that internal processes occur at 
the appropriate time of day or night in relation to the environmental cycle and to other 
functionally-affiliated events. For mammals, endogenous oscillations in gene expression 
are a prevalent feature of oscillatory cells residing in the suprachiasmatic nucleus (SCN) 
and non-SCN tissues. To determine whether immortalized cells derived from the rat SCN 
(SCN2.2) retain the intrinsic rhythm-generating properties of the SCN, oscillatory 
behavior of the SCN2.2 transcriptome was analyzed and compared to that found in the rat 
SCN in vivo. In SCN2.2 cells, 116 unique genes and 46 ESTs or genes of unknown 
function exhibited circadian fluctuations for 2 cycles. Many (35%) of these rhythmically-
regulated genes in SCN2.2 cells also exhibited circadian profiles of mRNA expression in 
the rat SCN in vivo. To screen for output signals that may distinguish oscillatory cells in 
the mammalian SCN from peripheral-type oscillators, the rhythmic behavior of the 
transcriptome in forskolin-stimulated NIH/3T3 fibroblasts was analyzed and compared 
relative to SCN2.2 cells in vitro and the rat SCN in vivo. Similar to the circadian profiling 
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of the SCN2.2 and rat SCN transcriptomes, NIH/3T3 fibroblasts exhibited rhythmic 
fluctuations in the expression of the core clock genes and 323 (2.6%) functionally diverse 
transcripts. Overlap in rhythmically expressed transcripts among these different oscillator 
models was limited to the clock genes and four genes that function in metabolism or 
transcription. Coupled with evidence for the rhythmic regulation of the inducible isoform 
of nitric oxide synthase (Nos) in SCN2.2 cells and the rat SCN but not in fibroblasts, 
studies examining the effects of antisense oligonucleotide-mediated inhibition of Nos2 
suggest that the gaseous neurotransmitter nitric oxide may play a key role in SCN 
pacemaker function. Thus, our comparative analysis of circadian gene expression in SCN 
and non-SCN cells has important implications in the selective analysis of circadian 
signals involved in the coupling of SCN oscillators and regulation of rhythmicity in 
downstream cells. 
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CHAPTER I 
INTRODUCTION 
OVERVIEW 
A universal property of nature is that nothing is constant and most events occur in 
cycles.  A preeminant example of this cyclicity is day and night. On Earth, diverse forms 
of life have evolved 24-hour or circadian (circa – around; dies – a day) timekeeping 
systems serving to coordinate internal biological events with the daily solar cycle. The 
generation of circadian rhythms by this timekeeping system ensures that internal 
processes occur at the appropriate time of day or night in relation to the environmental 
cycle and to other related events, both physiological and behavioral. Organisms, 
including cyanobacteria, fungi, plants, invertebrates, and vertebrates possess circadian 
timekeeping systems characterized by a common tertiary configuration – 1) 
input/entrainment pathways, 2) a core clockwork and 3) output pathways. While 
fundamental elements of the core clockwork have been identified across these diverse 
organisms, limited information is available on output pathways especially with regard to 
their functional roles in coordinating rhythmic processes in mammals (17). In fact, much 
remains to be understood about how this circadian timekeeping system communicates 
time within and among individual cells.    
Circadian rhythms – a historical perspective. Some of the earliest circadian 
rhythms were observed in the movements of flowering plants.  By using a kymograph to 
record the movements of plant leaves via a transducing actuator, Pfeffer (c.1910) first 
automated recordings of circadian rhythms of movement (19). Pfeffer’s drum could be rolled 
_____________ 
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on a sheet of paper to produce a negative image of the actuator needle’s tracings through 
the charcoal. Subsequent to these founding observations, a myriad of processes including 
behavior, metabolism, neuro-endocrine physiology, neuronal activity, cell division and 
numerous facets of gene expression (e.g., chromatin modification, mRNA abundance, 
translation and post-translational regulation) have been shown to exhibit circadian 
rhythms (120, 137, 44, 34, 76, 63, 158, 96, 20, 107, 27, 86, 132, 33, 163, 70). These 
processes exemplify the broad and diverse activities regulated by the circadian 
timekeeping system and, at the same time, outline the progression to a modern synthesis 
in our understanding of circadian timekeeping – overt rhythms of physiology and 
behavior arise from circadian rhythms of gene expression.  
Because of their tractability and high degree of fidelity in gauging circadian 
regulation, analyses of behavior, metabolism and gene expression are frequently 
employed as indices of circadian timekeeping in mammals (120, 137, 86, 132, 33). These 
processes can offer tangible measurements of circadian timekeeping.  For instance, 
behavioral activity in rodents can be analyzed for several months by means of measuring 
parameters of wheel-running activity (Fig. 1). Similarly, radioactively-labeled tracers 
such as 2-deoxyglucose can be used to gauge daily oscillations of metabolism in specific 
brain tissues and cell cultures. Furthermore, recent advances in technology, specifically 
the acceleration of mammalian genome sequencing and high-density lithography, have 
provided scientists with tools to simultaneously analyze the expression of many 
thousands of genes reproducibly. Thus, behavioral, metabolic, and gene expression 
processes are useful as indices of circadian timekeeping because these processes can be 
measured with accuracy and technical reproducibility. Although modern technological 
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advances have expanded the scope and accuracy of measuring these indices of circadian 
timekeeping, much of our understanding of mammalian timekeeping is still derived from 
examinations of the formal properties of the circadian rhythm itself. 
 
 
 
Fig. 1. Circadian wheel-running behavior in rodents. Representative circadian wheel-
running activity in an individual Sprague-Dawley rat during exposure to constant 
darkness across 48 hours. Daily activity bouts are double plotted. The endogenous period 
of the animal’s activity rhythm is 24.33 hours. 
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Formal properties of circadian rhythms. A cadre of formal properties serves as a 
benchmark in determining whether a biological oscillation is a bona fide circadian 
rhythm. By definition, a circadian rhythm must display a period of oscillation 
approximating a day and persists in the absence of environmental time cues (57). Because 
circadian rhythms oscillate independent of external time cues, the term free-run is used to 
describe the persistent nature of the rhythm (17). Entrainment to local environmental time 
is a second distinctive property of circadian timekeeping. This process provides for the 
temporal coordination of internal processes with external environmental cycles (64). 
Generally speaking, entrainment of internal processes can be likened to the Disney icons 
Cinderella, Snow White and Pooh riding on the outer train at Disney World. The time it 
takes these entertainment, and perhaps entrainment,  icons to completely travel around 
the park (their period of travel) is set by the velocity of the train. Now, let’s say that 
Cinderella is riding in the front car, Snow White is in the middle car and Pooh rides in the 
end car. Because these icons ride in different cars, their positions on the train establish 
the order in which they will pass by Space Mountain. Cinderella will always pass Space 
Mountain first and Pooh last. Pooh will also be the last to see an approaching 
honeycomb. Thus, by boarding the train, the relative positions of Cinderella, Snow 
White, and Pooh are coordinated with the cycle of the Disney train. Similarly, through 
entrainment, the period of the circadian timekeeping system is consistently coordinated 
with the cycle of the external environment. This coordination permits different circadian 
oscillations to maintain their temporal relationships across the circadian cycle. Just as 
Cinderella, Snow White and Pooh, are held to their relative positions as they ride the 
Disney train. 
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In nature, light-dark cycles entrain circadian rhythms and maintain the temporal 
relationships among circadian rhythms.  Photic signals derived from the light-dark cycle 
are the predominant zeitgebers (translated as “time givers” from German) capable of 
regulating the period and phase relationships of circadian rhythms (124). Every day 
circadian photoentrainment requires adjustments of circadian rhythms so that their 
endogenous periods equal the length of the entraining light/dark cycle. These adjustments 
are mediated through time-dependent phase shifts or discrete changes in the period of the 
circadian rhythm. The extent of these adjustments is equal to the difference between the 
circadian period and the length (usually 24 hours) of the entraining photoperiod. In 
addition to the regulation of the period of circadian rhythms, photoentrainment also 
entails phase control. Thus, through period and phase control, circadian photoentrainment 
insures that critical biological processes are coordinated with local environmental time so 
as to occur during appropriate phases of the light-dark cycle. For mammals, evidence of 
these features of circadian photoentrainment can be seen in the effects of light on 
circadian period [Compliance with Aschoff’s rule (the circadian period of a nocturnal 
organism increases with light intensity )], in the effects of light pulses on the phase of 
circadian rhythms, and in the limits of light to entrain (12, 124).  
A third feature of circadian timekeeping is that the period of a circadian rhythm is 
usually temperature compensated. Temperature compensation reflects a general 
independence of the endogenous circadian period (τ) in relation to changes in ambient 
temperature (78). The steadiness of the intrinsic circadian period (τ) across a range of 
temperatures is thought to stabilize the phase relations among circadian regulated 
processes, maintaining temporal precision among these processes. Pittendrigh (1954) first 
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demonstrated temperature compensation in Drosophila and this fundamental property has 
been borne out in numerous species (123, 121, 38). It is important to note that 
temperature compensation, like entrainment, has limits. Nonetheless, it is a beneficial and 
necessary property for faithful circadian timekeeping as the circadian period can remain 
true even when an organism encounters cold and warm environments.  
The mammalian circadian system. Based on the formal properties of circadian 
regulation and previous research observations, the mammalian circadian timekeeping 
system is organized into components comprising input pathways, a master circadian 
clock, and output pathways (Fig. 2). In mammals, the master clock responsible for 
coordinating circadian rhythms throughout the body resides in the suprachiasmatic nuclei 
(SCN) of the anterior hypothalamus, a region of the brain responsible for the regulation 
of many autonomic body functions (69). The SCN circadian clock contains many cell 
types some of which function as autonomous circadian oscillators called pacemaker cells.  
These pacemaker cells function with other SCN cells in integrating inputs, entraining to 
these inputs and transmitting outputs to collectively coordinate circadian rhythms 
elsewhere in the body (17).  Photic signals, emanating from the retina, are integrated in a 
specific region of the SCN, the ventrolateral SCN. These signals are then transmitted to 
other regions of the SCN, through neuronal and diffusible factors, to facilitate synchrony 
between the cellular activities of the SCN and the progression of the daily solar cycle. 
Lastly, through neuronal and diffusible output pathways, SCN pacemaker cells 
coordinate the physiological and biochemical functions of other cells and tissues 
throughout the body with the environmental cycle or with other internal rhythms (76) 
(Fig. 2). In summary, SCN pacemaker cells provide critical coordination of steady-state 
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circadian oscillations of cell function in target tissues.  Yet, before SCN cells can 
coordinate circadian rhythms outside the brain, SCN cells must themselves be entrained.  
Input/entrainment pathways. Detailed anatomical examination of the mammalian 
photoentrainment pathway has revealed mechanistic principles regarding how light 
governs entrainment of the SCN. Light stimulates irradiance-sensitive ganglion cells in 
the inner retina. These cells transmit photic signals to the SCN by means of the 
retinohypothalamic tract (RHT). Specifically, RHT fibers pass through the optic nerve 
and optic chiasm to form mono-synaptic connections with target cells within the 
ventrolateral SCN. Retinorecipient cells in the SCN then integrate and disseminate photic 
information to other cells in the SCN to facilitate entrainment of SCN pacemaker cells. 
These three basic components, the retina, retinohypothalamic tract (RHT), and 
retinorecipient cells residing within the ventrolateral region of the SCN, are essential for 
photoentrainment (40, 65) (Fig. 2).   
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Fig. 2. The mammalian entrainment pathway and circadian timing system. )The 
circadian locus in mammals resides in the suprachiasmatic nuclei (SCN) of the 
anterior hypothalamus. RHT fibers extending from the retina to the ventrolateral 
SCN function to transmit entraining signals to the SCN. Environmental signals are 
also transmitted to the intergeniculate leaflet in the thalamus. The intergeniculate 
leaflet and the Raphe nuclei indirectly modulate the entrainment of the SCN clock. 
Signals transmitting temporal information to the SCN clock mechanism function 
as inputs that synchronize the SCN clock with the external environment. Once 
entrained, the SCN transmits temporal information to other regions of the brain 
and body through output pathways. The SCN clock as well as many aspects of 
physiology affected by SCN outputs exhibit the formal properties of circadian 
rhythmicity. SCN output pathways, some of which are presumably rhythmically 
regulated, may feedback to modulate SCN activity. Rat brain drawing adapted 
from van Esseveldt et al., 2000 (152, used with permission). 
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Retinal ganglion cells are critical. Recent studies support the role of type III 
ganglion cells as the primary retinal photoreceptors involved in mammalian circadian 
photoentrainment (55). These cells reside in the ganglion cell layer of the inner retina and 
are distinguished from other ganglion cells in that they are intrinsically light-sensitive and 
express melanopsin, a photoreceptive molecule similar to the opsins expressed in rod and 
cone cells (55). Primary evidence for the role of melanopsin in mammalian 
photoentrainment is derived from genetic lesion studies (115, 134). Genetic ablation of 
the melanopsin (Opn4) gene in mice significantly impairs their photoentrainment as 
melanopsin  (Opn4-/-) mice exhibit a 40% attenuation in their phase shifting responses of 
circadian locomotor activity in response to light pulses. Because circadian photo-
responsiveness is not completely abolished in melanopsin (Opn4)-deficient animals, 
redundant photoentrainment mechanisms likely exist (134, 115). This notion is further 
supported by two critical observations: 1) in rats, SCN neurons exhibit spectral 
sensitivities and firing patterns in compliance with the photoreceptive properties of rods 
and cones and 2) in mice lacking rods and most of their cones, SCN cells still exhibit the 
expression of the light-induced immediate early gene c-fos. (3). 
The RHT. The RHT is a critical anatomical component in the mammalian 
timekeeping system. Transection of the RHT at the level of the ventrolateral SCN 
abolishes circadian photoentrainment (65). RHT fibers arise from the retina to innervate 
the rostral-to-caudal extent of the ventral SCN with the greatest density of contralateral 
neural connections occurring in the rostral third of the SCN (1). The monosynaptic 
projections of the RHT are thought to arise from melanopsin-containing retinal ganglion 
cells as transgenic animals expressing the marker gene LacZ in place of melanopsin show 
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LacZ expression in ganglion cell bodies and their afferent projections to retinorecipient 
cells in the SCN (55). Yet, it is speculated that these and other ganglion cells may project 
RHT fibers to other regions of the hypothalamus including the subparaventricular zone, 
preoptic, retrochiasmatic, and tuberal regions as well as the thalamic intergeniculate 
leaflet (1, 66, 119). An important indicator of RHT function is the expression of the 
immediate early gene c-fos in retinorecipient cells of the SCN (71). Several types of 
retinorecipient cells in the ventrolateral SCN express c-fos in response to brief light 
pulses (22, 35).  
RHT neurotransmitters. Glutamate and pituitary adenylate cyclase activating 
peptide (PACAP) are the primary neurotransmitters of the RHT that are responsible in 
communicating photic signals to SCN cells. Glutamate and PACAP co-localize in RHT 
fibers that terminate in the retinorecipient field of the SCN where SCN cells express 
receptors for glutamate (NMDA and AMPA) and PACAP (PAC1) (52, 99, 41, 51). 
Functional evidence for the role of these neurotransmitters in the RHT is supported by the 
observations that, similar to light, glutamate and PACAP elicit time-dependent phase 
shifts in circadian rhythms in vivo and in vitro (97, 141, 50, 54a). Furthermore, 
pharmacological inhibition of glutamate receptors attenuates light-induced expression of 
c-fos in the SCN; similarly, light-induced c-fos expression in PAC1-deficient mice is 
significantly blunted (51). Thus, multiple lines of evidence suggest glutamate and 
PACAP are critically important for light-induced phase shifting of the SCN clock.  
Other neurotransmitters involved in mediating mammalian photoentrainment 
include the gaseous neurotransmitter nitric oxide and the neuromodulator 5-HT 
(serotonin). Pharmacological inhibition of nitric oxide synthase, the enzyme responsible 
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for the production of NO, blocks glutamate-mediated phase-resetting action of the SCN 
clock (30, 157). Serotonergic innervation arising from the raphe nuclei has also been 
shown to influence the communication of the photic signals within the SCN. Serotonin, is 
thought to play a role in photic regulation of the SCN clock because 5-HT agonists 
directly induce phase shifts or modulate the resetting action of light (94a, 89, 126, 130). 
Recently, Pickard and co-workers have shown that serotonin can act directly on 
presynaptic 5-HT1B receptors on RHT fibers (118).  
The Suprachiasmatic Nucleus. Primary evidence for the circadian clock function 
of the SCN is derived from seminal lesion studies demonstrating that complete 
destruction of the bilateral SCN abolishes circadian rhythmicity in several behaviors 
(105, 146). And, transplantation of fetal SCN tissue or immortalized SCN cells restores 
behavioral rhythmicity in SCN-lesioned hosts (83, 129, 37, 142). An interesting feature 
of SCN tissue is that SCN transplants can pace formal properties of host circadian 
rhythmicity to match those of the donor SCN (129, 84).  This was definitively shown by 
transplanting SCN tissue derived from Tau mutant hamsters into wild type hosts such that 
the 20-hour period of homozygous (tau/tau) mutant hamsters was conveyed to host 
animals (129). Thus, the SCN can function as an autonomous timekeeper and as a 
pacemaker. These observations are intriguing as not all SCN cells are pacemaker cells.  
Basic cellular properties of the SCN. Some cells within the SCN display the 
capacity to exhibit autonomous oscillations of cell function. This feature is resoundingly 
supported by the observations that individual SCN neurons can exhibit their own unique 
circadian cycles of electrical activity in the absence of synaptic inputs (158, 61). Further 
support is derived from studies showing that SCN pacemaker cells exhibit intrinsic 
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circadian rhythms of cellular metabolism, neuropeptide secretion, and electrical activity 
that persist in the absence of external inputs in situ and in vitro (34, 44, 110, 131, 137). 
Interestingly, not all SCN cells exhibit self-sustained oscillations in their endogenous cell 
functions. Thus, examinations of the morphological, functional, and organizational 
properties of cells within the SCN will provide insight regarding how a consortium of 
oscillator and non-oscillator cells functions as a whole SCN to coordinate circadian 
rhythms throughout the body. 
The SCN is a bi-laterally symmetrical tissue residing ventral to the third ventricle 
in the anterior hypothalamus. The mammalian SCN comprises 8,000 - 10,500 neurons, 
displays a volume of ≈ 0.1 cubic mm, and expresses approximately 25 different 
neuropeptides and neurochemicals (69, 1). At the cellular level, SCN neurons typically 
show soma characterized by invaginated, sometimes paired nuclei, 2-3 dendrites, and 
short thin axons in close apposition to other neurons (69, 1). Many of these neurons 
express one or more neuropeptides. Prominent examples of SCN neuropeptides include 
vasoactive intestinal peptide (VIP), arginine vasopressin (AVP), and gastrin-releasing 
hormone (GRP). Less prominent neuropeptides include somatostatin, neurotensin, 
angiotensin II, and galanin (1). The functional importance of the neuropeptide VIP in the 
rhythmic properties of the SCN has been demonstrated in animals deficient in the 
expression of the VIP receptor VPAC2.  Genetic ablation of VPAC2 disrupts the intrinsic 
rhythms of the SCN and overt circadian rhythms of behavior (28, 54). Glial cells are also 
found throughout the SCN. An interesting observation is that astrocytes that express glial 
fibrilary acidic protein (GFAP) are predominantly found along side neurons expressing 
gastrin-releasing hormone in the ventrolateral SCN (151a). The importance of this glial 
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distribution is not known; however, Munekawa and co-workers (2000) suggest that in 
young rats, the developing RHT may promote the establishment of GFAP-containing 
astroglial cells in the ventrolateral subdivision of the SCN (108). 
Current research findings indicate that the unique rhythm properties of the SCN 
are derived in part from its organization (48). Several lines of evidence indicate that the 
SCN is compartmentalized. Neuronal fibers arising from the retina pass through the 
retino-hypothalamic tract to innervate the ventrolateral region of the SCN.  This region 
houses neurons rich in VIP and GRP and has been called the ventrolateral “core.” This 
core subdivision of the SCN also receives fibers containing neuropeptide Y and 5-
HT/serotonin, indicative of projections arising from the intergeniculate leaflet and raphe 
nuclei, respectively (1). In contrast to the SCN core, neurons in the dorsomedial region of 
the SCN are smaller, more densely packed, and exhibit strong AVP immunoreactivity 
(106, 69). This region has been called the SCN ‘shell.’ The ventrolateral core and shell 
subdivisions show distinct properties in the expression of genes, proteins, and rhythms of 
behavior. For example, in hamsters, a subnucleus of the SCN critically important in the 
maintenance of circadian behavioral rhythms has also been identified. This region shows 
the expression of the calcium-binding protein calbindin, a pattern of clock gene 
expression distinct from either the ventrolateral core or the dorsomedial shell, and is 
required for the transmission of circadian rhythms of behavior (48, 161, 85). 
Consequently, the organization of pacemaker cells as well as non-pacemaker cells within 
the SCN likely provide the SCN with its distinctive capacity to transmit temporal cues to 
other tissues and propagate rhythms of behavior. 
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Outputs from the SCN. Outputs from the SCN coordinate circadian rhythms of 
physiology throughout the body and propagate rhythms of behavior (for review see 69).  
These output signals are transmitted by neuronal connections and humoral factors (Fig.s 
2 and 3). Neuronal connections extend to both hypothalamic and extra-hypothalamic 
regions of the brain. Of the hypothalamus, the subparaventricular zone, the preoptic, 
supraoptic, and ventral medial nuclei are regions receiving SCN innervation (1). 
Extrahypothalamic regions innervated by SCN fibers are less clear because the small 
diameter of SCN axons makes their tracing difficult (69, 1). However, direct or indirect 
connections with the paraventricular nuclei, lateral septal nuclei, medial forebrain bundle, 
raphe nuclei, and superior cervical ganglion have been indicated. Furthermore, some 
subdivisions of the SCN show distinct neuronal projections to specific brain regions (1) 
(Fig. 3). Recently, Abrahamson and Moore (2006) have shown that some of the brain 
regions targeted by SCN efferents including the subparaventricular zone (SPVZ), the 
dorsomedial nucleus (DMN), and the posterior hypothalamic area-tuberomammillary 
nucleus (PHA-TMN) are responsible for transmitting rhythmic waking behavior in 
rodents (2). However, humoral factors secreted from the SCN also function in conveying 
temporal information to extra-SCN cells in the brain and tissues throughout the body. 
This notion is supported by two important research observations derived from asking the 
question if neural connections arising from the SCN were even necessary in transmitting 
behavioral rhythmicity, i.e. LeSauter et al., 1996 and Silver et al., 1996 (84, 143). The 
former two studies demonstrated that transplanted micropunches of SCN tissue (‘SCN 
islands’) or SCN tissue encapsulated in a permeable bio-polymer could restore circadian 
rhythms of behavior in arrhythmic SCN-lesioned animals (84, 143).  While these studies 
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showed neuronal connections were not required for the maintenance of behavioral 
rhythms, non-neuronal or humoral factors sufficient for the maintenance of these rhythms 
remained unclear. 
Some progress has been made in identifying humoral output signals secreted by 
the SCN.  However, most of these signals show limited roles in propagating circadian 
rhythms of behavior. Transforming growth factor alpha (TGF-α) is secreted from the 
SCN and functions in light-mediated suppression of locomotor rhythms (Weitz and co-
workers, 73). While no obvious role has been found for TGF-α in transmitting 
behavioral rhythmicity in constant darkness, genetic ablation of the TGF-α receptor 
epidermal growth factor receptor (EGFR) does disrupt the precision the 24-hour 
locomotor rhythm and intracranial administration of TGF-α suppresses activity during 
the day (73, 145). A better understood SCN-specific humoral factor is Prokeneticin 2 
(PK2). PK2 has been shown to be an output signal secreted by the SCN and it is 
necessary to propagate rhythms of behavior. Qualifying PK2 as a bona fide output is the 
observation that PK2 is not required for the SCN to exhibit intrinsic rhythms of 
endogenous cell function (24). Prokineticins signal via orphan G-protein linked receptors 
that regulate calcium mobilization, phosphoinostitide turnover, and activation of MAP 
Kinase pathways (24). Furthermore, Prokineticin 2, like Tgf-α is rhythmically expressed 
in the SCN and its receptors are expressed in SCN target tissues (24). Thus, the secretory 
and rhythmic properties of potential SCN output signals can be used to identify candidate 
substances involved in communicating phase information to sites outside the SCN. 
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Fig. 3. Organization of the SCN and its prominent projections in the brain. Based upon 
histological and immunocytochemistry analyses of coronal SCN sections, the SCN 
exhibits regional distinctions in the morphology of neurons and in the expression of 
neuropeptides. Tightly packed neurons in the dorsomedial SCN “shell” express 
predominantly AVP whereas loosely–packed neurons in the ventrolateral “core” express 
mostly arginine vasopressin; VIP, vasoactive intestinal polypeptide; GRP, gastrin-
releasing peptide; NPY, neuropeptide Y; and 5-HT, serotonin (A). Based on histological 
examinations of SCN efferents, the SCN extends projections to several hypothalamic 
regions and proximal zones including the PVH, paraventricular hypothalamic nucleus; 
PVT, paraventricular thalamic nucleus; VMH, ventromedial hypothalamic nucleus; 
MPN, medial preoptic nucleus; paraventricular thalamic nucleus; AVPe, anteroventral 
periventricular nucleus; OVLT, organum vasculosum lamina terminalis; vLS, ventral 
lateral septum; SPVZ, subparaventricular zone; DMH, dorsomedial hypothalamic 
nucleus; and PHA-TMN, posterior hypothalamic area-tuberomammillary nucleus. 
Acronyms shaded in red indicate projections that arise predominantly from the 
dorsomedial SCN. Recently, Abrahamson and Moore (2006) demonstrated that SCN 
efferents to the SPVZ regulate rhythms in rest-activity (waking) behavior via projections 
to the DMH and PHA-TMN, fibers known to extend to the brain cortex (B). 
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Molecular clockworks of the SCN. Recent genetic dissection of the SCN circadian 
clock has revealed that the molecular core of the timekeeping mechanism consists of 
mammalian orthologs of the Drosophila clock genes. Specifically, Period1 (Per1), Per2, 
Cryptochrome1 (Cry1), Cry2, and Bmal1 (Mop3) have been implicated as core elements of 
the molecular clockworks responsible for the generation of mammalian circadian rhythms 
based on evidence indicating that mutation or knockout of these genes in mice alters or 
abolishes the circadian rhythm of activity (163, 131, 132). In mammals, these genes form 
interlocking transcription-translation feedback loops similar to those observed in fungal and 
fly circadian clocks (163) (Fig. 4). BMAL1 and CLOCK are thought to form heterodimers 
and activate the transcription of the Per and Cry genes by binding to the E-box (CACGTG) 
domains on the promoters of these genes. In the cytoplasm, PER and CRY proteins 
accumulate, bind to each other as homo- or hetero-dimers, and translocate to the nucleus 
where they bind to BMAL1:CLOCK to negatively regulate their own transcription. The 
retinoic-related orphan nuclear receptor gene (ROR-alpha/ Rev-erb alpha) (148, 113, 125) is 
also thought to be involved in mediating the inhibitory effects of Cry and Per on the 
transcriptional activation of Bmal. The differential expression of core clock genes over the 
course of the circadian cycle is necessary for appropriately timed progression through the 
self-sustained feedback loops (Fig. 4). In turn, the circadian clock mechanism coordinates 
downstream rhythmicity in the expression of other genes controlling diverse biochemical, 
cellular, and physiological processes within the SCN (69). These clock-controlled genes are 
not essential for normal circadian function, but some presumably couple the clock 
mechanism to SCN-specific output signals that regulate rhythmicity in other neural substrates 
or endocrine organs.  
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Fig. 4. Molecular clockworks in the SCN. PERIOD proteins, PER1-3, form either homo- 
or heterodimers with PER or with CRY1 or CRY2 that inhibit the expression of the per 
gene. These dimers enter the nucleus and inhibit the CLK/BMAL1 complex that 
normally stimulates per expression via E-box binding. CRYs can also inhibit per 
transcription without the presence of PER. PER and PER/CRY dimers have a similar 
negative effect on the expression on CRY and, perhaps, also on other clock-controlled 
genes (CCGs). Rev-erbα, not pictured, is thought to be a common target of the positive 
and negative components of the clock mechanism. Rev-erbαis thought to regulate the 
expression of Bmal1 (125). 
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Peripheral oscillators. While previous dogma espoused that SCN cells are 
uniquely capable of generating endogenous molecular rhythms, recent studies 
demonstrate that many other tissues, e.g. heart, liver, and kidney, or cell lines show 
circadian oscillations of gene expression (139, 164, 160, 147, 114, 67). Studies using in 
vitro models have shown well-matched findings indicating that peripheral or non-SCN 
cells are also capable of expressing clock gene rhythms. Several fibroblast cell lines 
including rat-1 and NIH/3T3 fibroblasts show oscillating gene expression for 2-3 cycles 
when pulsed with a stimulus such as serum shock or forskolin. This molecular 
rhythmicity in peripheral tissues in vivo and in cultured fibroblasts is not restricted to core 
clock elements, but includes clock-controlled genes such as D-element binding protein 
(DBP) and Rev-erb α. Recently, circadian oscillations in the expression of the core-clock 
gene Per2 have been observed in liver, lung, heart, and other tissues extracted from SCN-
lesioned animals (162). These findings indicate that a common cellular program for 
circadian timekeeping is prevalent throughout the body and functional even in the 
absence of SCN, suggesting the notion that the circadian clockworks provide local time at 
the cellular level. Despite the similarity in the oscillatory nature of the core clockworks, 
peripheral oscillators and non-SCN cells do not exhibit functional properties equivalent 
to the SCN. SCN cells, not fibroblasts, restore circadian behavior when transplanted into 
arrhythmic SCN-lesioned hosts in vivo and also confer metabolic and molecular 
oscillations to co-cultured cells via the secretion of an unknown diffusible signal (8, 10). 
Collectively, these findings raise important questions regarding why the molecular 
clockworks found in SCN cells do not transmit similar pacemaker function to non-SCN 
cells. 
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Summary and critical questions. In mammals, the suprachiasmatic nuclei (SCN) 
of the anterior hypothalamus function as a master clock that regulates overt circadian 
rhythms throughout the organism (69). The SCN clock is also capable of producing self-
sustained circadian oscillations in many of its intrinsic molecular and cellular activities. 
SCN cells are marked by circadian regulation of neuropeptide secretion, cellular 
metabolism, and electrical activity in vivo and in vitro (43). Although the SCN is vital to 
the function of the mammalian circadian system, the expression and rhythmic regulation 
of these core clock genes are not spatially confined to this neural locus. Circadian 
rhythms in gene expression are a common property of the pacemaker in the mammalian 
suprachiasmatic nucleus (SCN), oscillators in peripheral tissues, and stimulated 
fibroblasts in vitro. Despite this similarity in the circadian regulation of the canonical 
clockworks, only SCN cells are capable of functioning as a pacemaker that drives 
oscillations in co-cultured cells and restores behavioral rhythmicity when transplanted 
into SCN-lesioned hosts. These observations provoke three critical questions in the field 
of circadian timing: 1) How are SCN oscillators that comprise the master clockwork in 
mammals different from (and perhaps similar to) peripheral oscillators?; 2) If cells in 
peripheral tissues express all the core components of the SCN clockwork, why are 
peripheral oscillators incapable of generating self-sustained high-amplitude circadian 
rhythms of cell function and functioning as a pacemaker by communicating rhythmicity 
to other cells?; and 3) What output signals are used to synchronize multiple autonomous 
clock neurons in the SCN?  
Rationale. Our current knowledge of the molecular organization of the 
mammalian circadian clockwork is lacking in an understanding of the molecular 
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substrates that provide the SCN with endogenous rhythms of gene expression and 
metabolism and the capacity to synchronize rhythms of gene expression in other cells 
outside the SCN. While peripheral oscillators and non-SCN cells do exhibit molecular 
oscillations of the canonical clock genes, these cells do not possess functional properties 
equivalent to the SCN. For instance, oscillations of clock gene expression can be induced 
via serum-shock in NIH/3T3 fibroblasts but these cells still lack the capacity to 
rhythmically metabolize glucose (8, 10). The most parsimonious explanation is that the 
SCN circadian clock produces output signals that are distinct from the outputs of 
peripheral circadian oscillators, albeit similar facets of circadian regulation are expected 
as the expression of core clock genes is wide spread throughout the body. To explore 
these issues, we have developed an immortalized line of rat SCN cells (SCN2.2) that 
retains the endogenous oscillatory and pacemaker properties of the SCN in vitro and in 
vivo.  SCN2.2 cells are capable of intrinsically generating self-sustained rhythms of 
metabolism and clock gene expression, of imposing these oscillations on cocultured 
fibroblasts, and of restoring behavioral rhythmicity when transplanted into SCN-lesioned 
hosts (36, 37, 8, 10). In the absence of other neural and endocrine inputs, the SCN2.2 
model may provide a unique opportunity to ultimately examine how the molecular clock 
imposes oscillatory properties on SCN cellular physiology and downstream oscillators 
(fibroblasts). In light of these observations, we hypothesize that 1) a major distinction 
between the circadian properties of SCN2.2 cells and the oscillatory behavior of 
stimulated fibroblasts is that fibroblasts may not express critical circadian pacemaker 
outputs found in SCN cells and 2) some of these SCN outputs may also function to 
synchronize SCN clock neurons.  
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This thesis describes experiments designed to identify 1) circadian genes – genes that 
show endogenous rhythmicity in their expression within the suprachiasmatic nucleus 
(SCN) and 2) pacemaker genes – candidate genes encoding outputs or intrinsic 
components of the SCN pacemaker.  
Will global characterization reveal overlapping patterns of circadian-regulated gene 
expression in SCN2.2 cells and the rat SCN? 
Specific Aim 1. Because SCN2.2 cells display circadian and pacemaker functions 
characteristic of the rat SCN, we hypothesized that global characterization of gene 
expression in the rat SCN and SCN2.2 cells would reveal overlapping patterns of 
circadian gene regulation. 
Do forskolin-pulsed NIH/3T3 cells exhibit patterns of global gene expression unique to 
peripheral oscillators when compared to rat SCN and SCN2.2 pacemaker models? 
Specific Aim 2. Because, peripheral oscillators lack pacemaker properties but 
display rhythms of clock gene expression, we hypothesized that forskolin-pulsed 
NIH/3T3 cells would exhibit different patterns of clock-controlled gene expression 
relative to those found in the rat SCN and SCN2.2 cells. We predicted that functional 
classifications would reveal some genes with circadian profiles in the rat SCN and 
SCN2.2 cells, but not NIH/3T3 cells, that may play a role in pacemaker output pathways, 
especially those genes involved in cellular communication.   
Does perturbation of candidate gene expression in SCN2.2 cells alter the capacity of 
SCN2.2 cells to drive rhythms of clock gene expression and metabolism in NIH/3T3 
cells? 
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Specific Aim 3. We hypothesized that the perturbation of candidate gene(s) 
identified in Specific Aims 1 and 2 would alter the capacity of SCN2.2 cells to drive 
rhythms of metabolism and gene expression in NIH/3T3 cells. We predicted that 
knock-down of a candidate gene will alter the capacity of SCN2.2 cells to convey 
rhythmic properties to co-cultured NIH/3T3 cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 24
CHAPTER II 
CIRCADIAN PROFILING OF THE TRANSCRIPTOME IN 
IMMORTALIZED RAT SCN CELLS* 
INTRODUCTION 
 Many organisms, ranging from cyanobacteria to humans, have evolved circadian 
clock mechanisms that provide for the rhythmic organization of internal biological 
processes so as to approximate the 24-hour time course of the daily solar cycle (45, 120). 
In mammals, the master clock responsible for the regulation of circadian rhythms 
throughout the body is located in the suprachiasmatic nuclei (SCN) of the anterior 
hypothalamus (69). Complete lesions of the SCN abolish circadian rhythmicity in a wide 
array of molecular, biochemical, endocrine and behavioral processes (104) and 
transplantation of fetal SCN tissue restores behavioral rhythmicity in SCN-lesioned hosts 
(129). Consistent with the timekeeping function of the SCN, many of its cellular 
activities and functions oscillate independent of environmental or external input. 
Circadian rhythms of gene expression, cellular metabolism, neuropeptide secretion, and 
neural activity are intrinsic to the SCN in vivo and persist following isolation of SCN 
cells in vitro (34, 44, 110, 131, 137).  
 The SCN clock mechanism consists of interlocked transcription-translation 
feedback loops in which the gene products of core components rhythmically suppress 
their own transcription or the expression of other clock genes. Clock, Period1 (Per1),  
 
______________________ 
*Used with permission. Menger GJ, Kim L, Thomas T, Cassone VM, and Earnest 
DJ. Circadian profiling of the transcriptome in immortalized rat SCN cells. Physiol 
Genomics 21: 370-81, 2005. 
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Per2, Cryptochrome1 (Cry1), Cry2, and Bmal1 (Mop3) have been identified as core 
elements of the molecular clockworks in the SCN based on evidence indicating that 
mutation or knockout of these genes in mice alters or abolishes circadian behavior (132). 
In turn, these core elements of the molecular clockworks coordinate downstream 
rhythmicity in the expression of other genes controlling diverse biochemical, cellular and 
physiological processes within SCN cells. Some of these clock-controlled genes 
presumably couple the clock mechanism to SCN-specific output signals that regulate 
rhythmicity in other neural substrates or endocrine organs. 
 Despite our current understanding of the molecular organization of the mammalian 
circadian clock, important questions remain with regard to how the core clock 
mechanism regulates clock-controlled genes in SCN cells and how these genes are 
configured in biochemical pathways so as to generate SCN outputs that synchronize or 
coordinate rhythmicity in other cells and tissues. We used an immortalized line of rat 
SCN cells (SCN2.2) to explore these issues because these cells retain many of the 
circadian properties of the SCN in vitro and in vivo. SCN2.2 cells are capable of 
endogenous, self-sustained rhythmicity, and of functioning as a pacemaker by imposing 
rhythmic properties upon co-cultured cells and by restoring behavioral rhythmicity when 
transplanted into SCN-lesioned hosts (8, 10 36, 37). In the absence of other neural and 
endocrine inputs, the SCN2.2 model also provides an opportunity to ultimately examine 
how the molecular clock imposes oscillatory properties on SCN cellular physiology. 
Using Affymetrix GeneChips, the transcriptome in SCN2.2 cells collected at 6-hour 
intervals over two circadian cycles was profiled and then compared to the temporal 
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patterns of gene expression observed in the rat SCN. This profiling of rhythmic gene 
expression was used to determine: 1) whether global properties of the rat SCN 
transcriptome are conserved in SCN2.2 cells; 2) the extent to which the transcriptome is 
rhythmically regulated by the circadian clock in SCN2.2 cells; and 3) whether 
rhythmically-regulated genes in SCN2.2 cells show similar patterns of expression in the 
rat SCN. Bioinformatic tools were applied to characterize the functional distribution of 
clock-controlled genes in SCN2.2 cells and their configuration within metabolic and 
signaling pathways. 
MATERIALS AND METHODS 
 SCN2.2 cultures and RNA extraction. For each of three biological replicates, 
SCN2.2 cells (passages 15 and 16) were seeded on laminin-coated culture dishes (60mm; 
Corning, Corning, NY) and maintained at 37°C and 5% CO2 in Minimum Essential 
Medium (MEM) supplemented with 20% FBS, 3000 µg/ml glucose and 292 µg/ml L-
glutamine. At 48-hour intervals, the medium was changed and cultures were split at 1:3 
or 1:4. Prior to experimental analysis, cultures were plated on multiple 6-well plates 
(35mm) coated with poly-D-lysine and laminin. At approximately 24 and 44 hours after 
plating, the culture medium was changed so as to respectively reduce the FBS 
concentration to 10% and then to 5%.  To facilitate cell cycle and circadian clock 
synchronization across cultures, cells were subjected to medium replacement and 
exposed to serum-free medium (Neurobasal medium supplemented with 3000 ug/ml 
glucose, 292 ug/ml L-glutamine and 1X B-27 serum-free supplement) containing 15µM 
forskolin (Calbiochem, La Jolla, CA) for 2 hours. Cultures were rinsed and thereafter 
maintained in serum-free Neurobasal medium with supplements. At the conclusion of the 
 27
forskolin treatment, cells were harvested from individual 6-well plates (approximate 
density = 9.5 x 104 cells/cm2) at 6-hour intervals for 48 hours and total cellular RNA was 
extracted using RNAeasy Midi-Kit protocols (Qiagen, Valencia, CA). RNA extracts from 
individual samples were treated with on-column DNase-I digestion and concentrated with 
sequential ethanol precipitations.  
 Rat SCN and RNA extractions. Adult male Long-Evans rats (175-200g; N=45) 
(Harlan Laboratories, Indianapolis, IN) were housed 2-3 per cage and maintained in the 
vivarium at the Texas A&M University System Health Science Center under a standard 
12h light:12h dark photoperiod (LD 12:12; lights-on at 0600 hr). At 1800 hr (circadian 
time [CT] 12), animals were exposed to constant darkness (DD) and 12 hours later (0600 
hr or CT 0), sacrificed under isoflurane anesthesia by decapitation at 6-hr intervals (N=5) 
for 48 hours using an infrared viewer. After the eyes were removed in the dark, SCN 
tissue was immediately dissected as described previously (34) under dim light, frozen in 
liquid nitrogen, and stored at –800C. SCN tissue from individual animals was separately 
homogenized in TRIzol reagent (Invitrogen, Carlsbad, CA) by aspiration through a 25-
gauge needle and then extracted total cellular RNA for all 5 animals at each timepoint 
was pooled into a single sample. RNA samples were subjected to on-column treatment 
with DNAse-I to digest genomic DNA and then stored at –80°C.  
 Affymetrix GeneChip analysis. Prior to microarray analysis, the quality of all 
SCN2.2 and rat SCN RNA samples was assessed by electrophoresis on 1% agarose gels 
containing 0.1µg/ml ethidium bromide. Experimental procedures including double 
stranded cDNA synthesis and biotinylated cRNA preparation were conducted according 
to protocols described in the Affymetrix GeneChip Expression Analysis Technical 
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Manual (82). Briefly, first strand cDNA was reverse transcribed from 15µg of total RNA 
using 600U of SuperScript II Reverse Transcriptase (Invitrogen) in a 20µl total volume 
containing T7-(dT)24 primer, 10mM DTT, 500µM of each dNTP, and 1X first-strand 
cDNA buffer for 1 hour at 42°C.  Second-strand cDNA was synthesized in 1X reaction 
buffer containing 200µM of each dNTP, 10U DNA ligase, 40U DNA polymerase I, and 
2U of RNase H (final volume = 150µl) for 2 hours at 16°C. Samples were then treated 
with 20U of T4 DNA polymerase for 5 minutes at 16°C and incubated in 10µl of 0.5M 
EDTA. Double-stranded cDNA was purified with Phase Lock Gel Electrophoresis 
(Eppendorf Scientific, Inc., Westbury, NY) and phenol/chloroform extraction followed 
by ethanol precipitation. Biotin-labeled cRNA was subsequently produced using 
BioArray HighYield RNA Transcript Labeling Kit (Affymetrix, Inc., Santa Clara, CA).  
Labeled cRNA was spin-purified (Qiagen) and fragmented. To assure the quality of 
labeling and fragmentation efficiency, unfragmented and fragmented cRNA products 
were analyzed on an Agilent 2100 bioanalyzer prior to hybridization on arrays. 
Fragmented biotinylated cRNA (15µg) was hybridized on Affymetrix GeneChip rat 
U34A arrays at 45°C and 60rpm in a GeneChip Hybridization Oven 640 (Affymetrix, 
Inc.) for 16 hours. 
 Following hybridization, arrays were washed and stained using Affymetrix 
protocols for antibody amplification staining on a GeneChip Fluidics Station 400 in 
conjunction with Affymetrix Microarray Suit 5.0 software. After a brief wash with a non-
stringent buffer, the stained signals on the array were then amplified with a solution 
containing 3µg/ml anti-streptavidin biotinylated antibody (Vector Laboratories, 
Burlingame, CA), 1X morpholine ethane sulfonic (MES) buffer, 2mg/ml acetylated BSA, 
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and 0.1mg/ml normal goat IgG for 10 min followed by a second staining with 
streptavidin phycoerythrin (SAPE) for 10 min at 25°C.  After a final wash with a 
stringent buffer, the probe array was scanned at the excitation wavelength of 570 nm 
using an Agilent GeneArray Scanner (Palo Alto, CA).  
 After scanning, each image was first checked for major chip defects or 
abnormalities during hybridization as a quality control. Arrays were scanned using a 
global scaling strategy in which the average absolute signal intensity of all arrays was set 
to an arbitrary target signal intensity of 500 prior to uploading into GeneSpring 6.1 
software (Silicon Genetics, Redwood City, CA).  
 Data processing and global analyses. GeneChip signal intensity data from three 
biological replicates of SCN2.2 cells and two technical replicates of the rat SCN derived 
from separate aliquots of pooled RNA samples were uploaded into GeneSpring 6.1 and 
filtered in an identical fashion. For each GeneChip probe set, signal intensities were 
converted to Log base 2 values and then normalized to the 50th percentile of all 
measurements. Experimental averages of normalized data were calculated for each of 9 
time points in SCN2.2 cells and for each of 8 time points in the rat SCN. The data were 
then sequentially filtered at three levels. To verify gene expression, we filtered the probe 
sets according to two criteria: 1) detection of a “Present” flag in 55% or more of the time 
points and 2) a raw signal intensity value of ≥50 which was above the average 
experimental background signal in 55% or more of the time points. In both SCN2.2 cells 
and the rat SCN, the temporal profiles of genes surpassing these expression criteria were 
filtered to isolate those showing stable expression. Stable genes were distinguished by 
temporal expression profiles that did not differ statistically (Standard correlation value: 
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p>0.995) from a flat line created with the GeneSpring 6.1“Draw Gene” tool. Finally, 
cycling genes with a peak-to-trough difference of 1.5-fold or greater and periodicities of 
18-30 hours were identified among the remaining transcripts using methods similar to 
those described previously (26, 93). The normalized data were cross-correlated (p>0.90) 
with cosine waves of specific phase and period using the PRISM software package 
(GraphPad, San Diego). For SCN2.2 cells, we imposed an additional requirement that 
circadian-regulated transcripts show at least one pair of non-overlapping standard errors 
bars between time points with the highest and lowest values. The analytical and 
amplitude criteria used to identify cycling transcripts in both SCN2.2 cells and the rat 
SCN are consistent with those applied in recent microarray studies profiling circadian 
gene expression (2, 13, 43, 65). Because our filtering parameters excluded some 
transcripts that were readily detectable in our and/or other analyses of the rat SCN, we re-
analyzed the normalized data using secondary expression criteria that identified genes 
with a raw signal intensity of ≥50 which was above the average experimental background 
signal in at least four of the time points in SCN2.2 cells and three or more of the time 
points in the rat SCN. Microarray data have been deposited in the National Center for 
Biotechnology Information's (NCBI) Gene Expression Omnibus (GEO) database 
(Accession Numbers GSE1654 and GSE1673). 
 Bioinformatics and validation. Because some genes surpassing circadian 
expression filters were represented by multiple probes on the RG-U34A GeneChip, we 
used GeneSpring 6.1, GenMAPP 1.0 & 2.0 freeware (29, 31) and bioinformatic tools 
available as links from the National Center for Biotechnology Information (NCBI) (109, 
127), including Basic Alignment Search Tool (BLAST) (11), to identify unique genes 
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with rhythmic patterns in SCN2.2 cells.  To corroborate rhythmicity in SCN2.2 cells, 
cycling genes were compared with those found in the rat SCN. For a limited set of clock 
and clock-controlled genes, quantitative PCR (qt-PCR) was also used to validate 
rhythmic expression in SCN2.2 cells. Per2, Bmal1, Nos2, and the calcium channel 
subunit α1C are primary examples of cycling genes that were validated by qt-PCR.  
Quantification of relative mRNA abundance was performed using TaqMan or SYBR-
Green real-time PCR technology (Applied Biosystems, Inc. [ABI], Foster City, CA). To 
generate single-strand cDNAs, total cellular RNA (1-2µg) was reverse transcribed using 
Superscript II (Invitrogen) and a primer mixture of oligo-dTs and random hexamers. 
Using the cDNA equivalent of 50ng of total RNA, triplicate aliquots of each sample were 
then PCR amplified in an ABI PRISM 7700 sequence detection system (56). The 
following probes and primers were designed using PrimerExpress software (ABI):  
rPer2 forward: 5'-TTCGACTACCTGCATCCAAAAG-3'  
rPer2 reverse: 5'-AAGTCCAGTCTTCGCATCGAT-3' 
rBmal1 forward: 5'-CCAAGAAAGTATGGACACAGAC-3' 
rBmal1 reverse: 5'-GCATTTTTGATCCTTCCTTGGT-3' 
rCry1 forward: 5'-CTGGCGTGGAAGTCATCGT-3' 
rCry1 reverse: 5'-CTGTCCGCCATTGAGTTCTATG-3' 
Id-1 forward: 5'-TGGTCTGTCGGAGCAAAGC-3' 
Id-1 reverse: 5'-TCCTTGAGGCGTGAGTAGCA-3' 
Nos2 forward: 5'- ACCCGACTGAAGCACTTTGG-3' 
Nos2 reverse: 5'-TCGTTGGGAGTGGACGAAG-3' 
α1C (Rob2) forward: 5'-CCGGAAGCCAGTGCATTTT-3' 
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α1C (Rob2) reverse: 5'-TGGTGAAGATCGTGTCATTGAC-3'  
α1C (Rob2) probe: 5'-FAM-CCAAACAACAGGTTCCGCCTGCAGT-TAMRA-3' 
α1A forward: 5'-GGATGACAACACCGTTCACTTC-3' 
α1A reverse: 5'- CCACCCTTTGCGATTTTGAT-3'  
α1A probe: 5'-FAM-TGGCTCTGATCCGAACCGCCC-TAMRA-3'  
α1G forward: 5'-CCTGCCTGTTGCCGAGAG-3'  
α1G reverse: 5'-CAGGAGACGAAACCTTGACTGA-3'   
α1G probe: 5'-FAM-CGGCCTATATCTTTCCTC-TAMRA-3'  
CypA forward: 5'-TGTGCCAGGGTGGTGACTT-3'  
CypA reverse: 5'-TCAAATTTCTCTCCGTAGATGGACTT-3' 
To control for differences in sample RNA content, 18S ribosomal RNA (rRNA) was 
amplified and multiplexed in the same reaction with target genes or amplified in separate 
cDNA aliquots (50ng) from the same RNA samples using the Ribosomal RNA Control 
Reagent Kit (VIC Probe, ABI). For normalization of the clock genes, Per2, Bmal1, and 
Cry1, rRNA or cyclophilin A (CypA) mRNA was amplified using the cDNA equivalent 
of 1ng total RNA. In both multiplex and conventional reactions, the relative mRNA 
abundance for a given target gene was calculated by normalization to corresponding 
rRNA or cyclophilin levels in each sample using the comparative CT method described in 
the ABI Prism 7700 Sequence Detection System User Bulletin #2 (PE-ABI). Values for 
the same target gene (amplicon) were adjusted for inter-assay variation according to ABI 
protocols. Relative abundance of target mRNA was represented as a percentage of the 
maximal value obtained within an individual experiment. 
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RESULTS AND DISCUSSION 
 Global properties. We separately examined temporal regulation of the 
transcriptome in SCN2.2 cells and in the rat SCN so as to compare global and specific 
facets of gene expression between these two experimental models. The breadth of gene 
expression was similar in SCN2.2 cells and the rat SCN. In SCN2.2 cells, 3993 out of the 
8,800 probes sets on the rat U34A GeneChip. For mRNA from the rat SCN 2929 probe 
sets surpassed stringent expression criteria (Table 1). Comparison of probe sets detected 
in both models with those in only the rat SCN indicates that SCN2.2 cells express 83% of 
the genes detected in the rat SCN (2430 out of 2929). The similarity in the extent and 
level of common gene expression across these experimental models suggests that SCN2.2 
cells retain SCN-like properties with regard to the regulation of genomic activity and the 
functionality of in vivo cellular pathways.  In addition, a wide array of genes was 
regulated in a similar fashion in SCN2.2 cells and the rat SCN. Many of the genes 
common to both models shared analogous patterns of stable or variable expression. 
Cyclin D3, brain-specific protein gene Rb109, and thioredoxin (Txn2) represent 
functionally diverse genes with stable expression in both models (Fig. 5A and 5B). 
Prominent examples of genes with variable expression in SCN2.2 cells and the rat SCN 
include nerve growth induced factor-A (Ngfi-A), metallothionein (Mt1a) and ubiquitin 
carboxyl-terminal hydrolase I (Uchl1). For many of these genes, relative levels of mRNA 
abundance were also comparable between these models.  
 Global circadian regulation. Recent studies profiling the transcriptome in the 
murine SCN have identified ≈100-365 circadian-regulated genes that mediate a wide 
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range of cellular functions (114, 149).  In the present study, a comparable number of 
genes in SCN2.2 cells were distinguished by circadian profiles. Specifically, 162 genes in 
SCN2.2 cells showed circadian rhythms of mRNA abundance that surpassed stringent 
expression criteria (Table 1). The amplitude of these SCN2.2 rhythms in gene expression 
ranged from 1.5 to 12-fold differences between peak and minimum levels of mRNA 
abundance. By comparison, 301 genes in the rat SCN displayed circadian oscillations that 
were identified using the same expression and rhythm criteria. Because 35% of the 
unique genes with rhythmic patterns in SCN2.2 cells surpassing stringent expression 
criteria exhibited similar oscillations in the rat SCN, some of these genes may be critical 
for the circadian clock and pacemaker properties of SCN cells. To screen additional 
genes in SCN2.2 cells with rhythmic profiles that passed secondary expression criteria 
(Table A.1, APPENDIX), we used three different approaches: 1) validation of 
rhythmicity for a limited set of these genes using qt-PCR, 2) comparative analysis to 
determine whether these genes were both expressed based on stringent criteria and 
rhythmically-controlled in the rat SCN, and 3) establishment of a limited homology table 
between the rat U34A and mouse U74A (version 2) GeneChips using GeneSpring 6.1 
(Table 2). Some of the rhythmic genes validated by qt-PCR in this supplementary 
screening analysis include inducible nitric oxide synthase (iNos or Nos2), calcium 
channel Rob2, and Per2 (Fig. 6 and 8). Our homology screen identified 50 homologs or 
functionally-related genes that were rhythmically expressed in murine tissues and 
SCN2.2 cells. Circadian-regulated genes that were identified in SCN2.2 cells and in the 
murine SCN include pericentriolar material 1 (Pcm1), DNA directed RNA polymerase II, 
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the putative chloride channel Clcn4-2, Id3a, Hsp 70 protein 5 (Hspa5) and Snap25 
(Table 2; Fig. 7). An interesting facet of our homology screen is that some genes with  
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Fig. 5. Temporal profiles of representative genes that are stably or variably expressed in 
both SCN2.2 cells (A) and the rat SCN (B). Symbols denote determinations of mRNA 
abundance (n= 3) at 6-hour intervals for Cyclin D3 (■), Rb 109 (●), Txn2 (♦) and Ngfi-A 
(▲). In this and subsequent figures, these values were derived by normalizing GeneChip 
Log base 2 signal intensity to the 50th percentile of all measurements per sample. The 
raw values for the 50th percentile of all measurements per sample are plotted as a black 
line in relation to the secondary ordinant in each panel. Thus, the normalized values 
between 3 and 60 for these genes indicate that their raw values were approximately 3- to 
60-fold greater than those for the 50th percentile.  
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     Comparison of gene expression and function in SCN2.2 cells and the rat SCN. (A) Global facets of gene expression/regulation are 
compared with regard to the number of transcripts that surpassed stringent expression criteria and whether these genes exhibited stable 
or rhythmic expression in SCN2.2 cells, the rat SCN, or both experimental models. For each comparison, the proportion of rhythmic 
genes relative to the total number of genes/probe sets on the GeneChip (8900) is also listed. (B) Rhythmic genes were subdivided into 
seven basic functional categories: 1) Energetics, 2) Cellular and Systems-level Communication, 3) Protein Dynamics, 4) Cellular 
Development, 5) Defense and Detoxification, 6) Cytoskeleton and Adhesion and 7) Unknown or ESTs. In each category, the 
number of cycling transcripts (and proportion relative to the total number of rhythmic genes) is compared between SCN2.2 cells, the 
rat SCN and both experimental models. 
Table 1. Comparison of gene expression and function in SCN2.2 cells and the rat SCN.  
A.  Global facets of gene expression/regulation     
 SCN2.2 cells  Rat SCN Common to both models 
Expressed according to stringent criteria 3993 2929 2430 
Stable genes fulfilling stringent expression criteria 1035 584 185 
Rhythmic genes fulfilling stringent expression criteria 162 301 57 
Percentage of examined genes with rhythmic profiles 1.82% 3.38% 0.64% 
     
B.  Functional Categorization of Rhythmic Genes    
 SCN2.2 cells  Rat SCN Common to both models 
Category 1 - Energetics 24 (15%) 34 (11%) 13 (54%) 
Category 2 - Cellular and Systems-level Communications 49 (30%) 64 (21%) 16 (33%) 
Category 3 - Protein Dynamics 20 (12%) 28 (9%) 5 (25%) 
Category 4 - Cellular Development 13 (8%) 17 (6%) 5 (38%) 
Category 5 - Defense and Detoxification 5 (3%) 10 (3%) 0  
Category 6 - Cytoskeletal and Adhesion 5 (3%) 10 (3%) 0 
Category 7 - Unknown or ESTs 46 (28%) 138 (46%) 18 (39%) 
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Table 2. Functionally-related genes with rhythmic profiles in SCN2.2 cells and murine SCN and/or liver 
A.  Rhythmic genes that surpass stringent expression criteria in SCN2.2 cells 
GenBank ID Locus Link ID Description / Symbol 
AA799672  117042 Ribosomal protein L6 (Rpl6) 
J01435  26196 ATP synthase 8, mitochondrial (mt-Atp8) 
AI171506  24552 Malic enzyme 1 (Me1) 
L20821  81803 Syntaxin 4 (Stx4a) 
AF035822  116500 Synaptosomal-associated protein, 29kD (Snap29) 
U35245  64060 Vacuolar protein sorting homolog (Vps33b) 
D43623  25756 Carnitine palmitoyltransferase 1b (Cpt1b) 
AA892799 LOC298085  Similar to glyoxylate reductase/hydroxypyruvate reductase 
AI177004  29637 Hmgc synthase 1 (Hmgcs1) 
J02585  246074 Stearoyl-Coenzyme A desaturase 1 (Scd1) 
L10152  25648 Solute carrier family 7, member 1 (Slc7a1) 
D89983 and AI043631 58961 Ornithine decarboxylase antizyme inhibitor (Oazi) 
X03347  LOC314174 P75 gag-fos fusion protein / similar to ubiquitin-like protein 
L16764  294254 Heat shock protein 70 1b (Hsp701b/Hspa1b) 
M30581 25391 ATPase, Ca++ transporting, ubiquitous (Atp2a3) 
U38376  24653 Cytosolic phospholipase A2 (Pla2g4a) 
S55427  24660 Peripheral myelin protein 22 (Pmp22) / growth-arrest-specific Gas-3 homolog 
S63521  25617 Heat shock 70kD protein 5 (Hspa5) 
AI236601  LOC288444  Similar to Heat shock protein (Hsp105) 
AA891669  79434 Ras oncogene family (Rab11b) 
U20796  259241 Nuclear receptor subfamily 1, group D, member 2 (Nr1d2) 
L27843  29463 Nuclear protein tyrosine phosphatase (Ptp4a1) 
U95920  81740 Pericentriolar material (Pcm1) 
AF000942  and AI171268  25585 Inhibitor of DNA-binding 3 (Id3) 
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Circadian-regulated genes in SCN2.2 cells that show homology to rhythmic genes reported in the murine SCN and/or liver. Listed are the 
GenBank and Locus Link ID for rhythmic genes in SCN2.2 cells that surpassed stringent (top) or  secondary (bottom) expression criteria and were 
circadian-regulated in the murine SCN and/or liver. Some murine homologs have not been identified in the rat GenBank or Locus Link databases 
and thus are specified as unknown. 
 
Table 2 continued 
B.  Rhythmic genes that surpass secondary expression criteria in SCN2.2 cells 
GenBank ID Locus Link ID Gene descriptor 
AA684929 NF Similar to NADH-ubiquinone oxidoreductase 
AB003991 25012 Synaptosomal-associated protein (Snap25) 
AA818499 298423 Cytochrome P-450, 4a3 (Cyp4a3) / lauric acid omega-hydroxylase 
AA818403 LOC299564 Similar to cytochrome P450 4F5 (Cyp4f5) 
AF035156 117182 Hydroxysteroid 17-beta dehydrogenase 3 (Dhb3) 
AA892512 LOC306750 Similar to LECT2 
S79214 25681 Procollagen type X (Col10a1)  
X74835 54240 Cholinergic receptor, nicotinic, delta polypeptide (Chrnd)  
E12742 LOC305384 / 12425 Similar to cholecystokinin-A receptor OR cholecystokinin A receptor (Cckar) 
L00111  24241 Calcitonin / calcitonin-related polypeptide, alpha (Calca) 
X59608 Close to LOC287438 Similar to DNA directed RNA polymerase II subunit 
Z36944  60586 Putative chloride channel (similar to Mm Clcn4-2) 
NM_011504 114095 Stxbp3 syntaxin binding protein 3 Mm.12155 0.040 9.28 10 
NM_025898 LOC366216 1500039N14Rik RIKEN cDNA/similar to SNAP-beta 
2610317A05 unknown 2610317A05Rik RIKEN cDNA  
2810009D21 unknown 2810009D21Rik RIKEN cDNA  
1190017B18 unknown 1190017B18Rik RIKEN cDNA 
C77032 unknown C77032 EST  none Mm.28726 0.069 11.79 10 
NM_008838 unknown Phosphatidylinositol glycan, class F  (Pigf) 
NM_025933 LOC290999 Similar to 2010110M21Rik RIKEN cDNA 
XM_138272 / XP_138272   LOC366733 Similar to RAP2A 
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Fig. 6. Validation of GeneChip analysis examining circadian gene expression in 
SCN2.2 cells. GeneChip (•, solid line) and qt-PCR (■, dashed line) determinations of 
relative mRNA abundance at 6-hour intervals are compared for (A) inducible nitric 
oxide synthase (iNos or Nos2), (B) Rob2 calcium channel α1C subunit, (C) calcium 
channel α1A, and (D) calcium channel α1G. For GeneChip analysis, determinations of 
relative mRNA were derived by normalizing values for Log base 2 signal intensity to 
the 50th percentile of all measurements per sample. For qt-PCR analysis, the plotted 
values correspond to the ratios of iNos or Nos2, Rob2, calcium channel α1A or calcium 
channel α1G/rRNA mRNA signal in which the maximal value for each experiment was 
set at 100%. GeneChip and qt-PCR values are respectively represented on the primary 
and secondary ordinant in each panel.  
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Fig. 7. Rhythmic regulation of Id3 (□), DNA-directed RNA polymerase II (■), the 
putative chloride channel Clcn4-2 (▲), Hsp 70 protein 5 (●), and Snap-25 (♦) 
expression in SCN2.2 cells. Symbols denote GeneChip determinations of mRNA 
abundance (n = 3) at 6-hour intervals.  The circadian profiles for these genes in SCN2.2 
cells were similar to those observed in the rat SCN (data not shown). 
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Fig. 8. Rhythmic patterns of Per2 (●) and Bmal1 (▲) expression in SCN2.2 cells. 
Symbols denote average values (n=3) for mRNA abundance at 6-hour intervals based 
on normalized GeneChip determinations (solid line) or on qt-PCR validation analysis 
(dashed line). The profile of Cry1 (■) mRNA expression is depicted for comparison. 
The qt-PCR profiles are derived from triplicate analyses of RNA samples at each 
timepoint (n = 3) and the plotted values correspond to the ratios of species-specific 
Per2, Bmal1 or Cry1/rRNA or CypA mRNA signal in which the maximal value for 
each experiment was set at 100%. GeneChip and qt-PCR values are respectively 
represented on the primary and secondary ordinant. 
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circadian patterns in both SCN2.2 cells and the rat SCN such as nerve growth induced 
factor-A (Ngfi-A) and ornithine decarboxylase antizyme inhibitor (Oazi) were 
rhythmically regulated in the murine liver, but not in the SCN (33, 114, 149).  
 To examine the phase of rhythmic genes expressed in SCN2.2 cells, we compared 
their first peak of cyclic mRNA abundance (maxima of normalized signal intensity) in 
relation to the first sampling interval and to the circadian expression profiles of core 
clock genes.  For example, circadian-regulated genes exhibiting maximal mRNA 
abundance during the first sampling interval (hour 0) and recurrent 24-hour peaks 
thereafter were assigned to Phase Group (PG) I. In a similar fashion, rhythmic genes with 
peak mRNA expression during the second (hour 6), third (hour 12) or fourth (hour 18) 
sampling interval were assigned to PG II, III and IV, respectively. Based on both gene 
array and qt-PCR analyses, peak mRNA expression in SCN2.2 cells was observed at hour 
0 and 24 for Per2 and at hour 12 and 36 for Bmal1 (Mop3) (Fig. 8) so the rhythms for 
these clock genes were respectively assigned to PG I and to PG III. Using these 
comparisons, phase was unambiguously assigned to 149 out of 162 genes with rhythmic 
profiles in SCN2.2 cells. Circadian phase could not be clearly assigned to the rhythmic 
patterns of 13 genes due to inconsistencies between experimental replicates and probe 
sets.  In SCN2.2 cells, 56 genes displayed PG I rhythms in which peak mRNA abundance 
coincided with the zenith of Per2 expression whereas 37 genes exhibited PG III 
oscillations in which peak levels were concurrent with the crest of Bmal1 expression. 
Thirty-eight and 18 circadian-regulated genes were identified in PG II and PG IV, 
respectively. The predominant distribution of circadian-regulated genes in SCN2.2 cells 
within phase groups coinciding with peak Per2 or Bmal1 expression is compatible with 
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phase cluster analyses of rhythmic genes in the murine SCN (70). Similarly, 53 and 141 
genes with cycling profiles in the rat SCN showed phase distributions that were 
respectively coincident with the maxima of Per2 or Bmal1 expression. 
Functional analyses of clock-controlled genes in SCN2.2 cells. Consistent with 
recent studies demonstrating that eukaryotic circadian clocks rhythmically regulate the 
expression of genes mediating diverse aspects of cell physiology (14, 23, 26, 32, 114, 69, 
149, 150), SCN2.2 cells exhibited circadian fluctuations in genes with a wide range of 
functions, such as metabolism, immunity, neurotransmission, and development. To 
examine the breadth of cellular processes regulated by the circadian clock, rhythmic 
genes in SCN2.2 cells that surpassed stringent expression criteria were organized 
according to one of seven broad physiological categories: 1) Energetics, 2) Cellular and 
Systems-Level Communication, 3) Protein Dynamics, 4) Cellular Development, 5) 
Defense and Detoxification, 6) Cytoskeleton and Adhesion and 7) Unknown or ESTs 
(Table 1B; Table 2). Based on their application to the 162 rhythmic genes surpassing 
stringent expression criteria in SCN2.2 cells, 15% regulate energetic processes such as 
cellular respiration, fatty acid recycling and steroid synthesis, 30% are involved in 
cellular or systems-level communication, 12% mediate the dynamics of gene expression 
by controlling protein translation, degradation or trafficking, 8% regulate aspects of 
cellular development, 3% are associated with defense and detoxification, 3% affect 
cytoskeletal elements, cellular adhesion or components of the extracellular matrix, and 
28% are ESTs or genes with uncharacterized functions (Table 1B). The prevalence of 
rhythmic genes in the cellular and systems-level communication category may reflect 
their degree of representation on the rat U34A GeneChip (i.e., ≈45% of annotated genes 
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with known functions). However, the distribution of circadian-regulated genes across 
other functional categories was not related to a preferential or exclusive bias on the array. 
Based on analysis using Simplified Gene Ontology lists in GeneSpring 6.1, genes 
involved in energetics, protein dynamics, cellular development, defense and 
detoxification and cytoskeleton and adhesion were respectively represented by ≈7%, 7%, 
20%, 15% and 6% of the probe sets on the array. Within the first four categories, 
rhythmic genes in SCN2.2 cells were further segregated into three or more functional 
clusters. 
 Energetics. The rhythmic regulation of metabolic activity is a hallmark circadian 
property of the SCN. For example, the circadian utilization of 2-deoxyglucose (2DG) is a 
well-documented marker of endogenous rhythmicity in both the rat SCN and SCN2.2 
cells (8, 10, 137). In addition, the SCN exhibits circadian regulation of genes encoding 
transporters for energy metabolites and metabolic enzymes (53, 135). Consistent with this 
evidence for the circadian control of SCN metabolism, 24 genes involved in energetic 
processes showed rhythmic expression profiles in SCN2.2 cells. These genes with 
energetic functions were subdivided into 4 functional clusters: 1) glucose metabolism and 
mitochondrial energy transduction (N=7); 2) lipid and fatty acid metabolism (N=7); 3) 
transporters of energy metabolites (transporters) (N=6); and 4) miscellaneous metabolism 
(N=4) (The table on page 62). Circadian-regulated genes involved in glucose 
metabolism include malic enzyme 1 (Me1), hexokinase 2 (Hk2), and glyoxylate 
reductase/hydroxypyruvate reductase (GenBank #AA892799), an enzyme that mediates 
the conversion of serine to glucose (60). The circadian clock in SCN2.2 cells also impacts 
upon mitochondrial energy transduction through the rhythmic expression of 
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mitochondrial ATP synthase 8 (mt-Atp8). Importantly, circadian regulation of Glut 1 
(Slc2a1), the primary facilitative transporter of D-glucose across the blood-brain barrier 
(94, 156), and Mct1 (Slc16a1), a major transporter of ketone bodies and lactate in glial 
cells (153), was observed in both SCN2.2 cells and the rat SCN. Rhythmically-expressed 
constituents of the miscellaneous metabolism cluster include two genes involved in 
steroidogenesis, 3-hydroxy-3-methylglutaryl-Coenzyme A reductase (Hmgcr) and Hmgc 
synthase 1 (Hmgcs1).  
 To address the question of how clock-regulated genes impose circadian rhythms of 
metabolism on SCN cells, we constructed a GenMAPP of circadian-regulated genes 
identified using stringent expression criteria (29, 31). In SCN2.2 cells, many of the 
rhythmic genes in the Energetics category are critically positioned so as to provide for 
the coupling of metabolic pathways associated with fatty acid recycling and the synthesis 
of cholesterol and poly-unsaturated fats (Fig. 9A) (42). For instance, fatty acid reservoirs 
fueling beta-oxidation in the mitochondria are functionally linked to the citric acid cycle 
by means of acetyl-CoA. In turn, citrate generated in the citric acid cycle can be used to 
form fatty acid acyl-CoAs that can replenish fatty acid reservoirs or contribute to the 
formation of polyunsaturated fats, cholesterol, and, ultimately hormone production. 
Within these pathways, circadian regulation of gene expression was observed in SCN2.2 
cells and validated in the rat SCN at four key points: Carnitine palmitoyltransferase 1b, 
Hmgc synthase 1 and Fatty acid synthase. Because these genes widely impact upon the 
regulation of synthetic, anabolic and catabolic processing of energy substrates, this 
finding suggests that circadian clock regulation of a small number of genes in crucial 
positions may provide effective strategy for transmitting temporal information throughout 
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different networks of cellular metabolism. It is interesting that circadian profiles of these 
strategically positioned genes share a common Phase Group assignment with that for 
Per2. 
 Despite ample evidence in both the present study and previous reports for the 
circadian regulation of genes involved energetic processes and redox status (53, 135), the 
functional significance of these and other metabolic oscillations in the SCN clock is 
unknown. According to a model developed by Pellerin and Magistretti (116), circadian 
clock regulation of transporters for energy metabolites may provide a basis for metabolic 
coupling between glial and neuronal cells within the SCN. During the subjective day, 
increased electrical activity in SCN neurons is associated with the release of the 
excitatory neurotransmitter such as glutamate, which subsequently induces glucose 
uptake and glycolysis in astrocytes. Thus, clock-regulated expression of Glut 1 (Slc2a1) 
and Mct1 (Slc16a1) may play a critical role in the rhythmic transportation of glucose 
across the blood-brain barrier and of lactate produced by astrocytes so as to fulfill the 
circadian metabolic requirements of SCN neurons.  
 Cellular and systems-level communications. Communication of temporal 
information to the rest of the brain and to peripheral tissues is critical function for the 
pacemaker function of the SCN. Rhythms of mRNA expression were identified in 
SCN2.2 cells for 49 genes mediating cellular or systems-level communication. Circadian-
regulated genes in the communication category were subdivided into 5 functional 
clusters: 1) neurotransmission (N=11); 2) extracellular factors (N=3); 3) G-protein 
coupled receptors and associated proteins (N=9); 4) cytosolic signal transduction (N=8); 
and 5) nuclear factors (N=18) (The table on page 62). 
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Fig. 9(a-c). GenMAPP analysis of circadian-regulated information flow in SCN2.2 cells 
in fatty acid and steroid metabolism, cell signaling cascades, and protein dynamics. 
GenMAPP analysis of circadian-regulated genes in SCN2.2 cells depicting their 
distribution in relation to information flow within pathways mediating (A) fatty acid and 
steroid metabolism, (B) G-protein coupled receptor, second messenger, and mitogenic 
signaling cascades, and (C) protein dynamics. Boxes indicate the relative positions of 
circadian-regulated genes surpassing stringent expression criteria. Phase group 
assignments of rhythmic genes and their coincidence with clock gene oscillations are 
denoted as I (Per2), II, III (Bmal1b) and IV. In some instances, no phase group was 
assigned due to inconsistencies between experimental replicates and probe sets. Solid 
lines denote probable interactions among rhythmically-expressed genes or other pathway 
components and/or products arising from these interactions. Dashed lines signify indirect 
or predicted functional interactions between circadian-regulated genes and critical 
elements of these pathways. 
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Fig. 9 continued. 
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 To understand how specific aspects of neurotransmission in SCN cells are 
modulated by the circadian clock, we further classified the rhythmic 11 genes within this 
cluster according to the following subgroups: 1) glutamatergic metabolism and signaling 
(N=4); 2) synaptic function and maintenance (N=4); and 3) miscellaneous 
neurotransmission (N=3) (The table on page 62). The IP3 receptor coupling element and 
immediate early gene Homer1 is an example of a clock-regulated gene associated with 
glutamatergic signaling in SCN2.2 cells and the rat SCN. Two ionotropic AMPA 
receptors genes Gria1 and Gria4 that passed secondary expression criteria (Table A.1) 
displayed circadian fluctuations of mRNA abundance in SCN2.2 cells. Circadian 
regulation of these glutamatergic signaling genes may contribute to the function of this 
neurotransmitter in circadian photoentrainment. Glutamate involvement in the 
transmission of entraining light signals by the retinohypothalamic tract to the SCN is 
supported by immunohistochemical localization of glutamate (21) and different subtypes 
of glutamate receptors within the retinorecipient subfield of the SCN (41, 151) and by 
physiological studies demonstrating that similar to light, glutamate elicits time-dependent 
phase shifts in circadian rhythms in vivo and in vitro (97, 141). In a similar fashion, 
glutamate has been shown to phase shift the SCN2.2 rhythmicity in luciferase-reported 
Ca2+/cAMP response element (CRE) activity (62). In addition to the oscillations in these 
glutamatergic signaling elements, the rhythmic expression of Glut-1 (glutamate 
transporter), Gclc and Got2 may be important in processes by which this neurotransmitter 
mediates the circadian regulation of the SCN clock by light because these genes serve to 
replenish pre-synaptic reservoirs of L-glutamate or to regulate glutamate-based carbon 
fixation and amino acid metabolism. 
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 Rhythmic genes in the synaptic function and maintenance cluster are associated 
with pre- and post-synaptic membranes and include Ykt6, Stx4a, Snap29, and the PSD-
95/SAP90-associated gene Dlgap1. Interestingly, Dlgap1, which possesses guanylate 
kinase activity when functionally expressed, has been implicated in the post-synaptic 
organization of voltage-gated potassium channels and NMDA receptors (111). 
Consequently, the rhythmic expression of Dlgap1 mRNA may reflect a divergent point of 
circadian gene regulation affecting multiple facets of post-synaptic function. Such 
divergent regulation may provide a platform for the intrinsic rhythm of SCN electrical 
activity in vivo and in vitro (44). Circadian rhythms of mRNA expression in SCN2.2 cells 
were also observed for genes that directly affect neuronal electrical properties and 
neurotransmitter production such as the voltage-gated potassium channel Kcng1, the 
inwardly-rectifying potassium channel Kcnj14 and A-2 arylamine N-acetyltransferase 
(Nat1) (The table on page 62). Because rectifying potassium channels are thought to 
contribute to the modulation of cardiac pacemaking (58), circadian regulation of a 
voltage sensitive channel like Kcnj14 may have some significance in the endogenous 
capacity of SCN cells to generate rhythmic patterns of electrical activity.  
 Of the remaining clock-controlled genes in the Cellular and Systems-level 
Communication category, most are G-protein coupled receptors (N=9), cytosolic 
signaling factors and transducers (N=8), or nuclear factors (N=18). To examine how 
temporal information may be transmitted from the cell membrane to the nucleus via these 
clock-regulated genes, we analyzed their functional positions within a GenMAPP 
encompassing G-protein coupled receptor, second messenger, or mitogenic signaling 
cascades (Fig. 9B) (29, 31). G-protein coupled receptors or associated proteins with 
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rhythmic patterns of mRNA expression in SCN2.2 cells included G-protein coupled 
receptor 48 (Gpr48), guanine nucleotide binding protein α12 (Gna12), muscle and 
microspikes RAS (M-ras), and the olfactory-like receptor (Ol1/Olf-r1). Using secondary 
expression criteria, circadian profiles were also observed in SCN2.2 expression of 
somatostatin receptor subtype (Sstr4), cholecystokinin A receptor (Cckar), angiotensin II 
receptor (Agtr2), orexin receptor-1 (Hcrtr1), 5-hydroxytryptamine 5A receptor (Htr5a), 
and the olfactory-like receptors Hfl-vn1, and Tpcr13 (Table A.1). The rhythmic 
regulation of monoamine receptors in SCN2.2 cells is consistent with observations on the 
function of this neurotransmitter system in the SCN in vivo and in vitro. The monoamine, 
serotonin, is thought to play a role in photic regulation of the SCN clock because 5-HT 
agonists directly induce phase shifts or modulate the resetting action of light (89, 126, 
130). 
 Downstream of these G-protein signaling elements, circadian regulation of 
moieties involved in cyclic AMP and MAP kinase signaling pathways in SCN2.2 cells 
may have important functional implications because these pathways are thought to 
modulate the transmission of photic input to the SCN (for review see 95). Circadian-
regulated genes in these signaling pathways such as adenylyl cyclase 3 (Adcy3) and MAP 
Kinase phosphatase 3 (Dusp6 or Mpkp3) may impact upon the regulation of cyclic AMP 
and phosphorelay transduction in SCN2.2 cells (Fig. 9B). By affecting cyclic AMP and 
MAP kinase signaling, the specific distribution of rhythmically-regulated genes within 
these pathways may differentially influence their interactions with other processes and 
thus provide an effective strategy for the circadian gating of SCN responses to input 
signals. CCAAT/enhancer binding protein beta (Cebpb), CREBBP/ EP300 inhibitory 
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protein 1, and activating transcription factor 3 (Atf3), provide representative examples of 
genes that may be circadian regulated as a function of their responsiveness to cyclic 
AMP. 
 Protein dynamics. The regulation of gene expression at the protein level is critical 
for the circadian clock function of the SCN. For instance, cyclical expression of 
translated gene products and post-translational modification are required for the 
appropriately timed progression and function of the self-sustained feedback loops that 
comprise the core clock mechanism (9, 163). Thus, cellular processes influencing protein 
dynamics such as protein synthesis, folding, modification, sorting, trafficking, and 
degradation are likely to have critical roles in the oscillatory properties of the SCN clock. 
Circadian regulation of mRNA levels in SCN2.2 cells was observed for 20 genes 
mediating protein dynamics. Clock-controlled genes in the Protein Dynamics category 
were further subdivided into 3 functional clusters: 1) degradation and synthesis (N=6), 2) 
protein sorting and trafficking (N=4), and 3) protein modification and folding (N=10) 
(The table on page 62). Ubiquitin carboxyl-terminal hydrolase L1 (Uchl1), ribosomal 
protein L6 and L21 (Rpl6 and Rpl21), vacuolar protein sorting homolog (Vps33b), the 
nucleoporin p58/p45, and heat shock 27 protein 1 (Hsp27/Hspb1) are representative 
examples of circadian-regulated genes within these functional clusters.  
 Circadian regulation of genes involved in protein dynamics may ultimately serve to 
resonate temporal information across cellular pathways that are not subject to clock 
control at the mRNA level. To examine this possibility, we used GenMAPP 2.0 to 
determine whether a few circadian-regulated genes involved in protein synthesis, 
degradation, and processing could effectively modulate the flow of temporal information 
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in SCN2.2 cells (Fig. 9C) (29, 31). Circadian oscillations of mRNA expression in 
SCN2.2 cells were observed in processes associated with the 60S ribosomal subunit 
(Rpl6 and Rpl21) and tRNA synthesis (aspartyl-tRNA synthetase [Dars]). Due to their 
location at the apex of pathways in the protein dynamics GenMAPP, rhythmic expression 
of these translation regulatory genes may have significant implications in clock control of 
gene function. Both of the 60S ribosomal genes Rpl6 and Rpl21 interact with the 
initiation complex to form the eukaryotic 80S ribosomal complex (42, 156) and aspartyl-
tRNA synthetase functions as a dimeric enzyme or part of a multi-enzyme complex 
comprising aminoacyl-tRNA synthetases for several amino acids including methionine 
(101). Because more than 4% of the amino acids in rPer2 are aspartyl residues, the 
rhythmic RNA expression of Dars, Rpl6, and Rpl21 could modulate the availability of 
cognate tRNAs as well as the actual ribosomal reading of the mRNA sequences for clock 
and even non-clock genes, thereby imposing oscillations on the activity or function of 
their protein products.   
 In the Protein Dynamics GenMAPP (Fig. 9C), 7 genes associated with chaperone-
like activities or post-translational processing and 4 genes involved in protein turnover 
and/or metabolism showed circadian expression profiles in SCN2.2 cells. 
Hsp701b/Hspa1b, Hsp105, Hsp27/Hspb1, Hspa5/Grp78, and pre-mtHsp70 
(mitochondrial type) are rhythmically regulated genes that encode heat shock proteins 
involved in the folding and targeted-destruction of proteins damaged by stress. Circadian 
regulation of Pmpca and Tcp1 may also contribute to clock control of protein dynamics 
because these genes are involved in post-translational processing of nacent polypeptides 
(68, 92).  
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 SCN2.2 cells also exhibited circadian oscillations in the expression of two genes 
involved in the proteasome targeting pathway, polyubiquitin and an ubiquitin recycling 
enzyme Uchl1. Circadian regulation of Uchl1 could modulate reservoirs of ubiquitin and 
thus influence the proteasome targeting of proteins. Because heat-shock 70 proteins are 
involved in targeting damaged proteins for proteasome-mediated degradation (18), the 
rhythmic regulation of Hsp701b/Hspa1b may contribute in parallel to the regulation of 
protein degradation. The possible role of these and other proteasome targeting genes in 
circadian clock function is supported by the recent finding that mutations of the Slimb 
gene, which functions in the ubiquitin–proteasome pathway, disrupts the circadian 
rhythm of activity in Drosophila (46, 70). It is also interesting that Vsp33b is 
rhythmically expressed in SCN2.2 cells because this gene is thought to facilitate vesicle-
mediated protein trafficking to lysosomes and participate in membrane docking and 
fusion between late endosomal and lysosomal compartments (42). The specific functions 
of Vsp33b and genes involved in proteasome targeting in SCN cells are not known but 
the circadian regulation of these genes may enable the clock to both impose its influence 
across diverse cellular pathways and sustain the feedback loops comprising its core.   
 Circadian regulation of translational, post-translational, and protein degradation 
elements suggests that the modulation of functional gene expression beyond the 
transcriptional level may contribute to dissemination of temporal information across 
cellular networks. For example, by regulating the expression of nuclear pore genes such 
as the nucleoporin p58/p45 and ribosomal genes such as Rpl6 and Rpl21, the circadian 
clock could directly modulate the efficiency of information flow from the nucleus and of 
ensuing polypeptide synthesis. This strategy could establish rhythms of bandwidth 
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necessary to transmit large amounts of information across physiological nodes during 
certain times of the day. Furthermore, circadian regulation of post-translational and 
proteasomal elements could provide node-specific control over the packaging and 
duration of such information volleys. In particular, the rhythmic expression of genes 
encoding heat-shock proteins, components within the ubiquitin-proteasome pathway or 
endosomal/lysosomal elements could impose the influence of time respectively on the 
folding dynamics of newly synthesized (or damaged) polypeptides, half-life of proteins 
targeted for ubiquitin-mediated degradation, and the degradation or recycling of 
extracellular and intracellular constituents.  In this regard, it is noteworthy that peak 
expression of several heat shock related genes including Hsp 105, Hspa5, and 
Hsp701b/Hspa1b occurred at times that would be optimal for influencing PG I rhythms 
which represent the majority of the circadian-regulated genes in SCN2.2 cells. Another 
interesting aspect of this GenMAPP analysis is that protein-processing elements 
responsive to internal stimuli such as glucose could play a role in adjusting how 
information is packaged and presented to specific physiological nodes.  To exemplify this 
possibility, rhythms of glucose metabolism could harmonize information flow by 
modulating the induction of glucose-responsive heat shock proteins such as pre-
mtHsp70/Grp75 and Hspa5/Grp78 (Fig. 9C) (103, 133). Collectively, the rhythmic 
regulation of translational, post-translational, and protein degradation elements are likely 
to have a broad impact upon the functional expression of rhythmic and stable gene 
transcripts.   
 Cellular development. In SCN2.2 cells, rhythmic mRNA expression was observed 
for 13 genes that mediate cellular development. Circadian-regulated genes in this 
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category were subdivided into 3 functional clusters: cell cycle (N=3); 2) DNA/chromatin-
related (N=3); and 3) growth and differentiation (N=7).  
 Organisms ranging from cyanobacteria to mammals display rhythms of cell division 
that are ”gated” by a circadian oscillator (20, 91, 107). The possible impact of the 
circadian clock in the indogenous control of the cell cycle in SCN cells is supported by 
the observation that SCN2.2 cells show rhythmic fluctuations of mRNA abundance in 3 
genes involved in regulating the cell cycle. In SCN2.2 cells, the oscillations of mRNA 
expression observed in rat cyclin E Serine/threonine protein kinase (Pctaire-2) and the 
cell cycle protein p55CDC (Cdc20) (The table on page 62) may serve to couple the 
clock mechanism to the cell cycle. In addition, another element of cell cycle regulation, 
cyclin L1 (Ccnl1), displayed rhythmic RNA expression in the rat SCN. 
 Rhythmic genes within the differentiation and growth cluster in SCN2.2 cells 
included the developmental genes, ornithine decarboxylase antizyme inhibitor (Oazi), 
and interferon related developmental regulator 1 (Ifrd). These genes were also 
rhythmically expressed in the rat SCN. Another developmental gene, Bmp4, was 
rhythmically regulated in SCN2.2 cells. Although the specific functions of this gene 
within the SCN are unknown, Bmp4 has been shown to regulate transcriptional factors, 
some of which are also rhythmically expressed in both SCN2.2 cells and the rat SCN. In 
a variety of cell lines including embryonic stem cells, Bmp4 has been shown to induce 
mRNA expression for immediate early genes such as Ngfi-A (Egr1) and members of the 
Id-gene family that inhibit the binding of basic helix-loop-helix (bHLH) transcription 
factors to DNA (59). The oscillations of these genes in SCN2.2 cells were validated 
either by parallel microarray analysis of the rat SCN or by qt-PCR. 
  
57
 Defense and detoxification. SCN2.2 cells exhibited rhythmic patterns of mRNA 
expression for 5 genes involved in Defense and Detoxification (Tables 1 and 3). 
Circadian-regulated genes in this category include the cell surface antigen (RT1-Aw2), 
p105 coactivator (U83883), an EST displaying similarity to mucin, prostaglandin-
endoperoxidase synthase 2 (Ptgs2) and interleukin 6 receptor (Il6r). Inducible nitric oxide 
synthase (iNos or Nos2) was also categorized in the Defense and Detoxification category 
and represented a prominent example of a rhythmic gene that only surpassed secondary 
expression criteria (Table A.1). Nonetheless, circadian expression of iNos mRNA was 
verified in SCN2.2 cells by qt-PCR (Fig. 6A) and was observed in parallel analysis of the 
rat SCN. Based on evidence indicating that a competitive inhibitor of all 3 isoforms of 
NOS, L-NAME, blocks glutamate- and N-methyl-D-aspartate (NMDA)-induced phase 
shifts of the SCN rhythm in neuronal firing rate in vitro (30, 157), the gaseous 
neurotransmitter nitric oxide (NO) is thought to be involved in the pathway by which 
glutamate mediates the phase-resetting action of light signals on the SCN clock. 
However, in vivo analyses using mutant mice do not appear to support this function for 
NO in the SCN because animals lacking neuronal or endothelial isoforms of Nos (nNos 
and eNos, respectively) show normal circadian entrainment to light-dark cycles and 
phase-shifting responses to light (74, 75). The present evidence for the circadian 
regulation of iNos in both SCN2.2 cells and the rat SCN suggests that this isoform merits 
further analysis to address conflicting observations on NO function in the circadian 
resetting of the SCN clock mechanism by light. 
 Cytoskeleton and adhesion. Five genes with cytoskeletal or cellular adhesion 
functions, integrin α E1 (Itgae), CD44 antigen (Cd44), tissue inhibitor of 
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metalloproteinase 1 (Timp 1), tropomyosin (Tmp1), and Dynamin-like protein (Dnml1) 
exhibited circadian expression profiles in SCN2.2 cells. Circadian regulation in both 
SCN2.2 cells was observed in the expression of 10 additional genes in this physiological 
category that surpassed secondary expression criteria (Table A.1), including Troponin I 
type 3 (Tnni3), vascular cell adhesion molecule 1 (Vcam1), and neural cell adhesion 
molecule 1 (Ncam1). Rhythmic expression of cytoskeletal and cellular adhesion 
constituents within SCN cells is consistent with anatomical and functional evidence for 
SCN oscillations in cellular and synaptic plasticity and their role in regulation of 
circadian rhythms. In the hamster SCN, the distribution of astrocytes expressing glial 
fibrillary acidic protein (GFAP) fluctuates over the circadian cycle and this structural 
rhythmicity may participate in the regulation of extracellular glutamate levels (81). Ncam 
has been specifically implicated in the regulation of SCN circadian function by studies 
demonstrating that transgenic mutant mice lacking different isoforms of this gene and an 
associated glycoprotein that regulates plastic interactions between nerve cells, polysialic 
acid (PSA), are distinguished by activity rhythms with decreased free-running periods 
and altered patterns of light-dark entrainment (140).  
 Summary. The gene profiling analyses in the present study indicate that SCN-like 
global and temporal patterns of gene expression are conserved in the SCN 2.2 
transcriptome. SCN2.2 cells and the rat SCN show similar properties with regard to 
relative levels of mRNA expression for many different genes, oscillations in the 
expression of the core clock genes, Per2, Bmal1 (Mop3), and Cry1, and circadian 
regulation of many clock-controlled genes. Many of these circadian-regulated genes in 
SCN2.2 cells and the rat SCN were homologs or functionally-related genes that exhibit 
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rhythmic expression profiles in the murine SCN and/or liver (114, 149). Despite the 
similarities in circadian regulation of the transcriptome in SCN2.2 cells and the rat SCN, 
there was not complete overlap in the rhythmically-regulated genes between these 
experimental models (Table A.2). Furthermore, the number of genes with circadian 
profiles in SCN2.2 cells was lower than that observed in the rat SCN and described 
previously for the murine SCN (114). It is possible that this inequality in the extent of 
circadian gene expression may be related to comparative differences in the cellular 
heterogeneity of SCN2.2 cells and the SCN in vivo. Although SCN2.2 cells were 
developed as a heterogeneous, rather than clonal, cell line to provide adequate 
representation of most SCN phenotypes especially those with pacemaker properties, the 
immortalization strategy used to establish this line may have inherently selected for or 
against certain cell types. Consequently, circadian, and even global, gene expression may 
be more restricted in SCN2.2 cells because this line does not express the full complement 
of cellular phenotypes found in the SCN due to selection bias in immortalization 
procedures. This possibility is supported by molecular and antigenic analyses indicating 
that the many SCN2.2 cells exhibit SCN-like peptidergic phenotypes but the overall 
proportion of peptidergic neurons in the line is less than that normally found in the SCN 
in situ (36). Alternatively, the diminished extent of circadian-regulated gene expression 
in SCN2.2 cells may reflect the absence of other neural and endocrine inputs that 
normally influence SCN rhythmicity in vivo.  Nonetheless, comparison of circadian gene 
expression in SCN2.2 cells and the rat SCN provides a robust filter for identifying genes 
that are rhythmically regulated by the circadian clock mechanism indigenous to SCN 
cells.   
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 In SCN2.2 cells, genes with circadian profiles were functionally diverse, but were 
most frequently associated with metabolic, cellular and systems-level communication, 
and protein dynamics. The prevalence of rhythmic genes in these categories is consistent 
with studies documenting their importance in the circadian photoentrainment and 
pacemaker functions of the SCN. Furthermore, GenMAPP analysis of rhythmically-
regulated genes involved in fatty acid and steroid metabolism, G-protein coupled 
receptors, second messengers and mitogenic cascades, and protein dynamics has yielded 
insight into how SCN2.2 cells manage information flow so as to modulate input to or output 
from the clock mechanism. In particular, circadian regulation of genes involved in protein 
synthesis and degradation, sorting and trafficking, and modification or folding may 
extend clock control to processes that are not rhythmically orchestrated at the 
transcriptional level. 
 In addition to profiling the extent of circadian expression in SCN cells (Table 3), the 
present analysis may have implications for understanding what molecular elements are 
necessary for the endogenous rhythm-generating and pacemaker properties of the SCN. 
Similar to the SCN in vivo, SCN2.2 cells are distinguished by the capacity to generate 
self-sustained rhythmicity in their own molecular or physiological processes and to 
restore behavioral rhythmicity to the entire animal when transplanted into SCN-lesioned 
hosts (37). Furthermore, these cells are capable of driving rhythms of clock gene 
expression and glucose metabolism in NIH/3T3 cells via the secretion of an unknown 
diffusible signal (8, 10). Although circadian expression of various clock and clock-
controlled genes can be induced in cultures of the rat-1 and NIH/3T3 fibroblasts by 
serum-shock treatment or activation of various signal transduction pathways (4, 15, 16), 
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these cell lines are non-rhythmic in the absence of this stimulatory input or SCN2.2-
derived signals and incapable of conferring this induced oscillatory behavior to other 
cells (8, 10). A possible explanation for the distinctions between the circadian properties 
of SCN2.2 cells and the rhythmic behavior of stimulated fibroblast lines is that fibroblasts 
may not express critical circadian output signals found in SCN cells. Consequently, 
comparison of circadian gene expression in SCN2.2 cells (or the rat SCN) with that in 
cells like NIH/3T3 fibroblasts or with other peripheral tissues, which contain all of the 
known components of the canonical clockworks, may provide an opportunity to identify 
candidate signals that mediate the pacemaking function of the SCN. 
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Table 3. Functional categorization of circadian-regulated genes in SCN2.2 cells (stringent expression 
criteria).   
GenBank ID Locus Link ID Gene descriptor 
Phase 
group
Category 1 - Energetics (24)   
Cluster 1 - Glucose metabolism and mitochondrial energy transduction (7)  
S56464 25059 Hexokinase 2 (Hk2) I 
AI171506 * 24552 Malic enzyme 1 (Me1) I  
K00750 * 25309 Cytochrome c, somatic (Cycs) I  
J01435 * 26196 ATP synthase 8, mitochondrial (mt-Atp8) I  
AA892799 298085 Similar to glyoxylate reductase/hydroxypyruvate reductase II  
M59460 64035 Liver glycogen phosphorylase (Pygl) III 
U21662  94273 
Mannosyl (α-1,6-)-glycoprotein β-1,2-N-acetylglucosaminyltransferase 
(Mgat2) III  
    
Cluster 2 - Lipid and fatty acid metabolism (7)  
J02585 * 246074 Stearoyl-Coenzyme A (CoA) desaturase 1 (Scd1) I  
M76767  50671 Fatty acid synthase (Fasn) I  
D43623  25756 Carnitine palmitoyltransferase 1b (Cpt1b) I  
D90109 * 25288 Long chain fatty acid coenzyme A (CoA) ligase 2 (Facl2) I  
AI030175 LOC301592  Similar to L-iditol 2-dehydrogenase / sorbitol dehydrogenase II 
X57988 * 29534 Peroxisomal membrane protein 3 (Pxmp3) IV  
AJ224120  85249 Peroxisomal membrane protein (Pmp26p or Peroxin-11) IV  
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Table 3 continued  
Cluster 3 - Transporters (6)  
D63834 * 25027 Monocarboxylate transporter (Mct1/Slc16a1) I  
AA799645 * 58971 FXYD domain-containing ion transport regulator 1 (Fxyd1) I-II  
M30581  25391 ATPase, Ca++ transporting, ubiquitous (Atp2a3) III  
L10152  25648 Solute carrier family 7, member 1 (Slc7a1) III  
S68135 * 24778 Glucose transporter / solute carrier family 2,member 1 /  (Glut 1/Slc2a1) III 
AA800202 * 311423 Similar to bicarbonate transporter related protein 1 (Slc4 11) IV  
    
Cluster 4 - Miscellaneous metabolism (4)  
M29249 and X55286 25675 3-hydroxy-3-methylglutaryl-Coenzyme A (CoA) reductase (Hmgcr) I 
AI177004 * 29637 Hmgc synthase 1 (Hmgcs1) I  
X08056 * 25257 Guanidinoacetate methyltransferase (Gamt) II  
L19998 * 83783 Sulfotransferase family 1A, phenol-preferring, member 1 (Sult1a1) III  
    
Category 2 - Cellular and Systems-level Communication (49)  
Cluster 1 - Neurotransmission (11)  
Glutamatergic metabolism and signaling (4)   
J05181 and S65555 25283 Glutamate-cysteine ligase catalytic subunit (Gclc) I-III 
AF093267 * and 
AF093268 *  29546 Homer1 and splice variant 1b, neuronal immediate early gene, 1 (Homer1) IV-I  
AA892012 25721 Glutamate oxaloacetate transaminase 2 (Got2) IV 
S59158 * (X63744 in rat 
SCN) 29483 Glutamate transporter (Glut-1) / solute carrier family 1, member 3 (Slc1a3) IV 
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Table 3 continued   
Synaptic function and maintenance (4)   
AF033027  64351 Prenylated SNARE protein (Ykt6) II  
L20821 * 81803 Syntaxin 4 (Stx4a) II  
U67137  65040 PSD-95/SAP90-associated / guanylate kinase associated protein (Dlgap1) III  
AF035822  116500 Synaptosomal-associated protein, 29kD (Snap29) IV  
Miscellaneous neurotransmission (3)   
AJ003065  276720 Inwardly-rectifying channel, subfamily J, member 14 (Kcnj14) I  
M81784  296395 Voltage-gated channel subfamily G member 1 (Kcng1) III  
U01344 * 116631 A-2 arylamine N-acetyltransferase 1 (Nat1) IV  
    
Cluster 2 - Extracellular factors (3)  
AA850734  and M32167  83785 Glioma-derived vascular endothelial cell growth factor (Vegf) I-IV  
M91595 25662 Insulin-like growth factor binding protein-2 (Igfbp2) III 
X14232  25317 Fibroblast growth factor 1 (Fgf1) III  
    
Cluster 3 - G-protein coupled receptors and associated proteins (9)  
AF061443 286994 G protein-coupled receptor 48 (Gpr48) I  
D89863 25482 Muscle and microspikes RAS (M-ras) I 
D85760  81663 Guanine nucleotide binding protein, alpha 12 (Gna12) II 
AA892635  85428 TC ras-like protein (Tc10) II  
AA891669 79434 Ras oncogene family (Rab11b) II-III 
U53475  266688 GTPase Rab8b (Rab8b) III  
AA893717 315298 Similar to Rac GTPase-activating protein III  
L34074  60451 Olfactory receptor (Ol1/Olf-r1) III-IV 
AF080435 * 64013 Phosducin-like protein (Pdcl/Phlp) IV  
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Table 3 continued  
Cluster 4 - Cytosolic signaling factors and transducers (8)  
L27843 29463 Nuclear protein tyrosine phosphatase (Ptp4a1) I  
AB002086 83809 Phox47 protein (p47) II 
M55075  64508 Adenylyl cyclase, type III (Adcy3) II  
U10188 25515 Polo-like kinase homolog (Drosophila) (Plk) III  
AJ000347 * 64473 3(2),5-bisphosphate nucleotidase (Bpnt1) III  
D88672 25097 Phospholipase D (Pld2) III 
U42627 116663 Dual specificity phosphatase 6 (Dusp6) IV  
U38376 * 24653 Cytosolic phospholipase A2 (Pla2g4a) IV  
    
Cluster 5 - Nuclear factors (18)  
E-box and immediate early factors (10)   
Y00396 24577 V-myc avian myelocytomatosis viral oncogene homolog (Myc) I 
AA892137 LOC311392  Similar to CREBBP/ EP300 inhibitory protein 1 I 
S77528 and X60769 24253 CCAAT/enhancer binding protein, beta (Cebpb) I 
X06769 314322 C-fos oncogene (c-fos) I 
AA875032 * NF Fos-related antigen, exon 4 I  
M63282 * 25389 Leucine zipper protein / Activating transcription factor 3 (Atf3) I  
U09228 * 84382 New England Deaconess E-box binding factor / transcription factor 4 (Tcf4) III  
AF023087 *, U75397 *, 
and and M18416 24330 Nerve growth factor induced factor A (Ngfi-A/Egr1) III-IV 
AA799560 171114 N-myc downstream regulated gene (Ndrg2) III-IV
U78102 * 114090 Krox-20 / early growth response 2 (Egr2) IV  
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Table 3 continued   
Other nuclear factors (8)   
X54250 117140 HIV type I enhancer-binding protein 1 (Hivep1) I 
M65251 * 29721 HIV type 1 enhancer-binding protein 2 (Hivep2) I  
L26292 * 114505 Kruppel-like factor 4 (Klf4) I  
U20796  259241 Nuclear receptor subfamily 1, group D, member 2 (Nr1d2) I  
AF000942 and  
AI171268 * 25585 Inhibitor of DNA-binding 3 (Id3) I  
L23148 * 24370 Inhibitor of DNA-binding 1, splice variant 1d1 II-III 
X84210  25492 Nuclear factor I/A (Nfia) III  
M87634  24370 Forkhead box O1 (Foxo1) IV-I  
    
Category 3 - Protein Dynamics (20)  
Cluster 1 - Degradation and synthesis (6)  
X03347 LOC366649 P75 gag-fos fusion protein / Similar to ubiquitin-like protein I  
AA859882 * 29545 Ubiquitin carboxyl-terminal hydrolase 1 (Uchl1) II  
D16554 192255 Polyubiquitin II  
AA799672  117042 Similar to ribosomal protein L6 (Rpl6) II  
AA849648 * 79449 Ribosomal gene L21 (Rpl21) II  
AI009682 * 116483 Aspartyl-tRNA synthetase (Dars) IV  
    
Cluster 2 - Protein sorting and trafficking (4)  
M15883  116561 Clathrin, light polypeptide (Cltb) II  
AF035951 294286 Kinesin family member, C1 (Kifc1) III 
U44979 171529 Kinesin-related protein 2 (KRP2) III 
U35245 64060 Vacuolar protein sorting homolog (Vps33b) IV  
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Table 3 continued  
Cluster 3 -Protein modification and folding (10)  
AI236601 * Close to LOC288444 Similar to Heat shock protein (Hsp105) I  
S63521  25617 Heat shock 70kD protein 5 (Hspa5/Grp78) I  
L16764 294254 Heat shock protein 70 1b (Hsp701b/Hspa1b) I  
AA875089 25403 Calpastatin (Cast) I-II 
AA900850 24818 T-complex 1 (Tcp1) I-II  
M57728  296588 Mitochondrial matrix processing protease, alpha subunit (Pmpca)   II  
AF056208  65053 PAM COOH-terminal interactor protein 1 (Pamci) IV  
AI176658 and M86389 24471 Heat shock protein 27 protein 1 (Hsp27/Hspb1) II  
AF000899 * 245922 Nucleoporin p58 (p58/p45) III 
S75280 LOC295778 Similar similar to Grp75 (Pre-mtHsp70/Grp75) IV-I 
    
Category 4 - Cellular Development (13)  
Cluster 1 - Cell cycle (3)  
D14015  25729 Rat cyclin E (Ccne) I  
AF052695 64515 Cell cycle protein p55CDC (Cdc20) III 
AB005540  314743 Similar to serine/threonine protein kinase-2 (Pctaire-2) III  
    
Cluster 2 - DNA/chromatin related (3)  
H33461 * 117520 Oxidation resistance 1 (Oxr1) III  
U95920 * 81740 Pericentriolar material (Pcm1) III  
AA964849 * 25591 ADP-ribosyltransferase 1 (Adprt) III  
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Table 3 continued 
Cluster 3 - Growth and differentiation (7)  
AI014163 * 29596 Interferon related developmental regulator 1 (Ifrd) I  
D89983 * and AI043631 58961 Ornithine decarboxylase antizyme inhibitor (Oazi) I  
S55427  24660 
Peripheral myelin protein 22 (Pmp22) / growth-arrest-specific Gas-3 
homolog I  
AF020618 171071 Myeloid differentiation primary response gene 116 (Myd116) I  
U66471  116679 Cell growth regulator (Cgr19) II  
Z22607 25296 Bone morphogenic protein 4 (Bmp4) II  
AF087037 54230 B-cell translocation 3 (Btg3) IV  
    
Category 5 - Defense and Detoxification (5)  
M58587 24499 Interleukin 6 receptor (Il6r) I 
M10094  24737 MHC class I cell surface antigen / RT1 class Ib gene (RT1-Aw2)   II  
U83883 64635 p105 coactivator (U83883) II  
AA891054 NF Similar to human mucin II  
S67722 29527 Prostaglandin-endoperoxide synthase 2 (Ptgs2) III 
    
Category 6 - Cytoskeletal and Adhesion (5)  
AF020046 83577 Integrin alpha E1 (Itgae) I 
M61875  25406 CD44 antigen (Cd44) I  
AI169327 116510 Tissue inhibitor of metalloproteinase 1 (Timp1) I 
AA875132  24851 Tropomyosin 1 (Tpm1) III  
AF020212  114114 Dynamin-like protein (Dnml1)  IV  
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Table 3 continued 
ESTs and Genes with Unknown Function (46)  
AA892598 * LOC294523 Similar to hypothetical protein MGC46970 I 
AI008131 LOC296217 S-adenosylmethionine decarboxylase (SamDC) I  
AA799637 EST  I 
AA799721 LOC315096  I 
AA799971 * LOC313369  I 
AA800156 * LOC310071  I 
AA800708 * LOC295310  I 
AA800853 * LOC305302  I 
AA859996 * LOC305436  I 
AA892638 * EST  I 
AA892863 * close to LOC295922  I 
AA963449 * Close to Cyp51  I 
AI011706 EST  I 
AI639039 * EST  I 
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Table 3 continued 
AA874889 Close to Unc5h2  I 
AA800693 * Close to 83578  I 
AA892137 EST  I 
AA893230 EST  II 
AA891054 EST  II 
AB000929 81828 Zona pellucida 2 glycoprotein (Zp2) II  
AA891499 LOC317360  II 
AA799497 EST  II 
AA799571 LOC291710  II 
AA799711 LOC288264  II 
AA799732 LOC303794  II 
AA800200 * LOC298426  II 
AA800735 EST  II 
AA800782 * LOC294082  II 
AA859626 LOC306352  II 
AA893260 close to LOC293779  II 
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Table 3 continued 
AA894259 * LOC304206  II 
AI639148 * LOC292262  II 
AI639425 LOC287133  II 
AA874876 
Very close to 
LOC306194  II 
AA859926 EST  III 
AA874827 EST  III 
AA875037 EST  III 
AA875348 LOC287598  III 
AA891774 LOC300983  III 
AA892339 LOC299262  III 
AI639097 * EST  III 
AI639413 * LOC307334  III 
H33614 EST  III 
H31604 EST  III 
AA800882 EST  IV 
AA874943 * EST  IV 
    
     Functional categorization of circadian-regulated genes in SCN2.2 cells. Listed are the GenBank, Locus Link ID, functional 
category/cluster and Phase Group assignment for unique genes and ESTs that surpassed stringent expression criteria and displayed 
circadian oscillations of mRNA expression in SCN2.2 cells. Rhythmic genes are segregated into seven broad functional categories: 1) 
Energetics, 2) Cellular and Systems-level Communication, 3) Protein Dynamics, 4) Cellular Development, 5) Defense and 
Detoxification, 6) Cytoskeleton and Adhesion and 7) Unknown or ESTs. Several of these categories are subdivided into clusters to 
further delineate gene function. The asterisk denotes genes that were rhythmic in SCN2.2 cells and the rat SCN. 
 
  
72  
CHAPTER III 
CIRCADIAN PROFILING OF THE TRANSCRIPTOME IN NIH/3T3 
FIBROBLASTS: COMPARISON WITH RHYTHMIC GENE 
EXPRESSION IN SCN2.2 CELLS AND THE RAT SCN* 
 
INTRODUCTION 
Circadian clocks have evolved as endogenous biological timekeeping mechanisms 
that coordinate a wide range of biological processes with the 24-hour period of the daily 
solar cycle. In mammals, the suprachiasmatic nuclei (SCN) of the anterior hypothalamus 
function as a master clock that regulates overt circadian rhythms throughout the organism 
(69). The SCN clock is also capable of producing self-sustained circadian oscillations in 
many of its intrinsic molecular and cellular activities. SCN cells are marked by circadian 
regulation of neuropeptide secretion, cellular metabolism, and electrical activity in vivo 
and in vitro (44, 137). Moreover, recent gene profiling studies indicate that up to 10% of 
the transcriptome is rhythmically expressed in the SCN in vivo and in immortalized rat 
SCN cells (114, 98). These endogenous molecular oscillations in the SCN are a critical 
property of the clock mechanism and presumably its output signals that regulate circadian 
rhythmicity in other cells or tissues. Specifically, the SCN timekeeping mechanism 
consists of interlocking feedback loops in which the core components, Bmal1 (Mop3),  
____________________ 
*Used with permission. Menger GJ, Allen GC, Neuendorff N, Nahm SS,Thomas TL, 
Cassone VM, and Earnest DJ. Circadian profiling of the transcriptome in NIH/3T3 
fibroblasts: comparison with rhythmic gene expression in SCN2.2 cells and the rat SCN. 
Physiol Genomics. Epub. 2007. 
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Period1 (Per1), Per2, Cryptochrome1 (Cry1), Cry2 and Rev-erbα, are rhythmically 
regulated through mutual interactions with their protein products. In turn, the molecular 
feedback loops involving these genes coordinate downstream rhythmicity in SCN-specific 
output genes that mediate clock-controlled oscillations in other neural or endocrine tissues.  
Although the SCN is vital to the function of the mammalian circadian system, the 
expression and rhythmic regulation of these core clock genes are not spatially confined to 
this neural locus. Instead, oscillations in the same genes forming the molecular core of the 
SCN clockworks occur widely in many peripheral cells and tissues (139, 164, 160). 
Studies using in vitro models have yielded compatible evidence indicating that peripheral 
or non-SCN cells are also capable of expressing clock gene oscillations. Rat-1 and 
NIH/3T3 fibroblasts exposed to serum shock or forskolin treatment are similar to 
immortalized cells derived from the rat SCN (SCN2.2) with regard to rhythmic 
fluctuations in clock gene mRNA abundance (15, 4, 8, 9, 10). However, this similarity in 
the oscillatory nature of core clock elements does not provide for equivalent functional 
properties because SCN cells have the capacity to act as pacemakers whereas peripheral 
tissues and cultured fibroblasts do not. For example, SCN2.2 cells, but not fibroblasts, 
restore circadian behavior when transplanted into arrhythmic, SCN-lesioned hosts in vivo 
(37) and also confer metabolic and molecular oscillations to cocultured cells via the 
secretion of an unknown diffusible signal (8, 10). Collectively, these findings raise the 
important question of why the molecular machinery found in the SCN and SCN2.2 cells 
does not propagate similar pacemaker function in fibroblasts. 
A potential explanation is that SCN output signals necessary for its function in 
coordinating rhythmicity among individual clock cells and in downstream oscillators may 
not be expressed or circadian-regulated in stimulated fibroblasts. In the present study, we 
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explored this possibility by analyzing global and circadian facets of gene expression in 
NIH/3T3 fibroblasts. Using Affymetrix GeneChips, the transcriptome in forskolin-
stimulated fibroblasts was profiled at 6-hour intervals over two circadian cycles and then 
compared to the patterns of gene expression observed in SCN2.2 cells and the rat SCN 
(98). This comparison of the NIH/3T3 and SCN transcriptomes was used to identify the 
extent of overlap and fundamental differences in their basic expression and circadian 
regulation of specific genes. Using bioinformatic tools, we next examined the functional 
distribution of both non-rhythmic and circadian-regulated genes that were found only in 
forskolin-stimulated NIH/3T3 fibroblasts or in SCN2.2 cells and the rat SCN. Because 
SCN-specific rhythms of gene expression were especially evident within pathways 
associated with intercellular communication and glucose metabolism, we probed 
implications of this information in differentiating candidate signals for the synchronization 
of SCN clock cells or pacemaker regulation of circadian rhythmicity in other cells. Based 
on evidence for the role of nitric oxide (NO) in resetting the SCN clock (30, 157) and the 
present observation that the inducible isoform of nitric oxide synthase (iNos or Nos2), an 
isozyme involved in NO production, is rhythmically expressed in the rat SCN and SCN2.2 
cells but not in NIH/3T3 fibroblasts, this diffusible messenger was targeted for 
supplementary analysis examining the effects of pharmacological inhibition on the 
endogenous oscillatory and circadian pacemaker functions of SCN2.2 cells. Specifically, 
we used our coculture model to determine whether treatment of SCN2.2 cells with the 
NOS inhibitor, NG-nitro-L-arginine methyl ester (L-NAME) alters their capacity to 
rhythmically regulate 2-deoxyglucose uptake and confer this rhythmicity to untreated 
NIH/3T3 fibroblasts.  
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MATERIALS AND METHODS 
NIH/3T3 cultures and RNA extraction. For each of three biological replicates, 
NIH/3T3 cells (passages 4 and 5) were seeded on culture dishes (60mm; Corning, Corning, 
NY) and maintained at 37°C and 5% CO2 in Dulbecco’s Minimum Essential Medium 
(DMEM; Invitrogen, Carlsbad, CA) supplemented with 20% fetal bovine serum (FBS; 
HyClone, Logan, UT), 3000 µg/ml glucose and 292 µg/ml L-glutamine.  At 48-hour 
intervals, the medium was changed and cultures were expanded 1:3 or 1:4. Prior to 
experimental analysis, cultures were plated in multiple T-75 flasks. At approximately 24 
and 44 hours after plating, the culture medium was changed so as to respectively lower the 
FBS concentration to 10% and then to 5%.  To facilitate cell cycle and circadian oscillation 
synchronization across cultures, cells were subjected to medium replacement and exposed 
to serum-free medium (DMEM) containing 15uM forskolin (Calbiochem, La Jolla, CA) 
for 2 hours. Cultures were rinsed and thereafter maintained in serum-free DMEM. 
Immediately after forskolin treatment, cells were harvested from individual flasks 
(approximate density: 1.3 x 106 cells/cm2) at 6-hour intervals for 48 hours and total 
cellular RNA was extracted using RNeasy Midi-Kit protocols (Qiagen, Valencia, CA).  
RNA extracts from individual samples were treated with on-column Dnase-I digestion and 
concentrated with ethanol precipitations.  
Affymetrix U74v2 GeneChip analysis. Prior to analysis, the quality of all NIH/3T3 
RNA samples was assessed by electrophoresis on 1% agarose gels containing 0.1ug/ml 
ethidium bromide.  Labeled cRNAs were produced from purified RNA collected at each 
time-point and hybridized on mouse U74v2 GeneChips. Experimental procedures 
including double-stranded cDNA synthesis and biotinylated cRNA preparation were 
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conducted according to recommended protocols described in Affymetrix GeneChip 
Expression Analysis Technical Manual (82) and processed as previously described for 
microarray analysis of SCN2.2 cells and the rat SCN (98). To assure the quality of labeling 
and fragmentation efficiency, unfragmented and fragmented cRNA products were analyzed 
on an Agilent 2100 bioanalyzer prior to hybridization on arrays. Fragmented biotinylated 
cRNA (15µg) was hybridized on Affymetrix GeneChip mouse U74 version 2 arrays at 
45°C and 60rpm in a GeneChip Hybridization Oven 640 (Affymetrix, Inc., Santa Clara, 
CA) for 16 hours. 
Following hybridization, arrays were washed and stained using Affymetrix protocols 
for antibody amplification staining on a GeneChip Fluidics Station 400 in conjunction with 
Affymetrix Microarray Suit 5.0 software. After a brief wash with a non-stringent buffer, 
the stained signals on the array were then amplified with a solution containing 3µg/ml anti-
streptavidin biotinylated antibody (Vector Laboratories, Burlingame, CA), 1X morpholine 
ethane sulfonic (MES) buffer, 2mg/ml acetylated BSA, and 0.1mg/ml normal goat IgG for 
10 min followed by a second staining with streptavidin phycoerythrin (SAPE) for 10 min 
at 25°C.  After a final wash with a stringent buffer, the probe array was scanned at the 
excitation wavelength of 570 nm using an Agilent GeneArray Scanner (Palo Alto, CA).  
After scanning, each image was first checked for major chip defects or abnormalities 
during hybridization as a quality control. Arrays were scanned using a global scaling 
strategy in which the average absolute signal intensity of all arrays was set to an arbitrary 
target signal intensity of 500 prior to uploading into GeneSpring 7.3 software (Agilent 
Technologies, Palo Alto, CA).  
Data processing and global analyses. GeneChip signal intensity data from three 
biological replicates of NIH/3T3 cells were uploaded into GeneSpring 7.2 and filtered in a 
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similar fashion to that used for SCN2.2 cells (98). For each GeneChip probe set, signal 
intensities were converted to Log base 2 values and then normalized to the 50th percentile 
of all measurements. Experimental averages of normalized data were calculated for each of 
9 time points in NIH/3T3 cells. The data were then sequentially filtered at three levels. To 
verify gene expression, we filtered the probe sets according to two criteria: 1) detection of 
a “Present” flag in 55% or more of the time points and 2) a raw signal intensity value of 
≥50 which was above the average experimental background signal in 55% or more of the 
time points. The temporal profiles of genes surpassing these expression criteria were 
filtered to isolate those showing stable expression. Stable genes were distinguished by 
temporal expression profiles that did not differ statistically (Standard correlation value: 
p>0.995) from a flat line created with the GeneSpring 7.3 “Draw Gene” tool. Finally, 
cycling genes with a peak-to-trough difference of 1.5-fold or greater and periodicities of 
18-30 hours were identified among the remaining transcripts using methods similar to 
those described previously (26, 98, 93). The normalized data were cross-correlated 
(p>0.90) with cosine waves of specific phase and period using the PRISM software 
package (GraphPad, San Diego, CA). In addition, we imposed the requirement that 
rhythmic transcripts show at least one pair of non-overlapping standard error bars between 
time points with the highest and lowest values. The analytical and amplitude criteria used 
to identify cycling transcripts in NIH/3T3 cells are consistent with those applied in 
experimental analyses using cDNA or oligonucleotide arrays to profile circadian gene 
expression (5, 26, 98, 93, 136). Microarray data have been deposited in the National Center 
for Biotechnology Information's (NCBI) Gene Expression Omnibus (GEO) database 
(Accession Number GSE 5810). 
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 To assess the false positive rate for profiling rhythmically expressed genes in our 
analysis, data files were randomized by converting each file to a two-dimensional data 
matrix and then assigning each element of the array a mapped integer key stored in a one-
dimensional array. The one dimensional array of keys was randomized by a perl module 
(List::Utils) utilizing a Fisher-Yates algorithm.  The shuffled keys were read from the array 
and converted to their corresponding location in the data matrix. Data values were then 
read from the data matrix and written to the output file sequentially, producing a 
randomized version of the original data file while maintaining the numerical composition 
of the file. This randomized data was then subjected to the same analytical and amplitude 
criteria used to identify cycling transcripts in the original data sets for NIH/3T3 cells. 
Based on this randomization analysis, we estimate false positive rates of approximately 
21% for NIH/3T3 cells. 
Bioinformatics and validation. Because some genes surpassing circadian 
expression filters were represented on the mouse U74v2 GeneChip multiple times, we used 
GeneSpring 7.3 and bioinformatic tools available as links from the National Center for 
Biotechnology Information (NCBI) (109, 127), including Basic Alignment Search Tool 
(BLAST) (11), to identify unique genes with circadian profiles in NIH/3T3 fibroblasts. To 
compare the expression profiles of specific genes in these fibroblasts with those found in 
SCN2.2 cells or the rat SCN, we identified genes that were commonly represented on the 
mouse (U74v2) and rat (U34a) GeneChips using the “Genome Homology” tool in 
GeneSpring 7.3. For a small subset of clock and clock-controlled genes, quantitative PCR 
(qt-PCR) was used to validate rhythmic expression in NIH/3T3 fibroblasts. Circadian 
expression of genes cAMP responsive element modulator (Crem), fatty acid synthase 
(Fasn), aryl hydrocarbon receptor nuclear translocator (Arnt), fibroblastic growth factor 7 
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(Fgf7), stearoyl CoA desaturase (Scd1), and the transcription factor Sef/If2(Tcf4) and the 
core clock genes Per2, Bmal1 (Mop3), Cry1, was validated by qt-PCR.  Quantification of 
relative mRNA abundance was performed using SYBR-Green real-time PCR technology 
(Applied Biosystems, Inc. [ABI], Foster City, CA). To generate single-strand cDNAs, total 
cellular RNA (1-2µg) was reverse transcribed using Superscript II (Invitrogen) and a 
primer mixture of oligo-dTs and random hexamers. Using the cDNA equivalent of 30ng of 
total RNA, duplicate aliquots of each sample were then PCR amplified in an ABI PRISM 
7700 sequence detection system (56). The following probes and primers were designed 
using PrimerExpress software (ABI):  
mPeriod 2 forward: 5’-ATGCTCGCCATCCACAAGA-3’ 
mPeriod 2 reverse: 5’ -GCGGAATCGAATGGGAGAAT- 3’ 
mCry1 forward: 5'-CTGGCGTGGAAGTCATCGT-3' 
mCry1 reverse: 5'-CTGTCCGCCATTGAGTTCTATG-3' 
mBmal1 (Mop3) forward: 5’-CCAAGAAAGTATGGACACAGACAAA-3’ 
mBmal1 (Mop3) reverse: 5’ - GCATTCTTGATCCTTCCTTGGT-3’ 
Aryl hydrocarbon forward: 5’-GCATGGGCTCACGAAGGT-3’ 
Aryl hydrocarbon reverse: 5’-AACAGGGTCCACGGAGCTAGT-3’ 
cAMP responsive element modulator forward: 5’-GGCTGCTGCCACAGGTG-3’ 
cAMP responsive element modulator reverse: 5’-CACCTTGTGGCAAAGCAGTAGT-3’ 
Fgf7 forward: 5’-AAGGGACCCAGGAGATGAAGA-3’ 
Fgf7 reverse: 5’-TGCCACAATTCCAACTGCC-3’ 
Scd1 forward: 5’-AACACCATGGCGTTCCAAA-3’ 
Scd1 reverse: 5’-GGTGGGCGCGGTGAT-3’ 
CypA forward: 5'-TGTGCCAGGGTGGTGACTT-3'  
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CypA reverse: 5'-TCAAATTTCTCTCCGTAGATGGACTT-3' 
To control for differences in sample RNA content, either cyclophilin A (CypA) mRNA or 
ribosomal RNA (rRNA) was amplified with the cDNA equivalent of 1ng total RNA from 
the same samples. For all reactions, the comparative CT method described in the ABI 
Prism 7700 Sequence Detection System User Bulletin #2 was utilized to calculate the 
relative mRNA abundance for a given target gene. Using this method, the amount of target 
gene mRNA in each sample was normalized first to corresponding CypA mRNA or rRNA 
levels, and then relative to a calibrator consisting of pooled cDNA from multiple samples 
that was analyzed on each reaction plate. Relative abundance of target mRNA was 
represented as a percentage of the maximal value obtained within an individual 
experiment. 
Analysis of circadian phase and gene tree clustering. Consistent with our 
transcriptional profiling analysis of SCN2.2 cells (98), the phase of rhythmic genes in 
NIH/3T3 cells was determined by comparing the first peak of cyclic mRNA abundance 
(maxima of normalized signal intensity) in relation to the first four sampling intervals and 
to the circadian expression profiles of core clock genes. Based on this comparative 
relationship, rhythmically-expressed genes showing peak mRNA abundance during the 
first (hour 0), second (hour 6), third (hour 12) or fourth (hour 18) sampling interval with 
recurrent 24-hour peaks thereafter were respectively assigned to Phase Group (PG) I, II, 
III, and IV. For genes within each phase group, gene tree clustering was used to identify 
clusters of transcripts with similar expression patterns. Genes displaying common 
expression patterns were positioned on nearby branches separated by a distance of 0.02 or 
less using the Gene Tree clustering tool in GeneSpring 7.3. Clustered branches fulfilling 
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this separation threshold were comparatively labeled in relation to the circadian expression 
profiles of clock or other clock-controlled genes within the cluster.   
RESULTS AND DISCUSSION 
Global and circadian properties of gene expression in NIH/3T3 cells. Global 
expression and circadian regulation of the NIH/3T3 transcriptome was examined over two 
cycles. In forskolin-stimulated NIH/3T3 cells, 5,830 (47%) of the 12,500 probe sets on the 
mouse U74v2 GeneChip fulfilled expression criteria. Of these detected probe sets, most 
(94%) displayed either stable (N=2391) or non-circadian (N=3111) patterns of expression 
(Table 4A). Relative to the total number of probe sets, a small proportion (2.6%) 
consisting of 157 unique genes and 166 ESTs or genes of unknown function was 
distinguished by circadian profiles in fibroblasts (Fig. 10). Oscillations in NIH/3T3 
expression profiles for some of these transcripts and the core clock genes Per2, Cry1, and 
Bmal1 (Mop3) were validated by qt-PCR (Fig. 11). For NIH/3T3 rhythms in mRNA 
abundance, the amplitude of differences between peak and minimum levels ranged from 
1.5 to 3.6-fold. The clock genes Per2 and Cry1 were among those oscillations with the 
highest rhythm amplitude in NIH/3T3 cells. The extent of circadian expression in the 
NIH/3T3 transcriptome is consistent with recent studies of serum-treated rat-1 fibroblasts 
(32) and in rat 3Y1 embryonic fibroblasts (47) in which the relative percentage (1-2%) 
and number of rhythmic genes (≈41-85) were similarly low. Based on direct comparisons 
of homologous transcripts, NIH/3T3 cells showed only a limited set of rhythmically-
expressed genes in common with serum-treated rat-1 fibroblasts (10%) and embryonic 
fibroblasts (15%) (32, 47). Annexin, Rora, Cdk4, Ubiqutin-like protein 4 (Ubl4), histone 
H2a, and RAN GTPase activating protein 1 represent genes with circadian profiles that 
were common among NIH/3T3 cells and these fibroblast lines (Table A.3).   
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     Comparative analysis of gene expression and function in NIH/3T3 cells, SCN2.2 cells, and the rat SCN. (A)  Array type, total 
number of probe sets, global characterization of transcripts fulfilling expression criteria and whether these genes were stably or 
rhythmically expressed in NIH/3T3 cells, SCN2.2 cells, the rat SCN, or in common among all oscillator models. For individual and 
common determinations, the proportion of rhythmic genes relative to the total number of genes/probe sets on the mouse and rat 
GeneChips is also listed. (B) Functional characterization of genes with non-rhythmic expression profiles based on their segregation 
into seven basic categories: 1) Energetics, 2) Cell Communication (including neurotransmission genes), 3) Protein Dynamics, 4) 
Cellular Development, 5) Defense and Detoxification, 6) Cytoskeleton and Adhesion, and 7) Unknown or ESTs. In each 
category, the number of non-rhythmic transcripts (and percentage relative to the total number of functionally annotated genes with 
acyclic profiles) is compared between NIH/3T3 cells, SCN2.2 cells, the rat SCN and all experimental models.    
Table 4. Comparison of gene expression and function in NIH/3T3 fibroblasts, SCN2.2 cells and the rat 
SCN. 
A.  Global facets of gene expression/regulation  
 NIH/3T3 SCN2.2 SCN Common  
Array Type mouse U74v2 rat U34A rat U34A  
Total Probe sets 12500 8800 8800 2255 
Probe sets passing expression criteria 5830 3993 2929 413 
Stable genes fulfilling stringent expression criteria  2391  520   584 60 
Rhythmic genes fulfilling stringent expression criteria 323 162 301 4 
Percentage of examined genes with rhythmic profiles 2.6% 1.8% 3.4% 0.2% 
B.  Functional categorization of non-rhythmic genes 
 NIH/3T3 SCN2.2 SCN Common  
Category 1 - Energetics 
55  
(2.6%) 
37  
(3.9%) 
32  
(5.3%) 
10  
(6.2%) 
Category 2 - Cell Communication (including Neurotransmission) 
455  
(21.7%) 232 (24.2%) 178 (29.3%) 
30  
(18.5%) 
Category 3 - Protein Dynamics 
241  
(11.5%) 
45  
(4.7%) 
16  
(2.6%) 
5  
(3.1%) 
Category 4 - Cellular Development  
1082 (51.6%) 
547 (57.2%) 331 (54.5%) 
108  
(66.7%) 
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Fig. 10. Venn diagram comparing circadian expression of homologous or functionally 
related genes in NIH/3T3 cells with that reported for rat-1 (32) and rat 3Y1 fibroblasts 
(47). Specific genes with rhythmic profiles in NIH/3T3 cells and rat 3Y1 or rat-1 
fibroblasts are listed in Table A.3. For each fibroblast line the percentage of rhythmic 
gene expression in proportion to the total number of genes or probe sets examined is 
denoted in parentheses.  
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The overlap in circadian gene expression between NIH/3T3 and rat-1 fibroblasts 
was especially evident within cell signaling genes associated with the Ras/MAPKinase 
pathway (32). The limited degree to which the circadian regulation of specific genes was 
common among NIH/3T3, rat-1, and rat 3Y1 embryonic fibroblasts may reflect 
differences in experimental analysis across these studies, including the developmental 
and/or species-specific origin (mouse verses rat) of these lines, the type of stimulus used 
to induce rhythmicity (forskolin versus serum shock), specific criteria for identifying 
rhythmicity, sampling interval and duration of analysis and the array type (Affymetrix or 
cDNA). The narrow scope and overlap of fibroblast oscillations in gene expression 
reported in this and previous studies are similar to that found among peripheral tissues in 
vivo (33). Collectively, these observations support the view that circadian regulation of 
the transcriptome is largely cell- or tissue-specific so as to provide for the local 
coordination of important processes associated with their distinct functions. 
Circadian phase and gene tree analyses. Based on comparisons of first peak of cyclic 
mRNA abundance in relation to the sampling intervals during the initial cycle (see 
Methods), rhythmic genes in NIH/3T3 cells were distributed across all phases of the 
circadian cycle. The circadian patterns and phase distributions of the clock genes Per2 
and Bmal1 (Mop3) and several other rhythmic transcripts were corroborated by qt-PCR 
(Fig. 11). In NIH/3T3 fibroblasts, peak mRNA levels were observed at hour 0 and 24 for 
Per2 and at hour 12 and 36 for Bmal1 (Mop3) so the profiles for these clock genes were 
respectively categorized as PG I and PG III oscillations. Of the 323 rhythmically-
expressed unique genes or ESTs in NIH/3T3 fibroblasts, 238 exhibited PG I oscillations 
in which peak mRNA abundance coincided with the zenith of Per2 expression whereas 
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23 exhibited PG III oscillations in which peak levels were contemporaneous with the 
crest of Bmal1 expression. The remaining groups of 25 and 37 transcripts with circadian 
profiles were distributed in PG II and IV, respectively.  
Rhythmically-expressed transcripts were analyzed further using gene tree 
clustering to determine whether the full temporal profiles were similar among a number 
of genes within each phase group. Within each phase group, clusters of rhythmic genes 
with similar expression profiles were assigned to a common branch. Gene lists of 
transcripts contained in these clusters are available at 
http://genenet.tamu.edu/servlet/GSWG. An interesting ramification of this analysis is that 
the specific temporal patterns of expression differ even among core clock components 
and other rhythmic genes with coincident peaks of mRNA abundance and thus common 
phase designation.  
Functional analyses of non-rhythmic and circadian gene expression in 
NIH/3T3 cells. To assess how fundamental cellular processes are differentially expressed 
in forskolin-stimulated NIH/3T3 fibroblasts, the Gene Ontology lists in GeneSpring 7.3 
were used to separately organize non-circadian and clock-controlled genes according to 
seven broad functional categories: 1) Energetics, 2) Cell Communication, 3) Protein 
Dynamics, 4) Cell Development, 5) Defense and Detoxification 6) Cytoskeleton and 
Adhesion and 7) Unknown or ESTs. Of the 5,502 detected probe sets with non-
rhythmic expression profiles in forskolin-stimulated fibroblasts, 2,100 functionally-
annotated genes were analyzed in this fashion. Functional categorization of these non-
rhythmic genes revealed that 2.6% control energetic processes (N=55), 1.3% regulate 
aspects of neurotransmission (N=27), 20.4% are involved in cellular communication  
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Fig. 11. Validation of GeneChip analysis examining Clock gene and circadian-regulated  
gene expression in NIH/3T3 fibroblasts. The profiles for GeneChip (λ, solid line) and qt-
PCR (ν, dashed line) determinations of relative mRNA abundance are compared for (A) 
Period 2 (Per2), (B) Cryptochrome 1 (Cry1) (C) aryl hydrocarbon receptor nuclear 
translocator (Arnt), (D) cyclic AMP response element modulator (Crem), (E) stearoyl Co-
enzyme A desaturase 1 (Scd1), and (F) fibroblastic growth factor 7 (Fgf7). For Per2, Cry1, 
Arnt, and Crem (A-D), the plotted values represent the averages (± SEM) of experimental 
replicates (n = 3) whereas individual determinations are shown for Scd1 and Fgf7 (E-F) to 
provide comparison within a given experiment. GeneChip determinations were established 
by normalizing values for Log base 2 signal intensity to the 50th percentile of all 
measurements per sample. For qt-PCR analysis, the plotted values correspond to the ratios 
of Per2, Cry1, Arnt, Crem, Scd1, and Fgf7/CypA mRNA signal in which the maximal value 
for each experiment was set at 100%. GeneChip and qt-PCR values are respectively plotted 
in relation to the primary and secondary ordinant in each panel. 
A B
C D
E F
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N=428), 11.5% mediate the dynamics of gene expression by controlling protein 
translation, degradation, or trafficking (N=241), 51.6% regulate aspects of cell 
development including growth and maintenance (N=1082), 2.6%, are associated with 
defense and detoxification (N=55), and 9.9% affect cytoskeletal elements, cellular 
adhesion, or components of the extracellular matrix (N=208). Approximately 3,400 genes 
could not be assigned to a specific category due to a lack of sufficient functional 
annotation (Table 4B). 
The 157 unique genes with circadian expression profiles in NIH/3T3 cells were 
similarly segregated into these broad categories and then subdivided further into specific 
functional clusters. In NIH/3T3 fibroblasts, 11% of the annotated genes with rhythmic 
expression profiles (N=17) were involved in the regulation of energetic processes. These 
genes with energetic functions were subdivided into 4 functional clusters: 1) glucose 
metabolism and mitochondrial energy transduction (N=2), 2) lipid and fatty acid 
metabolism (N=3), 3) transporters of energy metabolites (transporters) (N=4), and 4) 
miscellaneous metabolism (N=8) (Table A.4). In comparison with the SCN where there 
is ample evidence for the circadian regulation of genes associated with glucose 
metabolism and mitochondrial energy transduction (98), it is noteworthy that only two 
genes, 2,3-bisphosphoglycerate mutase (Bpgm) and ATP-specific succinyl-CoA 
synthetase beta subunit (Scs/Sucla2), in this functional cluster were rhythmically 
expressed in NIH/3T3 fibroblasts. The greatest proportion/number of genes with 
circadian profiles (35%, N=55) were involved in other forms of cellular communication.  
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Rhythmic genes in this category were further subdivided into functional clusters: 1) 
neurotransmission (N=2); 2) cytosolic signaling factors and transducers (N=25), 3) 
nuclear factors (N=22), 4) G-protein coupled receptors and associated proteins (N=5), 
and 5) extracellular factors (N=1). In the neurotransmission cluster, rhythmic mRNA 
expression in NIH/3T3 cells was similarly limited to two genes, glutamate cysteine ligase 
(Gclm) and the voltage-dependent calcium channel L type, α1C (Cacna1c). Of the 
rhythmically regulated genes with cytosolic signaling and transduction functions, two 
were involved in the regulation of the cAMP pathway: the cAMP-specific 
phosphodiesterases 4B (Pde4b) and 7A (Pde7a). In the nuclear factors cluster the 
rhythmically-expressed genes, CCAAT/enhancer binding protein (C/EBP), cAMP-
response element modulator (Crem), cAMP inducible gene 3 / immediate early response 
3 (Ier3), transcription factor 4 (Tcf4) and activating transcription factor 4 (Atf4), were 
also associated with the cAMP pathway. The sole extracellular factor with a circadian 
profile in NIH/3T3 fibroblasts was fibroblast growth factor 7 (Fgf7). Twenty-six genes 
(17%) with rhythmic patterns of expression in NIH/3T3 cells were involved in different 
aspects of protein dynamics including protein degradation and synthesis (N=15), protein 
sorting and trafficking (N=7), and protein modification and folding (N=4). Twenty-four 
rhythmic genes (15%) exhibited common functions in the regulation of cellular 
development. Rhythmic genes within the cell development category were involved in the 
regulation of cell cycle (N=5), maintenance of DNA and chromatin (N=10), and growth 
and differentiation (N=9). The defense and detoxification category encompassed 13% of 
the rhythmic genes in NIH/3T3 fibroblasts (N=21). Rhythmically regulated genes with 
defense and detoxification functions included small inducible cytokine subfamily D1, 
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cytokine inducible SH2-containing protein (Cish), and myeloid cell leukemia sequence 1 
(Mcl1). Circadian regulation was observed in 14 annotated genes with cytoskeletal or 
cellular adhesion functions (9%) and representative examples of rhythmic genes in this 
category included hyaluronic acid receptor (Cd44), h2-Calponin 2 (Cnn2), and Integrin 
alpha V (Cd51/Itgav) (Table A.4). Differential representation on the mouse U74v2 
GeneChip may be an influential factor in the observed prevalence of non-rhythmic genes 
mediating cell development and of rhythmic genes involved in cell communication 
because analysis using the Simplified Gene Ontology lists in GeneSpring 7.3 indicates 
that the probe sets on the array were biased for genes in these functional categories 
(≈21.3% and 11.1%, respectively).  
Cross-model comparison of global and circadian properties. Because our 
analyses of circadian gene expression in the rat SCN and SCN2.2 cells used the same 
array technology and applied the same expression and rhythm amplitude criteria as well 
as the cross- correlation with cosine waves (98), we next compared the NIH/3T3 and 
SCN transcriptomes with regard to global properties and temporal regulation of gene 
expression. The breadth of gene expression in NIH/3T3 and SCN2.2 cells was similar 
(47% and 45%, respectively) and greater than that observed in the rat SCN (33%). In 
NIH/3T3 fibroblasts, 5,830 out of the 12,500 probe sets (47%) on the mouse U74v2 
GeneChip surpassed expression criteria. Relative to the 8,800 probe sets on the rat U34a 
GeneChip, 3993 in SCN2.2 cells and 2929 in the rat SCN fulfilled expression criteria 
(Table 4A). Further comparisons revealed that the proportion of genes with stable 
expression profiles was greater in NIH/3T3 cells (19%, N=2391) than in SCN2.2 cells  
(12%, N=1035) or the rat SCN (7%, N=584), whereas the extent of circadian gene  
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Fig. 12. Comparative functional classification of circadian gene expression in NIH/3T3 
fibroblasts, SCN2.2 cells, and the rat SCN. In accord with our previous microarray 
analyses (98), rhythmically expressed transcripts in these oscillator models were 
comparatively subdivided into fifteen functional clusters, Glucose metabolism and 
mitochondrial energy transduction (A), Lipid and fatty acid metabolism (B), Transporters 
(C), Miscellaneous metabolism (D), Neurotransmission (E), Extracellular factors (F), G-
protein coupled receptors and associated proteins (G), Cytosolic signaling factors and 
transducers (H), Nuclear factors (I), Protein degradation and synthesis (J), Protein sorting 
and trafficking (K), Protein modification and folding (L), Cell Cycle (M), Maintenance of 
DNA and chromatin (N), Growth and differentiation (O), and two functional categories, 
Defense and Detoxification (P), and Cytoskeletal and Adhesion (Q). Bars depict the 
percentage of rhythmic transcripts in each functional cluster or category relative to the 
total number of annotated genes with circadian profiles in NIH/3T3 fibroblasts (N=157), 
SCN2.2 cells (N=116), and the rat SCN N=163). Specific functional clusters and 
categories in which the proportion of rhythmic gene expression was differentially greater 
in NIH/3T3 fibroblasts, or in SCN2.2 cells and the rat SCN are respectively labeled in red 
and blue. 
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expression was similar across these oscillator models (2.6, 1.8, and 3.4%, respectively; 
Table 4A). 
We also compared NIH/3T3 fibroblasts, SCN2.2 cells, and the rat SCN with 
regard to the functional distribution of genes with circadian profiles (Fig. 12). In all of 
these oscillator models, circadian fluctuations were observed in genes with a wide range 
of functions although rhythmic gene expression was typically more prevalent within 
certain functional categories or clusters. NIH/3T3 fibroblasts, SCN2.2 cells and the rat 
SCN exhibited some similarities in the functional distribution of circadian-regulated 
genes with cytosolic signaling factors, transducers, and nuclear factors in the cellular 
communication category commonly representing a large proportion of the annotated 
genes with rhythmic profiles. Corresponding to this functional distribution, genes 
mediating cellular communication are also prevalent among the cadre of rhythmic 
transcripts observed in mammalian peripheral tissues such as the liver, heart, and kidney 
(149, 147, 67, 114, 33). However, there were notable differences in the functional 
configurations of circadian gene expression in NIH/3T3 fibroblasts relative to those 
found in SCN2.2 cells and the rat SCN. Compared to the functional distribution of SCN 
oscillations, circadian rhythmicity in NIH/3T3 cells was differentially evident among 
genes associated with maintenance of DNA and chromatin (N), defense and 
detoxification (P), and cytoskeletal elements and adhesion (Q). Relative to NIH/3T3 
fibroblasts, circadian profiles in both SCN2.2 cells and the rat SCN were more prevalent 
among genes involved in glucose metabolism and mitochondrial energy transduction (A), 
neurotransmission (E), the regulation of G-protein coupled receptors and associated 
proteins (G), and protein modification and folding (L). The extent of circadian regulation 
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was similar among all three oscillator models only for genes affiliated with cell growth 
and differentiation (O) (Fig. 12). 
 We then collectively assessed NIH/3T3 fibroblasts, SCN2.2 cells, and the rat SCN 
for overlap as well as fundamental differences in the temporal regulation of 2,255 probe 
sets with common representation on both the mouse U74v2 and rat U34a GeneChips 
(Fig. 13). Of these 2,255 probe sets, 413 (18%) fulfilled expression criteria used in this 
study. Many of these genes (N=344) were distinguished by stable (N=60) or non-
circadian (N=284) expression profiles in NIH/3T3 fibroblasts, SCN2.2 cells, and the rat 
SCN (Table 4A), and functional annotations were identified for 162 of these non-
rhythmic probe sets using our filters. Functional analysis of the commonality in the non-
circadian expression of these annotated genes (N=162) across all three oscillator models 
revealed that these genes control diverse biological processes but were most prevalent in 
the cell communication (17.5%; N=27) and cellular development categories (67%; 
N=108) (Table 4B). It is interesting that the NIH/3T3 fibroblasts, SCN2.2 cells, and the 
rat SCN showed similar proportions of non-circadian gene expression in the cellular 
development and defense and detoxification categories (Table 4B). 
Overlap in circadian gene expression across NIH/3T3 fibroblasts, SCN2.2 cells, 
and the rat SCN was limited to 4 of the commonly represented genes on the mouse and 
rat arrays (0.2%; Fig. 13): stearoyl-coenzyme A desaturase 1 (Scd1), long chain fatty acyl 
CoA synthase (Facl), transcription factor 4 (Tcf4), and Ngfi-A/early growth response 1 
(Egr-1) (Table A.4). These rhythmic genes are involved in fatty acid or lipid metabolism 
(Scd1 and Facl), or function as nuclear factors in cell communication pathways (Tcf4 and 
Egr-1). Circadian expression of the core clock genes Per2, Cry1, and Bmal1 was also  
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Fig. 13. Venn diagram illustrating overlap and differences in the circadian 
expression of commonly-represented genes among NIH/3T3 fibroblasts, SCN2.2 
cells and the rat SCN. Probe sets for homologous or functionally related genes with 
mutual representation on both the mouse U74v2 and rat U34a GeneChips (N=2255) 
were analyzed and rhythmically-expressed genes in NIH/3T3 cells were compared 
with those identified previously in SCN2.2 cells and the rat SCN (98).  
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common among all three models, although this observation is based on qt-PCR analysis 
because the mouse and rat GeneChips are largely different with regard to the  
representation of specific clock genes. The limited degree of overlap in circadian gene 
expression between NIH/3T3 fibroblasts, SCN2.2 cells, and the rat SCN is consistent 
with reported comparisons of microarray data indicating that only 10% of the 
rhythmically-expressed transcripts were common to the SCN, peripheral tissues, and 
cultured fibroblasts (33), and that the canonical clock genes constituted the principal 
portion of this overlap in circadian gene expression. In both this review and the present 
comparative analyses, it is noteworthy that nuclear factors were identified as a prevalent 
functional categorization among the remaining common genes with circadian profiles. 
This observation suggests that the circadian regulation of nuclear factors may play a 
critical role in the common oscillatory function of different tissues throughout the body.  
 To complement this analysis of overlap between experimental models, the temporal 
expression profiles of the 2255 commonly represented probe sets were subsequently 
assessed for differences between NIH/3T3 fibroblasts and SCN cells. For genes and ESTs 
with non-circadian profiles, 194 (8.6%) were expressed in NIH/3T3 fibroblasts but not in 
SCN2.2 cells and the rat SCN. Of the annotated genes with non-circadian profiles that 
were exclusively expressed in NIH/3T3 cells, many were associated with cell 
communication (N=45; 23%) or cellular development (N=15; 8%) (Table A.4). It is 
interesting that the differential expression of non-circadian genes in NIH/3T3 cells 
includes three in the energetics category that function either in the transport of 
neurotransmitters [5-hydroxytryptamine (serotonin) transporter (Slc6a4) and glycine 
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transporter 1 (Glyt1)] or in the regulation of glucose metabolism [glycerol-3-phosphate 
dehydrogenase (Gdm1)]. Only 10 non-circadian genes (0.4%) were expressed in SCN2.2 
cells and the rat SCN but not in NIH/3T3 fibroblasts. These genes with SCN-specific 
non-circadian profiles included defender against cell death (Dad-1), prostaglandin F2 
receptor negative regulator (Ptgfrn), chemokine (C-X3-C motif) ligand 1  (Cx3cl1), ADP-
ribosylation factor 4 (Arf4), farensyl diphosphate synthase (Fdps), isopentenyl-
diphosphate delta isomerase (Idi1), par-3 (partitioning defective 3) homolog (Pard3), 
actin beta (Actb), serum and glucocorticoid-regulated kinase (Sgk), and gephyrin (Gphn).  
For rhythmic genes and ESTs, 26 (1.2%) were marked by circadian expression in 
NIH/3T3 fibroblasts but not in SCN2.2 cells and the rat SCN (Fig. 13). Annotated genes 
with fibroblast-specific circadian profiles were primarily involved in the regulation of 
cellular communication (N=8; 0.4%), and defense and detoxification pathways (N=6; 
0.3%). Based on our previous microarray study (98), 28 annotated genes, 8 of which were 
identified using supplementary screening analyses, exhibited circadian expression 
patterns in SCN2.2 cells and the rat SCN but not in NIH/3T3 fibroblasts (Table 5). It is 
noteworthy that functionally annotated genes with SCN-specific rhythms of expression 
were predominantly involved in the regulation of intercellular communication (N=16) 
and energetic processes related to glucose metabolism and transport (N=7). The 
distribution of circadian-regulated genes in the former functional category may have 
some significance with regard to SCN-specific signals necessary for the endogenous 
generation of self-sustained rhythmicity, temporal synchrony among individual clock 
cells or pacemaker coordination of circadian rhythmicity in downstream oscillators. 
Inducible nitric oxide synthase (iNos or Nos2), syntaxin 4 (Stx4a), A-2 arylamine N-
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acetyltransferase 1 (Nat1), Glycine receptor, alpha 1 subunit (Glra1), cytosolic 
phospholipase A2 (Pla2g4a), SAP kinase/mitogen-activated protein kinase 12 
(Mapk12/Erk-6), serine-threonine kinase receptor/activin a receptor type II-like 1 
(Acvrl1), calcitonin/calcitonin-related polypeptide, alpha (Calca), and pregnancy 
upregulated non-ubiquitously expressed CaM kinase (Pnck) are notable examples of 
genes in intercellular communication pathways with circadian expression profiles that 
were unique to SCN2.2 cells and the rat SCN. The identification of Nos2 as a distinctive 
SCN output signal using this comparative microarray and bioinformatics approach is 
particularly intriguing in relation to previous functional studies targeting the other 
isoforms of this enzyme, neuronal Nos (nNos or Nos1) and endothelial Nos (eNos or 
Nos3). These studies suggest that NO signaling is not essential for SCN circadian 
function because mutant mice lacking nNos or eNos show normal activity rhythms with 
regard to their free-running patterns, entrainment to light-dark cycles, and phase-shifting 
responses to light (74). However, the function of Nos2 in the SCN and the regulation of 
circadian rhythms has not been examined, presumably based on the implications of these 
studies and the prevailing bias that this isozyme is expressed by macrophages (88), but 
not SCN cells. 
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Table 5. Functional categorization of annotated genes with circadian profiles in SCN cells 
but not NIH/3T3 fibroblasts 
 
GenBank ID Gene descriptor (symbol) 
Category 1 - Energetics (N=7) 
Glucose Metabolism and Electron Transport Chain 
AI171506  Malic enzyme 1 (Me1) 
K00750  Cytochrome c, somatic (Cycs) 
J01435  ATP synthase 8, mitochondrial (mt-Atp8) 
Transporters  
D63834  Monocarboxylate transporter (Mct1/Slc16a1) 
S68135  Glucose transporter/solute carrier family 2, member 1/(Glut 1/Slc2a1) 
Miscellaneous metabolism  
AI177004  Hmgc synthase 1 (Hmgcs1) 
L19998  Sulfotransferase family 1A, phenol-preferring, member 1 (Sult1a1) 
 
Category 2 - Cell Communication (N=16) 
Neurotransmission  
L20821  Syntaxin 4 (Stx4a) 
U01344  A-2 arylamine N-acetyltransferase 1 (Nat1) 
U08259* N-methyl-D-aspartate receptor NMDAR2C subunit (Grin2c) 
D00833*  Glycine receptor, alpha 1 subunit (Glra1) 
AF007758* Synuclein 1, alpha (Snca) 
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Table 5 - continued 
GenBank ID                                Gene descriptor (symbol) 
Cytosolic signaling factors and transducers 
U38376  Cytosolic phospholipase A2 (Pla2g4a) 
X96488*  SAP kinase/mitogen-activated protein kinase 12 (Mapk12/Erk-6) 
L36088* Serine-threonine kinase receptor/activin a receptor type II-like 1 (Acvrl1) 
L00111* Calcitonin/calcitonin-related polypeptide, alpha (Calca) 
D86556* Pregnancy upregulated non-ubiquitously expressed CaM kinase (Pnck) 
U16359* Inducible nitric oxide synthase (iNos/Nos2) 
Nuclear factors 
M63282  Leucine zipper protein/activating transcription factor 3 (Atf3) 
U78102  Krox-20/early growth response 2 (Egr2) 
M65251  HIV type 1 enhancer-binding protein 2 (Hivep2) 
AF000942   Inhibitor of DNA-binding 3 (Id3) 
L23148  Inhibitor of DNA-binding 1, splice variant 1d1 
 
Category 3 - Protein dynamics (N=2) 
Degradation and synthesis 
AA859882  Ubiquitin carboxyl-terminal hydrolase 1 (Uchl1) 
AA849648  Ribosomal gene L21 (Rpl21) 
 
Category 4 - Cellular Development (N=3) 
Maintenance of DNA and chromatin 
H33461  Oxidation resistance 1 (Oxr1) 
AA964849  ADP-ribosyltransferase 1 (Adprt) 
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TABLE 5 - continued 
GenBank ID                              Gene descriptor (symbol) 
Growth and differentiation 
D89983  Ornithine decarboxylase antizyme inhibitor (Oazi) 
 
Category 5 - Defense and Detoxification (N=0) 
 
Category 6 - Cytoskeletal elements and Adhesion (N=0) 
     Functional categorization of annotated genes with circadian expression profiles in SCN2.2 cells and the rat 
SCN but not NIH/3T3 fibroblasts. Genbank ID, gene descriptor and symbol, and functional category/cluster are 
denoted for each gene that was rhythmically expressed in both SCN2.2 cells and the rat SCN. Genes with SCN-
specific rhythmic profiles were identified using previous expression criteria (98) and classified in accord with 
the functional categories as listed in Table 1. In addition, the energetics and cell communication categories were 
subdivided into the following clusters to further delineate gene function: Glucose metabolism and 
mitochondrial energy transduction, Transporters, Miscellaneous metabolism, Neurotransmission, G-
protein coupled receptors and associated proteins, Nuclear factors, Protein degradation and synthesis, 
Protein modification and folding, Maintenance of DNA and chromatin, and Growth and differentiation.  
Asterisks denote rhythmic genes that were identified using secondary expression criteria (98). 
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Summary. Previous studies have suggested comparisons of array data provide 
negligible information beyond the indication that circadian gene expression is highly 
disparate among different tissues or cell types. Our comparative analyses of gene 
expression profiles in NIH/3T3 fibroblasts, SCN2.2 cells and the rat SCN are certainly 
consistent with this general observation, but also underscore some implications of the 
limited overlap and substantial differences in rhythmic transcripts across these oscillator 
models. In conjunction with the canonical clock genes, Per2, Cry1 and Bmal1, genes that 
mediate fatty acid or lipid metabolism (Scd1 and Facl), or function as nuclear factors in 
cell communication pathways were the only rhythmically expressed transcripts in 
common among NIH/3T3 fibroblasts, SCN2.2 cells and the rat SCN. Further analysis is 
warranted to determine whether genes in these functional clusters are responsible for the 
common oscillatory properties of the SCN and other tissues or cells throughout the body. 
The present identification of SCN-specific differences provides further insight into why 
the SCN in vivo and SCN2.2 cells, but not fibroblasts, are capable of generating self-
sustained rhythmicity and functioning as circadian pacemakers. Nos2 and other circadian-
regulated genes involved in the regulation of intercellular communication were 
differentially identified as critical circadian signals expressed only in SCN cells. Based 
on our analysis of NOS function in this study, these genes will provide a suitable focus 
for identifying signaling pathways responsible for the coupling of SCN oscillators or the 
coordination of rhythmicity in other cells and tissues. 
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CHAPTER IV 
INVOLVEMENT OF THE NO/NOS2 SIGNALING PATHWAY IN 
THE CIRCADIAN PROPERTIES OF IMMORTALIZED SCN 
(SCN2.2) CELLS* 
INTRODUCTION 
An important functional property of the SCN is that its cells are capable of 
generating self-sustained molecular and physiological oscillations. Circadian rhythms in 
cellular metabolism, neuropeptide secretion, electrical activity, and gene expression are 
endogenous to the SCN in vivo and persist following isolation of SCN cells in vitro (69). 
Importantly, these molecular and physiological oscillations are not only an ensemble 
property of the entire nucleus but are also generated by individual SCN neurons, 
suggesting that the SCN contains a network of cell-autonomous oscillators. When 
maintained on microelectrode plates, individual neurons in dissociated culture of the rat 
SCN express independent oscillations in firing rate that differ widely with regard to 
circadian phase and period, despite the presence of synaptic connections (158). In similar 
fashion, SCN cells in brain slice preparations also exhibit multi-phasic waveforms in Per-
1-driven GFP-fluorescence (128). Because this rhythmic behavior is derived from the 
autonomous oscillations of individual neurons (128), identification of the processes 
responsible for the relative coordination of rhythmicity across multiple cellular clocks is 
_______________________ 
*Used with permission. Menger GJ, Allen GC, Neuendorff N, Nahm SS,Thomas TL, 
Cassone VM, and Earnest DJ. Circadian profiling of the transcriptome in NIH/3T3 
fibroblasts: comparison with rhythmic gene expression in SCN2.2 cells and the rat SCN. 
Physiol Genomics. Epub. 2007. 
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of critical importance for understanding the mechanisms by which individual SCN clock 
cells are coupled and function as a pacemaker that regulates circadian rhythms in other 
cells and tissues. 
Based on comparative microarray analyses described in the previous chapter, the 
observed prevalence of circadian expression profiles in SCN2.2 cells and the rat SCN 
among genes mediating intercellular communication may have some significance with 
regard to SCN-specific signals necessary for the endogenous generation of self-sustained 
rhythmicity and the temporal coordination of oscillations among individual clock cells or 
in other tissues. Among these intercellular signaling genes with SCN-specific circadian 
expression profiles, the identification of inducible nitric oxide synthase (iNos or Nos2), 
an isozyme involved in nitric oxide (NO) production, is intriguing for several reasons. 
First a role for the diffusible messenger, NO, in SCN pacemaker function is compatible 
with previous findings indicating that diffusible signals mediate the pacemaker function 
of SCN2.2 cells in conferring rhythmicity to cocultured fibroblasts (8, 10) and the 
restoration of behavioral rhythmicity by SCN transplants in vivo (143). Furthermore, Nos 
function in SCN regulation of circadian rhythms is supported by the observation that 
treatment with L-NAME, a reversible inhibitor of all three isoforms of NOS in the CNS 
(80), alters the endogenous generation of metabolic rhythmicity in SCN2.2 cells and their 
capacity to pace oscillations in cocultures of untreated NIH/3T3 fibroblasts (98a; Used 
with permission.) (Fig. 14). In addition, other Nos isoforms, neuronal Nos (nNos or 
Nos1) and endothelial Nos (eNos or Nos3), but not Nos2, have been targeted for 
functional analysis of their involvement in SCN circadian function. These studies 
demonstrate that mutant mice lacking nNos or eNos show normal activity rhythms with  
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Fig. 14. Temporal profiles of 2-DG uptake in cocultures containing L-NAME- or D-NAME-
treated SCN2.2 cells (top panel) and untreated NIH/3T3 fibroblasts (bottom panel). SCN2.2 cells 
were treated for 48 hours with the NOS inhibitor L-NAME (dashed line, ∆) and then cocultured 
for 60 hours with untreated NIH/3T3 cells (dashed line, ?). Control cultures of SCN2.2 cells 
were treated with its inactive enantiomer D-NAME (solid line, ▲) and then cocultured with 
untreated NIH/3T3 fibroblasts (solid line, ?). The shaded region in the top panel demarcates the 
interval of SCN2.2 treatment with L-NAME or D-NAME (hour 0-48). Symbols denote 
determinations of 2-DG uptake (n = 3; mean ± SEM) at 4-hour intervals. Values for 2-DG uptake 
are plotted as a function of time such that time 48 denotes when treated SCN2.2 cells were first 
cocultured with untreated NIH/3T3 fibroblasts. Asterisks indicate sampling intervals during 
which peak values for 2-DG uptake were significantly greater (p < 0.05) than those observed 
during preceding or succeeding minima. Used with permission (98a). 
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regard to their free-running patterns, entrainment to light-dark cycles, and phase-shifting 
responses to light (74, 75). Thus, Nos2 function in the SCN clock and the regulation of 
circadian rhythms warrants further investigation. 
The function of Nos2 in SCN regulation of circadian rhythms has not been 
examined presumably based on the implications of these studies and the prevailing bias 
that this isozyme is expressed by macrophages (88), but not by SCN cells. Using our 
coculture model, the present experiments examined the effects of antisense inhibition of 
iNOS expression on the endogenous oscillatory and pacemaker properties of SCN2.2 
cells. Morpholino antisense oligonucleotides were used to determine whether knock-
down of iNos expression in SCN2.2 cells alters their rhythmic regulation of 2-
deoxyglucose uptake and communication of this rhythmicity to cocultures of untreated 
NIH/3T3 fibroblasts. In comparison with approaches using transgenic mice in which a 
specific gene has been targeted for knock-out or disruption, application of this antisense 
method in our coculture model provides a unique advantage in examining iNos/Nos2 
function because NOS2 expression can be conditionally inhibited in SCN2.2 cells 
without affecting its expression in NIH/3T3 fibroblasts. This aspect presents an 
opportunity for dissociation of effects on the central pacemaker versus peripheral 
oscillators. Moreover, the utility of antisense morpholinos in knocking-down gene 
expression in SCN2.2 cells is supported by its successful application in previous studies 
(8, 10). 
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MATERIALS AND METHODS 
Propagation of cell lines and general culture conditions. SCN2.2 and NIH/3T3 
fibroblast lines of low passage number were propagated without antibiotics on culture 
dishes (60 mm; Corning, Corning, NY, USA) and maintained at 37 °C and 5% CO2 in 
minimum essential medium containing 10% fetal bovine serum (FBS), 3000 µg/ml 
glucose, and 292 µg/ml L-glutamine. Culture dishes containing SCN2.2 cells were pre-
coated with laminin. During cell propagation, the medium was changed at 48-h intervals, 
and cultures were split every 2–3 days when at confluence.  
Experiment 1. Is nitric oxide (NO) produced by SCN2.2 cells? Confluent 
SCN2.2 cultures were subcultured onto laminin and poly-L-lysine coated glass culture 
dishes (35 mm, World Precision Instruments, Sarasota, FL, USA ) in normal growth 
medium. Confluent cultures were rinsed two times with Dulbecco's phosphate-buffered 
saline (PBS; without calcium or magnesium, CMF), maintained in phenol red-free, 
HEPES buffered MEM with L-glutamine (imaging medium), and then treated with DAF-
FM diacetate (final concentration 10 uM diluted in 0.2% DMSO) (Molecular Probes, 
Eugene, Oregon, USA) or vehicle for 1 hour at 37 °C and 5% CO2. After treatment with 
DAF-FM, cultures were again rinsed with CMF and re-exposed to fresh imaging 
medium. Cultures were incubated at 37 °C and 5% CO2 for an additional 30 minutes to 
allow for the de-esterification of internalized DAF-FM diacetate. This method for 
detecting low concentrations of nitric oxide (NO) is based on the principles that DAF-FM 
diacetate is a cell-permeable reagent that reacts with NO when deacetylated by cellular 
acetates. This intracellular reaction increases the fluorescence emission characteristics 
(515 nm) of the label by ~160-fold (quantum yield, ~ 0.81) (Molecular Probes Product 
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Information Sheet MP 23841, May, 2001).  Imaging of intracellular NO was performed 
using 10-40X objectives an Olympus IX70 inverted microscope at the Real Time 
Imaging Lab Texas A&M Biology Shared Instrumentation Facility. Image acquisition of 
representative DAF-FM diacetate- and vehicle-treated cells was achieved using an Orca-
ER CCD camera (Hamamatsu, Bridgewater, NJ, USA) and SimplePCI imaging software 
(Compix, Cranberry Township, PA, USA).  
Experiment 2. Are the endogenous oscillatory and circadian pacemaker 
properties of SCN2.2 cells altered following antisense inhibition of iNos/Nos2? Using a 
coculture environment similar to that established in previous studies (8, 10), this 
experiment was conducted to examine the effects of antisense inhibition of iNos/Nos2 in 
SCN2.2 cells on their capacity to generate endogenous metabolic rhythms, and to 
communicate this rhythmicity to untreated NIH/3T3 fibroblasts. SCN2.2 cells derived 
from a single passage were plated on multiple 6-well companion plates (Falcon, Oxnard, 
CA, USA) and treated at time of seeding with antisense (n=3) or invert of antisense (n=3) 
Morpholino oligonucleotides (Gene Tools, LCC, Philomath, OR, USA) directed against 
rat-specific iNos /Nos2 mRNA. The published sequence of iNos /Nos2 was used to design 
an antisense oligonucleotide to the region of the mRNA containing the initiation ATG 
codon (109, 72). The iNos /Nos2 antisense and invert of antisense oligonucleotides were 
designed so as to have the same length (25-mers) and base composition (5′-
GCAAGCCATGTCTGTGACTTTGTGC -3′ and 5′-
CGTGTTTCAGTGTCTGTACCGAACG -3′, respectively). In parallel to these 
oligonucleotide-treated SCN2.2 cultures on companion wells, colonies of NIH/3T3 cells 
were established and maintained separately on cell-impermeable inserts (23 mm; pore 
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size=1 µm). Delivery of Morpholino oligonucleotides (final concentration=1.3 µM) into 
individual wells containing SCN2.2 cells was performed using the Endo-Porter delivery 
reagent, a system designed to promote endocytosis-mediated delivery of substances into 
the cytosol of adherent and non-adherent cells (Gene Tools, LCC, Philomath, OR, USA). 
The Endo-Porter delivery reagent was pre-mixed with prepared stock solution of 
Morpholino oligomers (invert and antisense). At the time of final passage SCN2.2 cells 
were treated medium containing the invert or antisense Morpholino 
oligonucleotide/Endo-Porter solution for 48 h. After removal of the delivery solution, the 
cells were rinsed two times with Dulbecco's phosphate-buffered saline (PBS; without 
calcium or magnesium) and then maintained in normal growth medium and cocultured 
with inserts containing untreated NIH/3T3 fibroblasts. After 20h in coculture, samples 
were collected at 4-h intervals for 52h to determine 2-deoxyglucose (2-DG) uptake in 
each coculture compartment. This analysis was performed on six companion wells and 
inserts at each time point across duplicate experiments. Cells were harvested with TRIzol 
reagent (Invitrogen, Carlsbad, CA, USA). Determinations of 2-DG uptake were then 
analyzed with a liquid scintillation counter.  
Measurement of 2-DG uptake. SCN2.2 and NIH/3T3 cells were assayed for 
uptake of 2-DG using methods described previously (37, 8, 10). Peak values for rhythmic 
2-DG uptake were identified when relative 2-DG levels were statistically higher than 
those observed during the preceding or succeeding minimum.  
Western blot analyses. Morpholino antisense inhibition of iNOS/NOS2 peptide 
levels was verified by Western blot analysis using the Novex Western Transfer Apparatus 
(Invitrogen). Samples from each time point were homogenized individually with TRIzol 
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reagent and soluble protein was extracted according to the manufacturer's protocols. In 
experiment 2, individual protein samples from antisense- or invert of antisense-treated 
SCN2.2 cells at each time point (n=3) were precipitated. The samples were boiled in 
sodium dodecyl sulfate sample buffer and loaded at 90 µg protein per lane onto 10% 
Tris–glycine gels. Following separation at 25 mA for approximately 2 h, proteins were 
transferred onto 0.45 µm nitrocellulose membranes and blocked overnight with 4% dried 
milk in Tris-buffered saline (TBS)–Tween (0.05%). With interceding rinses in TBS, 
membranes were probed for 48 h at 4 °C with rabbit anti- iNOS/NOS2 polyclonal 
antibody (pAb; 2 µg/ml; BD Biosciences) or rat anti-Tubulin monoclonal antibody 
(mAb) [YL1/2] (1:10,000; Abcam, Inc., Cambridge, MA, USA) followed by a 2-3-h 
incubation with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (at 
1:20,000; Bio-Rad, Hercules, CA, USA) or rabbit anti-rat IgG (at 1:20000; Abcam, Inc.). 
Immunoreactive signal for iNOS/NOS2 or tubulin was generated by enzyme-catalyzed 
chemiluminescence (Perkin Elmer, Boston, MA, USA) and detected on film (Biomax; 
Kodak, Rochester, NY, USA). Optical density measurements for size-appropriate bands 
were obtained using Molecular Analyst software (Bio-Rad, Hercules, CA, USA).  
Statistical analysis. Time-dependent fluctuations were identified by one-way analysis of 
variance (ANOVA). Paired comparisons between determinations of 2-DG uptake at 
specific time points were analyzed post hoc for statistical differences using the Newman-
Keuls sequential range test. For Western blot analyses, standard t-tests were performed to 
determine if iNOS/NOS2 protein levels as measured relative to TUBULIN protein levels 
in the same samples were significantly different between invert of antisense- and 
antisense-treated SCN2.2 cell cultures.  
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RESULTS AND DISCUSSION 
Experiment 1. SCN2.2 cells produce NO and express NOS2. Because recent 
microarray and qt-PCR results have demonstrated that SCN2.2 cells do indeed express 
Nos2 mRNA (98), we sought to first determine if these pacemaker cells produce NO and 
then whether these cells express NOS2 protein. Imaging of intracellular NO using the cell 
permeable fluorescent indicator DAF-FM diacetate revealed that NO is present in both 
neuronal and glial cell types comprising SCN2.2 cultures (Fig. 15). Based upon the 
heterogeneity of cellular morphologies in SCN2.2 cell cultures, we found that glial cells 
charcterized by large flat cell bodies and stellate extensions typically exhibited diffuse 
NO-labeling whereas cells exhibiting neuronal features such as small, round soma and 
thin processes showed more intense labeling (Fig. 15). These findings suggest that glial 
and neuronal components of the SCN may produce different levels of NO and/or exhibit 
different patterns of subcellular compartmentalization. The possible distinctions in NO 
production between glia and neurons in SCN2.2 cultures is interesting and may reflect 
differences in how NO synthases (NOS) are regulated within and across these cell types. 
For instance, concentrated levels of NO indicated in neuronal type SCN2.2 cells may 
reflect higher NOS levels or activitiy whereas less intense NO-labeling observed in SCN 
glial cells may indicate lower NOS levels or activity.  An intriguing question is whether 
NO production fluctuates in a circadian fashion across these different SCN2.2 cells.  
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Fig. 15. Cellular distribution of nitric oxide in confluent cultures SCN2.2 cells as 
determined by DAF-FM diacetate labeling. Representative images of DAF-FM diacetate 
labeling (A and C) and their respective Nomarski images (D and F) in two different fields 
of view in SCN2.2 cell cultures. Images to the right reflect 2.5X magnification of 
neuronal type SCN2.2 cells indicated by arrows. These cells are charcterized by round 
cell bodies and neuronal type extensions. All images were captured using 20X objective 
magnification and enhanced in Adobe Photoshop 7.0.  
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It is also possible that post-translational processes and subcellular 
compartmentalization of NOS isoforms may contribute to patterns of NO distribution and 
activity observed in different SCN2.2 cell types (7, 144, 112). Through post-translational 
processes such as palmitoylation, NOS isoforms can be differentially modified and 
directed to the cell body or plasma membrane (112). Since both neuronal and inducible 
isoforms of NOS (Nos1 and Nos2, respectively) are expressed in neurons and glia of the 
CNS (100, 117) and all three isoforms are expressed in the hypothalamus (74, 75, 154), 
the observed differences in NO localization in neuronal and glial components of SCN2.2 
cultures may be related to differences in post-translational processing and subcellular 
compartmentalization among NOS isoforms.    
Expression of NOS2 protein in SCN2.2 cells. Despite the prevailing bias that Nos2 
is only expressed by macrophages (88), our microarray data indicate that the mRNA 
encoding this isozyme is expressed in SCN2.2 cells and the rat SCN (98). Before 
examining the functional implications of Nos2 expression, we next determined whether 
NOS2 protein was expressed in SCN2.2 cells. Western blot analysis revealed that NOS2 
is expressed in SCN2.2 cells and its expression markedly increases after treatment with 
forskolin (30uM) (Fig. 16), which has been shown to augment the amplitude of 
molecular oscillations in SCN2.2 cells (62).  
Experiment 2. Endogenous oscillatory and circadian pacemaker properties of 
SCN2.2 cells are altered following antisense inhibition of Inos/Nos2. To assess the 
functional involvement of Nos2 in the circadian properties of SCN2.2 cells, we examined 
the effects of antisense inhibition of NOS2 expression on the capacity of SCN2.2 cells to 
endogenously generate metabolic rhythms and to convey these oscillations to cocultured  
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Fig. 16. Western blot analysis of forskolin-mediated increase in NOS2 abundance in 
SCN2.2 cells. Positive immunoreactivity for NOS2 protein is shown for SCN2.2 cells 
treated with vehicle (DMSO) (left lane) or 30 µM forskolin (right lane). 90 µg of total 
protein, as measured by the bicinchoninic acid method (Pierce, Rockford, IL, USA), were 
loaded in each well. Arrow indicates the predicted molecular weight of NOS2 
(approximately 130 kD).  
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cells. Previous functional studies using L-NAME, to globally inhibit Nos and NO activity 
in the SCN (80, 98a - used with permission.) have provided little opportunity to 
distinguish between Nos2 and other isoforms, neuronal Nos (nNos/Nos1) and endothelial 
Nos (eNos/Nos3), with regard to their relative importance in SCN circadian function. 
Consequently, analysis using Morpholino antisense approaches were necessary to directly 
assess Nos2 function in the endogenous rhythm-generating and circadian pacemaker 
properties of SCN2.2 cells.  
Sample collection for concurrent analysis of INOS/NOS2 protein levels and 
rhythmic 2-DG uptake was initiated 68 h after the onset of oligonucleotide treatment of 
SCN2.2 cells based on preliminary observations indicating that antisense 
oligonucleotides have no inhibitory effect on INOS/NOS2 expression in SCN2.2 cells 
prior to this interval. However, samples collected during the middle of the sampling 
period (96h) revealed that antisense treatment had a statistically significant effect in 
inhibiting NOS2 protein levels in SCN2.2 cells that were cocultured with NIH/3T3 cells 
(Fig. 17). NOS2 protein levels in antisense-treated SCN2.2 cells were 50% lower than 
those found in invert of antisense oligo-treated cells (Fig. 17).  
Consistent with previous studies (8, 9, 10), the temporal profiles of 2-DG uptake 
in invert-treated SCN2.2 cells and cocultured NIH/3T3 fibroblasts were marked by 
circadian rhythmicity for two cycles in vitro, with a 4h phase delay in NIH/3T3 
rhythmicity relative to that observed in SCN2.2 cells (Fig. 18). For both cell types in 
cocultures containing invert of antisense-treated SCN2.2 cells and NIH/3T3 cells, 2-DG 
uptake showed significant variation (p<0.05), with rhythmic peaks occurring at 24-h 
intervals. Maximal levels of 2-DG uptake significantly greater than the corresponding 
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Fig. 17. Western blot analyses of NOS2 and TUBULIN protein levels in Morpholino-treated 
SCN2.2 cells cocultured with NIH/3T3 cells. Comparison of NOS2 (A) and TUBULIN (B) 
protein levels in SCN2.2 cells treated with either invert of antisense oligonucleotides (Invert) or 
Nos2 antisense oligonucleotides (Antisense). Arrows indicate the NOS2 isoform (the predicted 
molecular weight approximately 130 kD) (above). Densitometric analysis of gels was utilized to 
quantify NOS2 protein levels in SCN2.2 cells and then normalized for TUBULIN in each 
treatment. Bars represent the mean (S.E.M.) determinations. NOS2-AS treatment significantly 
reduced NOS2 protein levels compared to with that observed for invert-treated cells. The asterisk 
(*) indicates statistical significance as determined by a standard T-test (p<0.05) (below).  
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minimum and occurred at 72 and 96 hours after transfection in invert-treated SCN2.2 
cells and at 76 and 100 h post-treatment in cocultured NIH/3T3 cells. In contrast, SCN2.2 
cells treated with Nos2 antisense oligonucleotides abolished the rhythm of 2-DG uptake 
in SCN2.2 cells and in cocultured NIH/3T3 fibroblasts. 2-DG uptake in antisense-treated 
SCN2.2 cells did not show significant maxima (Fig. 18).  
Summary. Based upon these observations, three independent but non-exclusive 
roles for the Nos2/NO pathway may be at work in SCN2.2 cells. First, the diminished 
abundance of NOS2 and presumably reduced function of the Nos2/NO pathway may 
upset the normal operation of SCN2.2 cell physiology. Alternatively, disruption of this 
pathway may directly impact the normal function of the canonical clockwork mechanism. 
However, because the self-sustained rhythmic properties of the SCN are thought to arise 
from the coupling of cell-autonomous SCN oscillators (158, 61, 128), reduced function of 
the Nos2/NO cell signaling pathway could disrupt the coupling and synchronization 
among populations of SCN2.2 oscillator cells. Consequently, desynchrony between 
individual SCN oscillator cells would seemingly compromise the ensemble function of 
the SCN in coordinating circadian rhythms in cells outside the SCN as well as its 
endogenous clock function. Enright (1980) suggests that changes of the coupling strength 
between oscillators will produce changes in the rhythm amplitude or period length and 
result in irregular ensemble rhythmicity (39). Indeed, SCN2.2 cells treated with 
Morpholino antisense oligonucleotides directed at the Nos2 gene exhibited an abolished 
circadian rhythm of 2-deoxyglucose uptake relative to invert of antisense oligo-treated 
SCN2.2 cell cultures. These findings indicate the involvement of the NO/Nos2 cell-
signaling pathway in the coordination of circadian rhythms in SCN2.2 cells.   
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Since NO is known to function as a gaseous neurotransmitter, NO may also 
function as a diffusible messenger in the coordination or synchronization of metabolic 
oscillations among populations of NIH/3T3 cells. For NIH/3T3 cells, altered transmission 
of diffusible synchronizing signals from SCN2.2 cells would presumably diminish their 
ensemble rhythm amplitude of 2-deoxyglucose uptake in accord with the aforementioned 
properties descibed by Enright (1980) (39). Concomitantly, desynchrony among  SCN2.2 
oscillator cells may affect the circadian regulation of output signals responsible for 
driving rhythmicity in cocultured NIH/3T3 cells. Because the circadian rhythm of 2DG 
uptake was abolished in untreated NIH/3T3 cells cocultured with Nos2 antisense-treated 
SCN2.2 cells, NO may function by either or both of these mechanisms. Thus, the 
metabolic rhythms of both SCN2.2 cells and NIH/3T3 fibroblasts may be sensitive to any 
loss of the temporal coordination between a large population of oscillating cells. Because 
the SCN clock is an autonomous property of individual SCN neurons (158, 61), the 
capacity of a population of SCN2.2 pacemaker cells to express endogenous rhythmicity 
and coordinate high-amplitude circadian signals controlling oscillations in NIH/3T3 
fibroblasts is likely to depend upon their communication and coupling. The findings of 
this study suggest that iNos/Nos2 contribute to this functional coupling and open the door 
for addressing two critical questions: 1) Is Nos2 necessary to drive NIH/3T3 rhythms and 
2) is it a necessary signal for SCN ensemble function or for the SCN to secrete a 
diffusible signal. 
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Fig. 18. Temporal profiles of 2-DG uptake in cocultures containing INVERT or 
ANTISENSE treated SCN2.2 cells (top panel) and untreated NIH/3T3 fibroblasts 
(bottom panel). SCN2.2 cells were treated for 48 hours with NOS2 ANTISENSE 
morpholino (-?-) and then cocultured with untreated NIH/3T3 cells (-?-) for 20 hours 
before sampling sampling began at 68 hours. Control cultures of SCN2.2 cells were 
treated with NOS2 INVERT morpholino (-?-) and then cocultured with untreated 
NIH/3T3 fibroblasts (-?-). Symbols denote determinations of 2-DG uptake (n = 3-6; 
mean ± SEM) at 4-hour intervals. Asterisks indicate sampling intervals during which 
peak values for 2-DG uptake were significantly greater (p < 0.05) than those observed 
during preceding or succeeding minima. 
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CHAPTER V 
GENERAL DISCUSSION AND CONCLUSIONS 
      Biological timekeeping systems have evolved in diverse taxa so that these organisms 
can adapt their internal biology and lifestyles in accord with the periodic environment. 
One of these timekeeping systems, the circadian timekeeping system, provides for the 
organization of physiological processes that are coupled to specific times of the light:dark 
cycle as well as the timing of other functionally-affiliated events inside the cell and 
throughout of the organism. Much of our understanding of circadian timekeeping systems 
is derived from founding studies of circadian rhythms in diverse organisms such as the 
fruit fly, bioluminescent bacteria, and nocturnal rodents. Victor Bruce, Karl Ashoff, 
Surge Daan, and Colin S. Pittendrigh, a prominent figure in the discipline of biological 
timing, established the foundation for the field by demonstrating that circadian rhythms 
of physiology and behavior are manifest in both single-celled and multi-cellular 
creatures. Further to their credit, these scientists established the formal properties used in 
the determination and analysis of bona fide circadian rhythmicity – properties that still 
serve as benchmarks in distinguishing circadian oscillations which damp from circadian 
rhythms that are self-sustaining. For both single- and multi-celled organisms, three 
formal properties are used to assess bona fide circadian rhythmicity, i.e. circadian 
rhythms necessarily exhibit 1) entrainment, 2) temperature compensation, and 3) 
persistency of a near 24-h rhythm in the absence of external input (122). 
     In creatures ranging from prokaryotes to humans, the circadian timekeeping 
system is configured such that three mechanistic components, designated in accord with 
their distinctive functional roles in 1) input pathways, 2) a core oscillator, or 3) output 
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pathways, interact to give rise to overt circadian rhythms of physiology and behavior. In 
mammals, this configuration is structured such that the suprachiasmatic nuclei (SCN) 
function as a master oscillatory locus that receives photic signals by means of the RHT 
and transmits output by means of neuronal and diffusible signals. Some of these outputs 
coordinate circadian rhythms throughout the body whereas others presumably feedback 
to the SCN via autocrine, paracrine, or neuroendocrine mechanisms. 
It had been accepted for many years that the SCN function as a unique master 
oscillatory locus by driving circadian rhythms throughout the body via its output signals. 
This perception arose from several experimental observations. First, that ablation of the 
SCN abolished coordinated circadian rhythms in a wide range of molecular, 
physiological, and behavioral activities and that transplantation of only SCN tissue could 
restore rhythmicity in SCN-lesioned animals supported the notion that the SCN possessed 
intrinsic circadian properties which non-SCN tissues lacked (104, 79, 147, 129, 69, 138). 
Another avenue of experimentation demonstrated that the SCN actually constituted a 
network of cell-autonomous oscillators as individual SCN cells were shown to exhibit 
independently-phased circadian oscillations of neuronal electrical activity in one study 
and, in another, multi-phasic, cell-autonomous circadian rhythms of Period1-driven GFP-
fluorescence (158, 128). Yet, more intriguing was the observation that even in the 
absence of exogenous synchronizing stimuli, including agents emulating RHT-derived 
signals, i.e. glutamate and PACAP, SCN tissue was still able to exhibit intrinsic 24h 
rhythms of metabolism, electrical activity, and gene and neuropeptide expression, in vitro 
(131, 34, 44, 110, 131, 137). Thus, the SCN was seen to exhibit not only unique cell-
autonomous properties of circadian timekeeping but also indigenous pacemaker 
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properties, e.g. SCN cells could synchronize their circadian rhythms, even in the absence 
of external stimuli, and drive rhythms elsewhere in the body. The observation of these 
special properties of the SCN supported the notion that the SCN functioned as a 
collection of circadian pacemaker cells - pacemaker cells that were inherently different 
from cells residing in peripheral (non-SCN) tissues.  
Circa 1997, Steve Reppert’s and other laboratories began unveiling the molecular 
architecture of the core clockwork operating within the SCN (131, 132). It was shown at 
the message (mRNA) level and via protein profiling or direct gene knock-out studies that 
the core clock components oscillated in a circadian manner and functionally comprised 
molecular feedback loops that not only regulated the daily progression of their own 
rhythmic expression but, also, the normal 24-hour progression of overt circadian rhythms, 
in general. These findings fully supported a synthesis of ideas proposing that circadian 
rhythms of behavior and physiology extended from circadian rhythms of gene expression, 
a doctrine examined in this body of work. That the oscillations of the core clock genes 
were self-sustaining within the SCN, in vivo and in vitro, also gave rise to the designation 
of these genes as the ‘molecular gears’ of the ‘SCN clockwork’  (131, 132). Hence, since 
the SCN was believed to be inherently distinct from non-SCN tissues, the discovery that 
these molecular gears were expressed in the SCN began to fill in some of the gaps in 
explaining just how SCN cells were unique from non-SCN cells. However, very 
important experimental observations would soon emerge and actually uproot the notion 
that the SCN alone were distinguished by the expression of clockwork genes. 
During the late 1990s, the use of serum-shock and cell synchronization paradigms 
in cell culture-based experiments was unequivocally demonstrating that non-SCN cells, 
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i.e. rat-1 and NIH/3T3 fibroblasts, could also display high-amplitude circadian 
oscillations of clock gene expression (15, 16, 8, 9, 10). And, by the turn of the century, 
real-time analysis of gene expression in non-SCN tissues had revealed that intrinsic 
circadian rhythms of clock gene expression were definitely not an exclusive feature of the 
SCN. The real-time recordings of circadian oscillations of PERIOD2::LUCIFERASE 
expression in non-SCN tissue explants and in individual cells derived from transgenic 
PERIOD2::LUCIFERASE-SV40 knock-in mice removed all doubt that even non-
differentiated cells, i.e. fibroblasts pulled from the tip of the mouse tail, could exhibit 
persistent cell-autonomous rhythms of gene expression in the absence of SCN cell-
derived signals (162, 159). Thus, the earlier perception that the SCN functioned to drive 
circadian rhythms throughout the body was not completely correct. What seemed to be a 
more precise interpretation of the sum of all experimental observations to this point was 
that the SCN functioned to synchronize or provide coordination among downstream 
oscillators residing in non-SCN tissues.  
The finding that molecular rhythms were also presents in non-SCN cells and 
tissues prompted scientists in the field, even SCN-centrics, to redress the fundamental 
properties of the SCN that distinguished its cells from cells residing in peripheral tissues. 
To accomplish this task, two general experimental fronts were at work within the field: 1) 
comparative microarray-based analyses of the transcriptomes in SCN and peripheral 
tissues and 2) comparative physiological and functional analyses of cell-culture models 
that emulated the SCN and peripheral tissues.  
First, microarray-based studies were undertaken to identify SCN cellular pathways 
regulated by the core clockwork in the mouse, a model system with a relatively well-
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annotated genome at the time, to, not only, verify and characterize the gene-based 
doctrine of circadian regulation of cell function but, also, to shed light on molecular 
elements that might distinguish the SCN from non-SCN tissues such as liver, heart, and 
kidney (114, 149, 147, 67). These microarray-based studies clearly demonstrated that the 
molecular clockwork operating in the SCN coordinated rhythmicity in the expression of 
numerous genes that controlled diverse biochemical, cellular and physiological processes 
within the murine SCN, in vivo (114, 149). But, for comparative analyses, i.e. murine 
SCN vis-à-vis liver, heart, and kidney, the quintessential finding was that very few of the 
rhythmic genes expressed in the SCN were rhythmically expressed in any of a number of 
peripheral tissues (33). At the level of the transcriptome, distinctions between the SCN 
and peripheral tissues were easily seen.  
This first experimental front also sought to identify genes and cell pathways that 
might function as SCN output signals, e.g. neuronal and diffusible signals that conveyed 
coordination of rhythmicity to non-SCN tissues, by means of their rhythmic expression in 
the SCN. Because some of these rhythmic genes, i.e. Prokineticin 2 and Tgf-α, were 
found to operate within neuronal or cell signaling pathways, these genes were fair game 
to screen as candidate output signals in the coordination of circadian rhythmicity in non-
SCN tissues (24, 73, 145). However, a major hurdle in pursuing the goal of identifying 
output signals was gene selection: Which of the hundreds of genes expressed in the SCN 
were relevant to the indigenous functional properties of the SCN? While functional 
classification of the genes rhythmically expressed in SCN tissue could provide some 
insight regarding the potential role of a gene in a SCN output pathway, it did not 
completely compensate for the strategic confines of some of the earlier microarray-based 
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studies. In general, these studies did provided a characterization of the scope, function, 
and functional diversity and prevalence of rhythmic genes expressed in SCN and non-
SCN tissues. However, what was needed to achieve the goal of directly identify candidate 
SCN output signals was the use of microarray-based analyses as an exclusionary screen. 
The second experimental front at work in the field focused on comparative 
physiological and functional analyses of cell-culture models that emulated the SCN and 
peripheral tissues. To examine the physiological and functional properties of the SCN 
that distinguish its cells from those residing in peripheral tissues, David Earnest and co-
workers developed an immortalized SCN (SCN2.2) cell line. SCN2.2 cells were shown to 
retain many of the properties of the SCN, in vivo and in vitro, and display functional 
properties that are unique vis-à-vis non-SCN cells, i.e. NIH/3T3 fibroblasts. For instance, 
a prominent feature of SCN2.2 cell cultures is their capacity to exhibit intrinsic circadian 
rhythms of endogenous molecular and metabolic functions, a characteristic not observed 
in cultures of non-SCN cells, presumably because these cells lack the capacity to self-
synchronize. Another notable property is that SCN2.2 cells can communicate circadian 
rhythms of metabolism and gene expression to co-cultures of NIH/3T3 fibroblasts by 
means of a diffusible signal. Again, this property is not observed in non-SCN cells, as 
inferred from the observation that NIH/3T3 cells cannot coordinate or synchronize 
rhythms in co-cultured fibroblasts (8, 10). Thus, at physiological and functional levels, 
marked distinctions are also observed between SCN cells and non-SCN cells: 1) SCN2.2 
cells show intrinsic synchrony whereas NIH/3T3 fibroblasts do not and 2) SCN2.2 cells 
can coordinate rhythms in non-SCN cells whereas NIH/3T3 fibroblasts cannot. 
 124 
 
The tractability of SCN2.2 cells as an in vitro model and the clear functional 
distinctions observed between SCN2.2 cells and NIH/3T3 fibroblasts provided us with an 
opportunity to address goals that earlier microarray-based analyses of SCN and non-SCN 
tissues could not address. Namely, it was now possible to identify of a small set of 
rhythmic genes expressed within SCN cells, in vivo and in vitro, that were likely to 
underlie the unique functional properties of SCN cells. In fact, a direct microarray-based 
comparison of SCN2.2 cells and the rat SCN seemed to be a good first approach in 
pursuing the identification of rhythmic genes expressed in SCN cells that were 
functionally-relevant to their indigenous properties. We considered this approach to be 
the initial stages of a new, third, experimental front that incorporated a much needed and 
robust microarray-based screen to identify a small group of candidate genes and cell 
pathways by means of excluding genes not likely involved in the unique properties of 
SCN cells. We hypothesized that comparative circadian profiling of the transcriptome in 
SCN2.2 cells and the rat SCN, in vivo, would isolate a set of genes relevant to the 
functional properties observed in SCN2.2 cells (CHAPTER II). We predicted that these 
genes would work in cell pathways to 1) couple the cell-autonomous rhythm properties of 
individual SCN cells so as to permit ensemble 24-hour rhythms of cell function and / or 
2) coordinate circadian rhythms in non-SCN cells.  
Based on this initial comparative analysis (CHAPTER II), we found that many 
SCN-like global and circadian properties of gene expression were conserved in SCN2.2 
cells. SCN2.2 cells and the rat SCN show 1) similar properties with regard to mRNA 
expression levels for many rhythmic and non-circadian genes, 2) oscillations in the 
expression of the core clock genes, and 3) many (35%) of the rhythmically-regulated 
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genes in SCN2.2 cells display rhythmic mRNA expression in the rat SCN, in vivo.  A 
major finding derived from this study was that a predominance of genes rhythmically 
expressed in both SCN2.2 cells and the rat SCN were affiliated with cellular or systems-
level communications and energetics pathways. Using functional and cartographic 
analyses, several of the rhythmic genes operating in these pathways were found to 
function at strategic points of pathway regulation. Thus, an important insight derived 
from the findings of this study was that the flow of temporal information to and from the 
clockwork mechanism in SCN cells might be achieved through the rhythmic regulation of 
key elements operating within cell signaling and energetics pathways.  
Notably, at the heart of this comparative microarray-based analysis, was the 
identification of a special set of genes. This set of genes was special because it housed 
genes rhythmically expressed in both SCN models and many of these genes showed 
functional relevance to the indigenous properties of SCN cells by means of their 
affiliations with cellular or systems-level communications and energetic pathways. Nerve 
growth factor induced–A (Ngfi-A), Inducible nitric oxide 2 (iNos/Nos2), 
Monocarboxylate transporter (Mct1/Slc16a1), Glucose transporter/solute carrier family 2, 
member 1/ (Glut1/Slc2a1), Phosducin-like protein (Pdcl/Phlp), and SAP kinase/mitogen-
activated protein kinase 12 (Mapk12/Erk-6) are prominent examples of the 57 genes in 
this group. Knowledge that these genes were rhythmically regulated in the SCN and 
SCN2.2 cells and operating in cell pathways that potentially underpinned one or more of 
the unique properties of SCN cells was a major step towards advancing the field’s 
understanding of the molecular basis of SCN cellular function.  
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Soon, however, pressure was mounting for us to start addressing the $64,000 
question: Did one or more of these genes or their affiliated cellular pathways actually 
underpin the capacities of SCN2.2 cells to exhibit intrinsic rhythmicity and coordinate 
oscillatory properties in co-cultured NIH/3T3 cells? What was needed was an 
experimental determination of functional relevance. But which of the 57 genes in this 
special set was most likely to be functionally relevant to the hallmark indices of circadian 
function exhibited by SCN2.2 cells? And, should we focus on candidate genes that might 
function in cell pathways to coordinate rhythms in downstream oscillators or those that 
might underlying the capacity of SCN2.2 cells to self-synchronize? Indeed, one or more 
of the genes identified at the heart of this study could influence both types of indigenous 
properties. 
One of the signaling pathways that rose to the top was the NO/Nos2 signaling 
pathway.  Nos2 was the only one of three NOS isoforms that was found by means of our 
comparative circadian profiling study to be rhythmically expressed in SCN2.2 cells and 
the rat SCN. And, previous analysis of generalized inhibition of NOS isoforms was 
shown to disrupt the endogenous rhythmic properties of SCN2.2 cells whereas isoform-
specific knockouts (Nos1 and Nos3) in mice produced no significant perturbations of 
circadian behavioral properties, in vivo. Based on these observations, we hypothesized that 
the NO/Nos2 pathway, functioned importantly in the coupling of individual SCN oscillator 
cells. The testing of this hypothesis using the SCN2.2 cell line seemed to be a logical path 
to pursue. Yet, critical insight that provided additional support for investigating this 
pathway was extended from a plausible alternate hypothesis: the NO/Nos2 pathway 
might also function as a SCN output pathway that coordinates circadian rhythms in co-
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cultured NIH/3T3 cells. This alternate hypothesis was given force and form by the second 
major aim of our experimental front - Circadian profiling of the transcriptome in 
NIH/3T3 cells: comparison to SCN2.2 cells and the rat SCN (CHAPTER III).  Because 
SCN2.2 cells were shown by Allen and co-workers (2001) to retain the capacity to 
synchronize circadian oscillations in co-cultured NIH/3T3 fibroblasts by means of a 
diffusible factor, we hypothesized that rhythmic genes expressed in SCN2.2 cells and the 
rat SCN but not NIH/3T3 fibroblasts would function critically in the capacity of SCN 
cells to coordinate circadian oscillations in non-SCN cells (8, 10).  
To test this hypothesis, it was necessary to conduct a thorough circadian profiling 
of the transcriptome in NIH/3T3 fibroblasts (CHAPTER III). Motivation for such an 
analysis arose from the fact that a comprehensive understanding of the genes and cell 
pathways regulated by the clockwork in NIH/3T3 cells was lacking. Indeed, knowledge 
of the scope, diversity, and functional facets of circadian regulation in NIH/3T3 cells was 
not only critical for the generation of hypotheses regarding the functional distinctions 
seen between SCN and non-SCN cells but, also, important in identifying common 
elements of circadian regulation among different types of oscillators. Secondly, the set of 
genes identified by our initial comparative analysis (SCN2.2 cells vis-à-vis rat SCN) was 
still rather large (N=57) (CHAPTER II). Because non-SCN cells had been shown to 
exhibit intrinsic rhythms of gene expression, it was necessary to address the issue of 
whether some of the genes housed within this initial set of rhythmic genes were also 
rhythmically expressed in NIH/3T3 fibroblasts, even though these cells did not exhibit 
similar functional features of SCN2.2 cells. Thus, by means of an exclusionary screen, a 
modus operandi exploited by Richter and co-workers in identifying the hypothalamus as 
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the region of the mammalian brain housing the circadian clock, we predicted that we 
would identify a small subset of rhythmic genes that were specific to SCN cells and 
highly likely to function critically in either synchronizing and / or coordinating circadian 
oscillations in non-SCN tissues.  
Based on the circadian profiling of the transcriptome in NIH/3T3 cells, a small 
proportion (2.6%) consisting of 157 unique genes and 166 ESTs or genes of unknown 
function was distinguished by rhythmic profiles in these fibroblasts (CHAPTER III). A 
prevalence of these rhythmic transcripts was functionally-affiliated with cell 
communication, defense and detoxification, and cytoskeletal pathways. These findings 
are consistent with reports of rhythmic genes expression in other fibroblasts (rat-1 and 
3Y1 fibroblasts) (32, 47). For instance, genes such as Annexin, Rora, Cdk4, Ubiqutin-like 
protein 4 (Ubl4), histone H2a, Ig kappa chain V-region, and RAN GTPase activating 
protein 1 represent rhythmically-expressed genes that were commonly regulated in 
NIH/3T3 cells and other fibroblast lines (Table A.4). The comparable extents and similar 
functional profiles of circadian regulated genes observed among NIH/3T3 cells and these 
other fibroblasts lines provided additional substantiation, beyond that already established 
by our co-culture model (8, 10), for the use of NIH/3T3 cells as a peripheral oscillator 
model in our comparative microarray-based screen. 
Next, to screen for output signals that functionally distinguish SCN cells from 
peripheral-type oscillators in which the canonical clockworks are similarly regulated, the 
rhythmic behavior of the transcriptome in forskolin-stimulated NIH/3T3 fibroblasts was 
analyzed and compared to rhythmic genes identified in SCN2.2 cells in vitro and the rat 
SCN (CHAPTER III). This comparative examination revealed that similar to the 
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circadian profiling of the SCN2.2 and rat SCN transcriptomes, NIH/3T3 fibroblasts 
exhibited rhythmic fluctuations in the expression of the core clock genes and functionally 
diverse transcripts, many of which functioned cellular communication pathways. Overlap 
in circadian-regulated transcripts among NIH/3T3 fibroblasts, SCN2.2 cells and the rat 
SCN was limited to the core clock genes and four other genes that mediate fatty acid and 
lipid metabolism or function as nuclear factors. Because earlier microarray-based studies 
had not report these metabolic genes to be commonly expressed among SCN and non-
SCN oscillators, our comparative microarray-based screen provided new insight and 
stimulated questions regarding the functional roles of metabolic pathways within the 
mammalian timekeeping system.  
Yet, the highlight of this microarray-based screen was the identification of a 
select subset of candidate genes (N=28) that were shown to exhibit 1) SCN cell-specific 
circadian expression and 2) functional roles in cell pathways that potentially contribute to 
the indigenous properties of SCN cells function, i.e. self-synchrony and coordination of 
rhythmicity in non-SCN cells. Indeed, this comparative microarray-based analysis of 
SCN cells and NIH/3T3 cells effectively chiseled our initial set of 57 genes to 28 genes. 
Prominent examples of these 28 genes include Malic enzyme 1 (Me1), Monocarboxylate 
transporter (Mct1/Slc16a1), Glycine receptor, alpha 1 subunit (Glra1), N-methyl-D-
aspartate receptor NMDAR2C subunit (Grin2c), Krox-20/early growth response 2 
(Egr2), and, as previously mentioned, Inducible nitric oxide synthase (iNos/Nos2). Thus, 
the identification of genes rhythmically expressed in the SCN in vivo and SCN2.2 cells, 
but not NIH/3T3 cells provided the field with opportunities to investigate a very select 
subset of candidate genes that likely underlie SCN-specific properties. 
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While several cellular pathways/mechanisms are known to be functionally 
involved in the coupling or synchronization of individual SCN cells, including electrical 
and chemical-based coupling (87, 25, 13, 6, 90), our comparative microarray screen 
provided momentum for addressing whether the NO/Nos2 signaling pathway (a novel 
candidate) contributes to either the functional coupling of individual SCN2.2 oscillator 
cells, the coordination of metabolic rhythmicity in cocultured NIH/3T3 cells, or both 
properties. We now had a good candidate gene pathway and we now could address that 
$64,000 question. Experiments described in CHAPTER IV show that SCN2.2 cells 
produce NO and express NOS2 protein independent of forskolin stimulation. We also 
show that antisense oligonucleotide-mediated reduction in the expression of the Nos2 
gene alters the capacity of SCN2.2 cells to exhibit 1) sustained endogenous circadian 
rhythms of metabolism and 2) coordination of oscillatory properties in non-treated 
cocultured NIH/3T3 cells. Because the SCN clock is an autonomous property of 
individual SCN cells (158, 61), the capacity of a population of SCN2.2 pacemaker cells 
to express endogenous rhythmicity and coordinate high-amplitude circadian signals 
controlling oscillations in NIH/3T3 fibroblasts is likely to depend upon their communication 
and coupling. The findings presented in Chapter IV suggest that NO/Nos2 contributes to 
this functional coupling.  
The examination of Nos2 function in SCN2.2 cells have provided a foundation for 
future experiments aimed at investigating the function of other cellular elements that 
potentially underpin the unique pacemaker properties of SCN2.2 cells (CHAPTER III). 
Indeed, a primary goal of our microarray-based screen was the identification of a select 
subset of genes that likely permit SCN cells to function within this context. Thus, the 
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functional roles of the remaining 27 SCN cell-specific rhythmic genes should be explored 
with similar rigor as that applied in our study of Nos2. Along these lines, the importance of 
genes that did not display circadian regulation but did show SCN cell-specific expression 
should not be minimized. Antisense oligonucleotide-mediated knockdown of gene expression 
was a powerful tool in determining that Nos2 was, indeed, functionally relevant to the unique 
properties of SCN2.2 cells and this approach is very applicable to future examinations of other 
candidate genes, rhythmic and non-rhythmic. Ultimately, animal gene knockout models will 
be necessary components in the study of these genes’ functions, in vivo.  
The subsequent challenges in understanding the specific contributions of these 
candidate genes to the properties of SCN cells and the function of the mammalian 
timekeeping system, in general, will depend upon maintaining distinctions between two 
properties: 1) the coordination of rhythmicity in downstream oscillators and 2) self-
synchrony. For example, it is known that NO functions broadly in cell physiology; 
cellular biochemicals known to interact directly with nitric oxide synthases include 
calcium-dependent calmodulin CAM Kinase, soluble guanylyl cyclase, and flavanine 
adenine dinucleotide (FAD). NO can affect both ras- and calcium-based signaling 
pathways directly (7, 112, 109). So, examining how these diverse signaling components 
and pathways interact to affect the capacity of SCN cells to function as a network or their 
capacity to coordinate rhythmicity in downstream cells are important but distinct 
investigative pursuits? Because our investigation of Nos2 function in relation to the 
pacemaker properties of SCN2.2 cells (CHAPTER IV) has not precisely addressed 
distinctions between the coordination of rhythmicity in downstream oscillators and self-
synchrony, future experiments are necessary.  
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Experiments taking advantage of the cell-heterogeneous nature of the SCN2.2 
culture model can facilitate valuable insight regarding these mechanistic distinctions. 
Because coupling between individual SCN neurons has been shown to be critical to the 
ensemble clock properties of the SCN (13, 87), we can address the importance of 
NO/Nos2 in relation to the physical and biochemical network properties of SCN2.2 cells 
(neurons and glia). Additionaly, we will need to explore the functional importance of 
NO/Nos2 in the coordination of intracellular pathways affecting the autonomous clock 
property of SCN cells. Critical questions include whether NO production and diffusion 
rates vary over time, whether the NO/Nos2 pathway provides chemical coupling of 
SCN2.2 neurons directly or through downstream signaling components, i.e. soluble 
guanylyl cyclases, ras, and calcium, and whether SCN2.2 glial cells are necessary for this 
coupling (Fig. 19). The outcome of these experiments will be critical in shaping 
questions regarding NO/Nos2 function in vivo. In a similar fashion, continued 
investigation of genes selectively identified as SCN outputs by means of our comparative 
examinations of the transcritpome in bona fide peripheral oscillator and circadian 
pacemaker models will be useful in advancing our understanding of circadian timing as it 
extends from cell to tissue to organism – then back to the cell.   
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       DESYNCHRONY                           SYNCHRONY 
 
Fig. 19. Possible modes of NO/NOS2 operation in SCN2.2 cells. In a population a 
desynchronized SCN oscillators, NO may function critically in relation to the cell 
autonomous clock property of individual SCN neurons (blue ?) or in the coordination of 
interacellular pathways that function to synchronize the electrical activities of these 
neurons and, presumably, metabolic activities in glial cells (grid).  Importantly, these two 
modes of NO function in SCN2.2 cells need not be mutually exclusive. While it is not 
known if NO levels vary over time in SCN2.2 cell cultures, evidence for circadian 
fluctuations of extracellular NO, as assessed by the presence of nitrite in the dorsal SCN 
(102), suggests NO has the potential to act as a rhythmic synchronizing signal for 
SCN2.2 cells and, perhaps, for cocultured NIH/3T3 cells as well. Circadian peaks in the 
expression of Nos2/NO could broadcast temporal cues through several cell-signaling 
pathways affected by NO.  
NO
NO
NO NO
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NO
NO NO
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In summary, a major distinction between SCN and non-SCN cells is not 
necessarily attributable to inherent differences in their capacities to exhibit clockwork 
oscillations but rather their different capacities to self-synchronize and extend oscillatory 
coordination to non-SCN cells. The subsequent challenges in understanding the specific 
roles of pacemaker genes such as Nos2 in the function of the mammalian timekeeping 
system will depend on the parsing of important functional distinctions. Investigation of 
cell pathways facilitating the functional coupling of SCN cells (158, 128) is immensely 
important in regards to enhancing our knowledge of how the SCN functions as a self-
sustaining network of circadian oscillators. Equally important is the identification and 
investigation of potential SCN output pathways that coordinate oscillatory behavior in 
cells residing in non-SCN peripheral tissues. Our comparative analysis of circadian gene 
expression in SCN2.2 cells, the rat SCN, and NIH/3T3 fibroblasts offers important 
insights and implications in the selective analysis of circadian signals involved in the 
coupling of SCN oscillators and the regulation of rhythmicity in downstream oscillator 
cells. Specifically, our study has provided the field with a select subset of candidate genes 
to examine in these functional contexts. One of these genes is Nos2. 
Yet, our analyses do possess some caveats that must be mentioned. First, despite 
the similarities in circadian regulation of the transcriptome in SCN2.2 cells and the rat 
SCN, there was not complete overlap in the rhythmically-regulated genes between these 
experimental models as SCN2.2 cells are not completely representative of the SCN. This 
difference may be related to comparative differences in the cellular heterogeneity of 
SCN2.2 cells and the SCN in vivo or may reflect the absence of extra-SCN factors that 
normally influence SCN rhythmicity in vivo. Secondly, for SCN2.2 cells, our functional 
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analysis revealed that a majority of annotated circadian-regulated genes were associated 
with cellular and systems-level communication functions. Although the prevalence of 
rhythmic genes in this category is consistent with studies documenting their importance 
in the circadian photoentrainment and pacemaker functions of the SCN, a marked bias for 
genes affiliated with cellular and systems-level communication was represent on the rat 
genome U34 GeneChips used in this examination. Finally, our comparative analysis of 
the transcriptome in NIH/3T3 cells, the rat SCN, and SCN2.2 cells did not cover all of 
the genes represented on each of the different GeneChips but, rather, the set of 
homologous genes commonly represented on both GeneChips. It is probable that new 
SCN-specific genes as well as new commonly-regulated genes will arise from future 
bioinformatic analyses of our GEO data sets as knowledge of gene homology and gene 
function advances. Thus, new insights and novel interpretations may evolve from the data 
and findings of this study as it is revisited from time to time. 
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APPENDIX 
Table A.1. Functional categorization of circadian regulated genes in SCN2.2 cells (secondary 
expression criteria).   
GenBank ID 
Locus Link 
ID Gene descriptor 
Phase 
group 
Category 1 - Energetics (11)   
X73653  84027 Glycogen synthase kinase 3 beta III  
AA684929  NF Similar to NADH-ubiquinone oxidoreductase III  
X59737  29593 Ubiquitous mitochondrial creatine kinase (Ckmt1) III  
AI070142 24624 Propionyl coenzyme A carboxylase, beta polypeptide I 
U28975  116509 Glycine transporter 1 (Glyt1) I  
X80395  60422 
Acetylcholine transporter (vesicular) / solute carrier family 18, member 3 
(Slc18a3) II  
AF031234 NF Ileal sodium-dependent bile acid transporter III 
L32601  171516 20 alpha-hydroxysteroid dehydrogenase (2α-Hsd) III  
AA818403  LOC299564 Similar to cytochrome P450 4F5 (Cyp4f5) III  
J05035  24950 Steroid 5-alpha-reductase (Srd5a1) IV  
AA892232  81759 Renin-binding protein (Renbp) II  
    
Category 2 - Cellular and Systems-level Communication (54)  
D28512 25731 Synaptotagmin 3 (Syt3) II-III  
AF044201  246274 Neural membrane protein 35 / lifeguard (Lfg) II  
AB003991  25012 Synaptosomal-associated protein (Snap25) III  
U26402 54309 Synaptotagmin 5 (Syt5) IV-I 
X17184  50592 Glutamate receptor, ionotropic, AMPA1(Gria1) I  
S94371  29629 Glutamate receptor, ionotropic, AMPA4 (Gria4) I  
X74835  54240 Cholinergic receptor, nicotinic, delta polypeptide (Chrnd)  II  
D00833  25674 Glycine receptor, alpha 1 subunit (Glra1) III  
U31815 24239 Voltage-dependent channel, alpha 1C subunit (Cacna1c/Rob2) I 
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Table A.1 continued 
AF061266  89821 Transient receptor protein 1 (Trrp1) IV  
X83581 29719 Inwardly-rectifying channel, subfamily J, member 16 (Kcnj16) II 
AJ007628  114032 Voltage-gated channel, subfamily H, member 4 (Kcnh4) II  
U75210 117018 Voltage-gated channel, subfamily H, member 2 (Kcnh2) / Erg (r-erg) II-IV  
M31433  24766 Voltage-gated, type 2, alpha 1 polypeptide (Scn2a1) II  
Z36944  60586 Putative chloride channel (similar to Mm Clcn4-2) II  
AB013112  65054 Aquaporin 9 (Aqp9) III  
X92070  25041 Purinergic receptor P2X-like 1 (P2rxl1) II  
L40030  94203 Placenta growth factor (Pgf) I  
D90219  114593 Natriuretic peptide precursor, C-type (Nppc) I  
X55183  29183 Amphiregulin (Areg) I  
M23643  25569 Thyrotropin-releasing hormone (THR)  II  
K01701  25504 Neurophysin / oxytocin (Oxt)  II  
L00111  24241 Calcitonin / calcitonin-related polypeptide, alpha (Calca) II  
X58294  54231 Carbonic anhydrase 2 (Ca2) II-III  
X56551  29348 Fibroblast growth factor 7 (Fgf7) II-III  
M12579  25194 Gonadotropin-releasing hormone 1 (Gnrh1) IV-I  
L10072  25689 5-hydroxytryptamine (serotonin) receptor 5A (Htr5a) II  
M84009  25432 Dopamine receptor D4 (Drd4) II  
AF041244  25593 Orexin receptor-1 / hypocretin receptor 1 (Hcrtr1) I  
U04738 25555 Somatostatin receptor subtype 4 (Sstr4) II 
L02842  25449 Follicle stimulating hormone receptor (Fsh-r) II  
D43778  24182 Angiotensin II type 2 receptor (Agtr2) II  
E12742  
LOC305384 
OR 12425 
Similar to cholecystokinin-A receptor / cholecystokinin A receptor 
(Cckar) III  
AF091574  65140 Olfactory receptor 41 (Ol41) III  
AF091576  LOC315571 Similar to olfactory receptor MOR171-5 / HFL-VN1  III  
X89701  LOC302957 Similar to olfactory receptor-like protein 5 / TPCR13  III  
AA848831  116744 Endothelial differentiation G-protein-coupled receptor, 2 (Edg2) III  
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Table A.1 continued 
AB009463  89787 Low density lipoprotein receptor-related protein 3 (Lrp3) III  
AI639289 266806 Rab6 interacting protein 2 (Elks) III 
AF064868  79146 Brain-enriched guanylate kinase-associated (BEGAIN) III  
M82826  24592 Neurofibromatosis protein type I (NF1) III  
M18332  25522 Protein kinase C, zeta (Prkcz) II  
L36088  25237 Serine-threonine kinase receptor / activin a rec. type II-like 1 (Acvrl1) II  
D86556  29660 Pregnancy upregulated non-ubiquitously expressed CaM kinase (Pnck) II  
X96488  60352 SAP kinase / mitogen-activated protein kinase 12 (Mapk12/Erk-6) II  
U21954 171287 Eph receptor A7 (Epha7) III 
U48596  116667 MAP kinase kinase kinase 1 (MEKK1/Map3K1) III  
M31809 24675 Protein phosphatase 3, catalytic subunit, beta (Ppp3cb) I 
AJ011035 85240 Phospholipase C beta (Plcb2) III 
U73458  29714 Protein tyrosine phosphatase, receptor-type, N polypeptide 2 (Ptprn2) I  
AA892207  LOC292426  Similar to zinc finger Krab I  
U01146  54278 Nuclear receptor subfamily 4, group A, member 2 I  
AI234969  54254 Gata-binding protein 4 (Gata4) II  
L13202  29203 Forkhead box D3 (Foxd3) II  
    
Category 3 - Protein Dynamics (5)  
J00778  24691 Pancreatic trypsin (Prss1) II  
AA892512 LOC361205 Similar to LECT2 I  
X59608  
Close to 
LOC287438 Similar to DNA directed RNA polymerase II subunit I  
U30813  LOC315406  Aspartyl-tRNA synthetase (pseudogene) III  
AA875646 246303 Hypothetical RNA binding protein RDA288 (Rda288) III  
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Table A.1 continued  
Category 4 - Cellular Development (7)  
U24174  114851 Cyclin-dependent kinase inhibitor 1A (Cdkn1a) I  
AB000216  171440 Ankyrin repeat protein (Cca3) I  
U73586  24361 Fanconi anemia group C (Fancc) III  
U08290  94270 Neuronatin alpha (Nnat-alpha) I  
AI070026  24452 Homeobox gene A11 / Homeo box A2 (Hoxa2) II  
M31076  24827 Transforming growth factor alpha (Tgfa) IV-I  
    
Category 5 - Defense and Detoxification (12)  
U09815  24256 Carcinoembryonic antigen (CGM3) I  
X62325  LOC290188 TcRValphaT48a2 / T cell receptor V-alpha J-alpha I  
M23889  24820 T-cell receptor beta chain (Tcrb) I-II  
L37971  NF T-cell receptor alpha-chain (Tcra) II  
S79523  29259 Lymphocyte selectin / L-selectin (Sell) II  
L07398  LOC314510 Similar to immunoglobulin heavy chain III  
AF006619, D83661, 
S71597, and U03699 24599 Inducible nitric oxide synthase (iNos/Nos2) I-III  
Z69594 25259 Glycoprotein 5 (Gp5) IV-I  
X57565 63867 UDP-glucuronosyltransferase 2A1 (Ugt2a1) II  
AA818499  298423 Lauric acid omega-hydroxylase / cytochrome P-450, 4a3 (Cyp4a3) III  
X62086 25642 Cytochrome P450, subfamily 3A, polypeptide 3 (Cyp3a3) III  
AF072865 50551 Thioredoxin reductase (TrxR2) IV-I  
    
Category 6 - Cytoskeleton and Adhesion (10)  
M92074 29248 Troponin I, type 3 (Tnni3) I  
L24776  117557 Tropomyosin 3 (Tmp3) II-III  
AF075250 29605 Myosin heavy chain polypeptide 13 (Myh13) III  
AA799508 64862 Microtubule-associated proteins 1A/1B light chain 3 (Mpl3) IV  
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Table A.1 continued    
S79214 25681 Procollagen type X (Col10a1)  II  
X06564 24586 Neural cell adhesion molecule 1 (Ncam1) III  
X63722 25361 Vascular cell adhesion molecule 1 (Vcam1) III-IV  
X71466 81686 Matrix metalloproteinase 2 (Mmp2) II 
X02601 171045 Matrix metalloproteinase 3 (Mmp3) II  
    
 
ESTs and Genes with Unknown Function (32)  
AA800680  LOC311794 Similar to ankyrin-repeat protein Nrarp I  
AA799678  54702 EGL nine homolog 3 (Egln3 ) I  
M31032  192266 Glutamine/glutamic acid-rich protein (Grp-Ca)  II  
M19357  301472 Gamma-F-crystallin, gamma 4-1 (Crygf) III  
AA799552 LOC303472 Similar to ankyrin-repeat protein Nrarp I 
AA800218 LOC304496  I 
AA894318 EST  I 
AI639028 EST  I 
AI639525 EST  I 
H31747 EST  I 
AA874978 
Close to 
LOC315114  I 
AA892526 EST  I 
AA800717 LOC300670  I-II 
AA874877 EST  II 
AA892561 EST  II 
AA893192 close to 170847  II 
AI639027 LOC310568  II 
AI639201 LOC305631  II 
AI639422 
Close to 
LOC289234   II 
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Table A.1 continued    
H33301 EST  II 
H33448 LOC296361  II 
AA875255 LOC305540  II-III 
AA859718 LOC306328  III 
AI638972 EST  III 
AI639305 LOC289479  III 
H31982 EST  III 
D84482 
Close to 
LOC301336  III 
U34897 LOC310146  III 
AA893366 
Close to 
LOC293171  III 
U31866 
Close to 
LOC305204  III 
AA944973 LOC302035   IV 
 
    Functional categorization of circadian-regulated genes in SCN2.2 cells. Similar to Table 1, the GenBank, Locus Link ID, 
functional category/cluster and Phase Group assignment are listed for unique genes and ESTs that surpassed secondary 
expression criteria and showed rhythmic patterns of mRNA expression. 
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Table A.2. Functional categorization of circadian-regulated genes in the rat SCN (stringent 
expression criteria).   
GenBank ID Locus Link ID Gene descriptor 
Phase 
group 
Category 1 - Energetics (34)   
Cluster 1 - Glucose metabolism and mitochondrial energy transduction (7)  
J01436 NF Cytochrome B III 
L25387 60416 Phosphofructokinase C (PFK-C/Pfkp)  I 
L11694 24645 Phosphoglucomutase 1 (Pgm1) I-II 
K00750 25309 Cytochrome c, somatic (Cycs) I 
J01435 26196 ATP synthase 8, mitochondrial (mt-Atp8) I-II 
AI171506 24552 Malic enzyme 1 (Me1) II 
M27467 54322 Cytochrome oxidase subunit Vic (Cox6c) III 
    
Cluster 2 - Lipid and fatty acid metabolism (4)  
U02096 80841 Fatty acid binding protein 7, brain (Fabp7) II 
J02585 246074 Stearoyl-Coenzyme A (CoA) desaturase 1 (Scd1) I 
D90109 25288 Long chain fatty acid coenzyme A (CoA) ligase (Facl2) I-III 
X57988 29534 Peroxisomal membrane protein 3 (Pxmp3) I 
    
Cluster 3 - Transporters (3)  
D63834 25027 Monocarboxylate transporter (Mct1/Slc16a1) I 
S68135 58971 Glucose transporter / solute carrier family 2, member 1 / (Glut 1/Slc2a1) IV 
AA800202 25391 Similar to bicarbonate transporter related protein 1 (Slc4 11) I 
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Table A.2 continued 
Cluster 4 - Miscellaneous metabolism (20)  
M95768 81652 Di-N-acetylchitobiase (Ctbs) I 
M95591 29580 Farnesyl diphosphate farnesyl transferase 1 (Fdft1) III 
M84719 25256 Flavin-containing monooxygenase 1 (Fmo1) III 
L34262 29411 Palmitoyl-protein thioesterase (Ppt)  I 
M26686 25604 Protein-L-isoaspartate (D-aspartate) O-methyltransferase (Pcmt1) I-III 
M19533 25518 Peptidylprolyl isomerase A (Ppia) I 
S77494 24914 Lysyl oxidase (Lox) II 
S72505 LOC360447 Glutathione S-transferase I 
U07971 81660 L-arginine:glycine amidinotransferase (Gatm) I 
J03481 64192 Quinoid dihydropteridine reductase I 
L19998 83783 Sulfotransferase family 1A, phenol-preferring, member 1 (Sult1a1) IV 
U81186 84013 
Smooth muscle-specific 17beta-hydroxysteroid dehydrogenase type 3 
(Hsd17b12) I 
U83880 25062 Glycerol-3-phosphate dehydrate dehydrogenase (mtGPDH/Gpd2) I-II 
X78949 64475 Prolyl 4-hydroxylase alpha subunit (P4ha1) I 
X08056 25257 Guanidinoacetate methyltransferase (Gamt) IV 
Y12178 24268 Bilitranslocase / Ceruloplasmin (Cp) III 
X16554 29562 Phosphoribosylpyrophosphate synthetase subunit I (Prps1) I 
AI177004 29637 Hmgc synthase 1 (Hmgcs1) I 
M10934 25703 Retinol-binding protein / retinol binding protein 4, plasma (RBP/Rbp4) II 
AF043642 83624 Matrin cyclophilin (Matrin-cyp/Ppig) III 
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Table A.2 continued 
Category 2 - Cellular and Systems-level Communication (64)  
Cluster 1 - Neurotransmission (15)  
Glutamatergic metabolism and signaling 
(6)   
M61099 24414 Metabotropic glutamate receptor 1 (Grm1) I 
M92076 24416 Metabotropic glutamate receptor 3 (Grm3)  I 
M83561 29559 Glutamate receptor, ionotropic, kainate 1 (Grik1) I 
U08259 24411 N-methyl-D-aspartate receptor NMDAR2C subunit (Grin2c) III 
AF093267 and 
AF093268 29546 Homer1 and splice variant 1b, neuronal immediate early gene, 1 (Homer1) I-III/I
X63744 29483 Glutamate transporter (Glut-1) / solute carrier family 1, member 3 (Slc1a3) I 
Synaptic function and maintenance (4)   
M64780 25592 Agrin (Agrn) I 
AB003991 25012 SNAP-25A I 
L20821 81803 Syntaxin 4 (Stx4a) I 
AF007758 29219 Synuclein 1, alpha (Snca) I 
Miscellaneous neurotransmission (5)   
M63901 25719 7B2 protein / Secretory granule neuroendocrine, protein 1 (Sgne1)  I 
M22254 24766 Sodium channel, voltage-gated, type II, alpha polypeptide (Scn2a1) I 
U01344 116631 A-2 arylamine N-acetyltransferase 1 (Nat1) I-III 
U78090 245960 Potassium channel regulator 1 I 
M86621 25399 
Dihydropyridine-sesitive L-type calcium channel alpha-2 subunit 
(Cacna2d1) II 
    
Cluster 2 - Extracellular factors (2)  
M62641 24659 Pro-melanin-concentrating hormone (Pmch) IV 
S49491 29237 Proenkephalin related sequence (Penk-rs) III 
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Table A.2 continued 
Cluster 3 - G-protein coupled receptors and associated proteins (10)  
M64236 24807 Tachykinin receptor 1 / Substance P receptor (Tacr1/SPR)  IV-I 
U12568 64664 ADP-ribosylation factor-like protein 3 (Arl3/Rard3) I 
AF076619 58844 Growth factor receptor bound protein 14 (Grb14) I-II 
AF091563 309574 Olfactory receptor gene (Olr1687/QIL-LD1)  III-IV
L12380 64310 ADP-ribosylation factor 1 (Arf1) I 
AJ001320 29365 Multiple PDZ domain protein (Mpdz) II 
U76206 171108 G protein-coupled receptor 105 (Gpr105) I 
X57764 50672 Endothelin receptor type B (Ednrb) I 
X55812 25248 Cannabinoid receptor 1, brain (Cnr1) I 
X52311 117180 Unr protein (Unr) I-III 
    
Cluster 4 - Cytosolic signaling factors and transducers (21)  
M83298 117104 
Caldesmon 1 / protein phosphatase 2, regulatory subunit B, alpha 
(Ppp2r2a) I 
L36088 25237 Activin receptor like  kinase 1 / activin A receptor type II-like 1 (Acvrl1) III 
U26397 80849 Inositol polyphosphate 4-phosphatase (Inpp4a) I 
U48288 25228 A-kinase anchoring protein (Akap11) I 
D84346 58823 NCK-associated protein 1 (Nckap1) I 
U15734 29218 
Reticulocalbin 2 / Taipoxin-associated calcium binding protein-49 
(Rcn2) I 
U17901 116645 Phospholipase A-2-activating protein (Plap/Plaa) I 
U16655 140693 Phospholipase C delta-4 (Plcd4) IV  
AF095927 64538 Protein phosphatase 2C (Ilkap) III 
AF012714 29688 Multiple inositol polyphosphate histidine phosphatase 1 (Minpp1) I 
D45920 84587 130kDa-Ins(1,4,5)P3 binding protein I 
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Table A.2 continued    
D17521 84360 Protein kinase C-regulated chloride channel / chloride channel 3 (Clcn3) I 
D28560 84050 Ectonucleotide pyrophosphatase/phosphodiesterase 2 (Enpp2) I-III 
X58828 117063 Protein-tyrosine phosphatase, non-receptor type 2 (Ptpn2) I-III 
X16043 NF Phosphatase 2A catalytic subunit isotype alpha I 
U38376 24653 Cytosolic phospholipase A2 (Pla2g4a) IV 
AF080435 64013 Phosducin-like protein (Pdcl) IV-I 
X16044 24673 Ppp2cb: protein phosphatase 2a, catalytic subunit, beta isoform I-II 
AJ000347 64473 3(2),5-bisphosphate nucleotidase (Bpnt1) I 
M93017 170699 Rat alternatively spliced mRNA / ATPase, Ca++-sequestering (Atp2c1) I-II 
    
Cluster 5 - Nuclear factors (16)  
E-box and immediate early factors (6)   
U17254 79240 Nuclear receptor subfamily 4, group A, member 1 (Nr4a1/Ngfi-B) I-II 
AF023087 and U75397 24330 Nerve growth factor induced factor A (Ngfi-A/Egr1) III 
U78102 114090 Krox-20 /  early growth response 2 (Egr2) III-IV
U09228 84382 NE Deaconess E-box binding factor / transcription factor 4 (Tcf4) III 
X96437 294235 Immediate early response 3 (Ler3/PRG1) IV 
AA875032 NF Fos-related antigen, exon 4 I 
Other nuclear factors (10)   
M65251 29721 HIV type 1 enhancer-binding protein 2 (Hivep2) I 
U30381 58820 Zinc finger binding protein 148 (Znf148) I 
U48247 64353 LIM domain-containing protein / enigma homolog (Enh) II-III 
L23148 24370 Inhibitor of DNA-binding 1, splice variant 1d1 III 
U67082 25165 KRAB-zinc finger protein KZF-1 / zinc finger protein 386 (Znf386) I 
M63282 25389 Leucine zipper protein / Activating transcription factor 3 (Atf3) III 
X59993 312440 Putative zinc finger protein / jumonji domain containing 1A (Jmjd1a) I 
L26292 114505 Kruppel-like factor (Klf4) I-II 
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Table A.2 continued    
L06804 117555 
Myristoylated alanine-rich protein kinase C substrate / LIM homeobox 
protein 2 (Lhx2) III 
    
Category 3 - Protein Dynamics (28)  
Cluster 1 - Degradation and synthesis (18)  
M29358 29304 Ribosomal protein S6 (Rps6) I 
U30485 and AI009682 116483 Aspartyl-tRNA synthetase (Dars) I 
U64705 303831 Protein synthesis initiation factor 4AII I 
U11071 LOC298510 Polyadenylate-binding protein-related protein mRNA, 3' end. III 
AF096835 29702 Eukaryotic translation initiation factor 2 alpha kinase 3 (Eif2ak3) II-III 
AB022014 116722 Proteasome (prosome, macropain) 26S subunit, non-ATPase (Psmd10) I-II 
D21800 29676 Proteasome (prosome, macropain) subunit, beta type 3 (Psmb3) IV 
D30804 29674 Proteasome (prosome, macropain) subunit, alpha type 7 (Psma7) II 
D90258 NF Proteasome subunit RC8 I 
L14684 114017 Mitochondrial elongation factor G (Gfm) I 
AF000899 245922 Nucleoporin p58 (p58/p45) I-III 
X96426 25435 Eukaryotic elongation factor-2 kinase (Eef2k) I 
Y00826 58958 Integral membrane glycoprotein gp210 / nuclear pore protein (Pom210) I-III 
X82396 64529 Cathepsin B (Ctsb) II  
X67859 81783 Sjogren syndrome antigen B (Ssb) I  
AA859882 29545 Ubiquitin carboxyl-terminal hydrolase 1 (Uchl1) IV-I  
AA849648 79449 Ribosomal gene L21 (Rpl21) III 
M58340 83840 Ribosomal protein S6 kinase, polypeptide 1 (Rps6kb1) I  
    
Cluster 2 - Protein sorting and trafficking (2)  
J03583 54241 Clathrin, heavy polypeptide (Hc) I 
U75400 60384 Coatomer beta subunit beta 2 (Copb2) I-II 
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Table A.2 continued 
Cluster 3 -Protein modification and folding (8)  
X82021 81800 Heat shock related protein / suppression of tumorigenicity 13 (St13) I 
U95727 84026 DnaJ (Hsp40) homolog, subfamily A, member 2 (Dnaja2) I 
U68562 63868 OR 25462 Chaperonin 60 (Hsp60) and chaperonin 10 (Cpn10/Hspe1) I 
AF006617 29734 
Stress 70 protein chaperone, microsome-associated, 60kD human 
homolog (Stch) I 
S78556 NF 75 kda glucose regulated protein I 
AI236601 Close to LOC288444 Similar to Heat shock protein (Hsp105) I-III 
L11319 65166 Signal peptidase complex (18kD) (Spc18) I 
L18889 29144 Calnexin (Canx) III-IV
    
 
Category 4 - Cellular Development (17)  
Cluster 1 - Cell cycle (1)  
AF030091 114121 Cyclin L1 (Ccnl1) I 
    
Cluster 2 - DNA/chromatin related (5)  
M64986 25459 High mobility group box 1 (Hmgb1) I 
D45254 64530 Cellular nucleic acid binding protein (Cnbp) I 
H33461 117520 Oxidation resistance 1 (Oxr1) I 
U95920 81740 Pericentriolar material (Pcm1) I 
AA964849 25591 ADP-ribosyltransferase 1 (Adprt) III 
    
Cluster 3 - Growth and differentiation (11)  
L13619 64194 Growth response protein /  insulin induced gene 1 (Cl-6/Insig1) I 
U03414 93667 Neuronal olfactomedin-related ER localized protein (D2Sut1e/Olfm1) III 
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Table A.2 continued    
D82074 29458 BHF-1 / Neurogenic differentiation 1 (Neurod1) III 
Y07704 65190 Best5 protein (Best5) III 
U95178 79128 Disabled homolog 2 (Dab2) I 
X62322 29143 Epithelin 1 and 2 / Granulin (Grn) III 
AI014163 29596 Interferon related developmental regulator 1 (Ifrd) I 
D89983 58961 Ornithine decarboxylase antizyme inhibitor (Oazi) I-III 
AF017437 29364 
Integrin-associated protein / CD47 antigen (Rh-related antigen, integrin-
associated signal transducer) (Cd47) III 
D88250 192262 Serine protease / complement component 1 (C1s) II 
    
Category 5 - Defense and Detoxification (10)  
M76740 24573 Intestinal mucin / mucin 3 (Muc3) III 
M81642 25439 Coagulation factor II / thrombin receptor (F2r) II-III 
M86564 29222 Prothymosin alpha (Ptma) I 
U41803 64476 Hypertension-related protein / mitofusin 2 (Mfn2) I-III 
S79676 25166 Interleukin-1 beta-converting enzyme / caspase 1 (Casp1) IV-I 
AF087944 60350 Monocyte differentiation antigen CD14 I-II 
D10926 29436 Tissue factor pathway inhibitor (Tfpi) I 
AF029240 365527 MHC class Ib RT1.S3 (RT1.S3) / RT1 class I, M6, gene 2 II 
L26268 29618 B-cell translocation gene 1, anti-proliferative (Btg1) I 
U90829 84019 APP-binding protein 1 (Appbp1) I 
    
Category 6 - Cytoskeletal and Adhesion (10)  
S85184  Cathepsin L proenzyme III 
U18314 25359 Lamina associated polypeptide 2 / thymopoietin (LAP2/Tmpo)  I 
U09357 25613 Protein tyrosine phosphatase zeta/beta (Ptprz1) I 
AF104362 83717 Osteoadherin / osteomodulin (Omd) I-II  
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Table A.2 continued 
AF097593 83501 Cadherin 2 (Cdh2) I  
AJ012603 57027 A disintegrin and metalloproteinase domain 17 (Adam17) II 
D90401 26955 Afadin (Af6) IV 
M88469 64456 F-spondin (Sponf) I  
X70369 84032 Pro alpha 1 collagen type III (Col3a1) I-III 
M23697 25692 Plasminogen activator, tissue (Plat) I 
    
ESTs and Genes with Unknown Function (138)  
AA799442 EST  I 
AA799466 EST  III  
AA799594 EST  IV 
AA799621 EST  I 
AA799889 EST  I 
AA799899 EST  IV 
AA799971  LOC313369  I 
AA800156  LOC310071  I-III 
AA800184 EST  I 
AA800200  LOC298426  II 
AA800551 EST  I 
AA800693  Close to 83578  I 
AA800701 EST  I 
AA800708  LOC295310  II 
AA800738 EST  IV 
AA800749 EST  III 
AA800782  LOC294082  II 
AA800808 EST  I 
AA800853  LOC305302  II  
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Table A.2 continued 
AA800948 EST  IV 
AA818226 EST  III 
AA849648 EST  III 
AA859652 EST  I-II 
AA859702 EST  I-II 
AA859954 EST  I 
AA859996  LOC305436  II 
AA860030 EST  I-III 
AA860047 EST  I 
AA866383 EST  I 
AA874943  EST  I 
AA875032 EST  I 
AA875190 EST  I 
AA875198 EST  I 
AA875206 114590 Ubiquilin 1 (Ubqln1) I-III 
AA875233 EST  III 
AA875598 EST  III 
AA891035 EST  I 
AA891580 EST  II 
AA891634 EST  I 
AA891681 EST  I 
AA891734 EST  I 
AA891824 EST  I-III 
AA891834 EST  I 
AA891851 EST  I 
AA891872 EST  I 
AA892027 EST  IV  
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Table A.2 continued 
AA892056 EST  I 
AA892083 EST  III 
AA892094 EST  I 
AA892128 EST  III 
AA892306 EST  I 
AA892367 EST  III 
AA892390 EST  I-II 
AA892548 EST  I 
AA892554 EST  I 
AA892557 EST  I-II 
AA892559 EST  III 
AA892598 LOC294523 Similar to hypothetical protein MGC46970 II 
AA892638  EST  I-III 
AA892820 EST  IV-I 
AA892828 EST  I 
AA892859 EST  I-II  
AA892860 EST  I 
AA892863  close to LOC295922  I 
AA893330 EST  I 
AA893436 EST  III 
AA893602 EST  IV-I 
AA893673 EST  II 
AA893853 EST  II 
AA894101 EST  I 
AA894193 EST  I 
AA894259  LOC304206  IV-I 
AA894282 EST  I 
  
175
 
 
Table A.2 continued 
AA894321 EST  III 
AA925473 EST  I 
AA925717 EST  III 
AA943331 EST  III 
AA945169 EST  II 
AA946040 EST  IV 
AA946439 EST  II-III 
AA955859 EST  II 
AA957961 EST  III 
AA963449  Close to Cyp51  I 
AA998683 EST  IV 
AI010357 EST  I 
AI010580 EST  I 
AI012275 EST  I 
AI012595 EST  I 
AI029805 EST  III 
AI102868 EST  IV 
AI103671 EST  I-III 
AI103838 EST  IV 
AI170685 EST  I 
AI170776 EST  I 
AI171090 EST  III 
AI171268 EST  III  
AI171630 EST  I 
AI176170 EST  I-II 
AI177404 EST  I 
AI227887 EST  I 
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Table A.2 continued 
AI229497 EST  IV 
AI230572 EST  III 
AI230602 EST  III 
AI231354 EST  I-II 
AI231807 EST  I-III 
AI233225 EST  I 
AI233365 EST  III 
AI234604 EST  I 
AI236484 EST  I 
AI237592 EST  I 
AI638985 EST  I 
AI639015 EST  I-II 
AI639039  EST  III 
AI639044 EST  III 
AI639076 EST  III 
AI639097  EST  III-IV
AI639128 EST  II 
AI639148  LOC292262  IV 
AI639149 EST  II 
AI639161 EST  II 
AI639187 EST  III 
AI639324 EST  I 
AI639410 EST  I 
AI639413  LOC307334  IV-I 
AI639429 EST  III 
AI639448 EST  III 
AI639521 EST  I 
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Table A.2 continued 
H31323 EST  II 
H33426 EST  II 
H33629 EST  I 
M13100 24540 Long interspersed repetitive DNA sequence LINE3 (Lre3). I 
M91235 NF Rat VL30 element mRNA. I 
U48828 NF Retroviral-like ovarian specific transcript 30-1 mRNA. I-II 
U49058 245924 CTD-binding SR-like protein rA4 I 
U61729 286988 Proline rich protein 2 (Pnrc1) I 
X52817 NF C1-13 gene product IV-I 
X60351 NF Alpha B-crystallin (ocular lens tissue) IV 
AB008538 79559 Activated leukocyte cell adhesion molecule (Alcam) I 
     Functional categorization of circadian-regulated genes in the rat SCN. Listed are the GenBank, Locus Link ID, functional 
category/cluster and Phase Group assignment for genes and ESTs that surpassed stringent expression criteria and displayed 
circadian profiles of mRNA expression in the rat SCN.  
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Table A.3. Genes with circadian profiles common to NIH/3T3 cells and Rat-1 or Rat 3Y1 
fibroblasts. 
Gene descriptor (symbol) 
Rat-1 
(32) 
Rat 3Y1 
(47) 
Period 2 (Per2) X X 
Cryptochrome 1 (Cry1) X X 
Brain and muscle ARNT-like protein (Bmal1 or Mop3) X  
Annexin  XI (Anxa11) X X 
Cell-division kinase 4 (Cdk4)  X 
Ubiquitin-like 4 (Ubl4) X
Histone H2a(A)-613, H2a(B)-613, and H2b-613 (H2b) genes  X 
Immunoglobulin kappa chain V-region (Igk-V28) X
RAN GTPase activating protein 1 (Rangap1)  X 
Voltage-dependent, L type, alpha 1C calcium channel 
(Cacna1c)  
X 
 
     Genes with circadian expression profiles in NIH/3T3 cells and in rat-1 or 3Y1 fibroblasts. The gene descriptor and 
symbol are listed for rhythmic genes identified in NIH/3T3 cells that correspond to functionally similar or homologous 
genes with rhythmic patterns observed in rat-1 (32) or rat 3Y1 fibroblasts (47).  
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Table A.4. Functional categorization of temporal profiles of gene expression in NIH/3T3 cells 
GenBank ID Gene descriptor (symbol) 
Phase 
Group
Category 1 - Energetics  
Cluster 1 - Glucose Metabolism and Electron Transport Chain 
Rhythmic (N=2) 
*X13586 2,3-bisphosphoglycerate mutase (Bpgm) I 
*AF058955 ATP-specific succinyl-CoA synthetase beta subunit (Scs)/  IV 
 succinate-Coenzyme A ligase, ADP-forming (Sucla2)  
NIH/3T3-specific non-rhythmic genes (N=1) 
D50430 Glycerol-3-phosphate dehydrogenase (Gdm1) 
  
Cluster 2 - Lipid and fatty acid metabolism  
Rhythmic (N=3) 
X13135 Fatty acid  synthase (Fasn) I 
†M21285 Stearoyl-coenzyme A desaturase 1 (Scd1) I 
†U15977 Mus musculus long chain fatty acyl CoA synthetase (Facl) I 
NIH/3T3-specific non-rhythmic genes (N=1) 
L42293 Acyl-coenzyme A/cholesterol acyltransferase (Soat1) 
  
Cluster 3 - Transporters  
Rhythmic (N=4) 
*U17132 Zinc transporter 1 (Znt1/Slc30a1) I 
AF035526 Kanadaptin/solute carrier family 4 (anion exchanger), member 1, adaptor protein (Slc4a1ap) I 
U74079 Solute carrier (sodium/hydrogen exchanger), isoform 3 regulator 1 (Slc9a3r1) I 
*U13838 ATPase, H+ transporting, V1 subunit B, isoform 2 (Atp6v1b2) IV 
  
180
 
 
 
Table A.4 continued 
NIH/3T3-specific non-rhythmic genes (N=5) 
X67056 Glycine transporter (Glyt1) 
L23755 Solute carrier family 19 (sodium/hydrogen exchanger), member 1 (Slc19a1) 
X66119 5-hydroxytryptamine (serotonin) transporter (Slc6a4) 
AB015800 Octn2 solute carrier family 22 (organic cation transporter), member 5 (Slc22a5) 
M21247 Uncoupling protein 1 (mitochondrial, proton carrier) (Ucp1) 
 
Cluster 4 - Miscellaneous metabolism  
Rhythmic (N=8) 
X61172 Mouse mRNA for alpha-mannosidase  II I 
X07888 3-hydroxy-3-methylglutaryl coenzyme A reductase, exon 2 (Hmgcr) I 
U12961 NAD(P)H menadione oxidoreductase 1, dioxin inducible (Nqo1) II 
L42996 Nuclear-encoded mitochondrial  acyltransferase  I 
U52524 Hyaluronan synthase 2 (Has2) I 
K01515 Hypoxanthine guanine phosphoribosyl transferase (Hprt) I 
M35970 Mouse tumor metastatic process-associated protein (NM23/Nme1) I-IV 
Z23077 S-adenosylmethionine decarboxylase, pseudogene 1/Amd-ps1 I 
NIH/3T3-specific non-rhythmic genes (N=9) 
U20257 Class IV alcohol dehydrogenase (Adh3) 
X98055 Glutathione S-transferase theta (Gstt1) 
AF074926 Heparan sulfate N-deacetylase/N-sulfotransferase 1 (Ndst1) 
M34141 Prostaglandin-endoperoxide synthase 1 (Ptgs1) 
M81483 Calmodulin dependent phosphatase catalytic subunit (Ppp3cb) 
AB001607 Prostacyclin synthase (Ptgis) 
AF001871 GRP1 Pleckstrin homology, Sec7 and coiled-coil domains 3 (Pscd3/Grp1/AI648983) 
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Table A.4 continued  
U18975 Beta-1,4 N-acetylgalactosaminyltransferase (Galgt1) 
AF031467 Branched-chain amino acid aminotransferase (Bcat2) 
 
Category 2 - Cellular Communication  
Cluster 1 - Neurotransmission  
Glutamatergic metabolism and signaling (1 rhythmic, 0 non-rhythmic) 
Rhythmic (N=1) 
*U95053 Glutamate cysteine ligase/gamma-glutamylcysteine synthetase (Gclm) I 
NIH/3T3-specific non-rhythmic genes (N=0) 
 
Synaptic function and maintenance  
Rhythmic (N=0) 
NIH/3T3-specific non-rhythmic genes (N=1) 
D38375 Syntaxin 3D-2 (Stx3) 
 
Miscellaneous neurotransmission  
Rhythmic (N=1) 
U17869 Voltage-dependent, L type, alpha 1C calcium channel (Cacna1c) I 
NIH/3T3-specific non-rhythmic genes (N=6) 
Z49916 Chloride channel 4-2 (Clcn4-2) 
X82655 Acetylcholine receptor beta 2 neural (beta 2-subunit) 
Y09585 Serotonin 4L receptor (Htr4) 
U37249 Arylamine N-acetyltransferase stable form (Nat2) 
AF051947 T-type calcium channel alpha-1 subunit (Cacna1h) 
X94908 Serotonin 1D receptor (5-HT1D) 
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Table A.4 continued 
Rhythmic (N=1) 
*Z22703 Fibroblast growth factor 7 (Fgf7) I 
NIH/3T3-specific non-rhythmic genes (N=4) 
X72307 Hepatocyte growth factor (Hgf) 
X55573 Brain-derived neuroptrophic factor (Bdnf) 
X99572 c-fos induced growth factor (Figf) 
AF004874 Latent TGF-beta binding protein-2 (Ltbp2) 
 
Cluster 3 - G-protein coupled receptors and associated proteins 
Rhythmic (N=5) 
U08110 RAN GTPase  activating  protein  1 (Rangap1) I 
L32752 Mouse (clone  M2) GTPase (Ran) I 
U10551 GTP binding  protein (gene  overexpressed  in  skeletal  muscle) I 
L38444 Mus musculus (clone  U2) T-cell specific GTPase (Tgtp) II 
*D87901 ADP-ribosylation factor 4 (Arf4) I 
NIH/3T3-specific non-rhythmic genes (N=8) 
U08354 Melanocortin-5 receptor (Mc5r) 
D49956 8-oxo-dGTPase (Mth1) 
L08075 Phosducin (Rpr1) 
AB004879 M-Ras (M-Ras) 
AF019371 CCK-B/gastrin receptor (Cckbr) 
D86563 Rab 4 (Rab4a) 
U33005 Tbc1 (Tbc1d1) 
AB004315 RGS4 Regulator of G-protein signaling 4 (Rgs4) 
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Table A.4 continued 
Cluster 4 - Cytosolic signaling factors and transducers 
Rhythmic (N=25) 
AF086905 Mus musculus protein kinase (Chk2) II 
M96163 Mus musculus (clone 2) serum inducible kinase  (SNK) I 
*X13664 Neuroblastoma ras oncogene (Nras) I 
X76850 Mus musculus mRNA for MAP kinase-activated protein kinase 2 I 
X63440 Protein tyrosine phosphatase, non-receptor type 12 (Ptpn12) III 
AF039574 Serine/threonine kinase  2 (Slk) I 
U68171 Phosphodiesterase 7A (Pde7a) IV 
*D37801 Protein tyrosine phosphatase, receptor type D (Ptpn21) I 
*AF006201 Mus musculus prostaglandin F2 alpha receptor regulatory protein (Ptgfrn) IV 
U84411 Mus musculus protein tyrosine phosphatase (PRL-1) I 
AB020202 Mus musculus mRNA for adenylate  kinase isozyme 2 I 
U73478 Acidic nuclear phosphoprotein 32  III 
AJ223071 Mus musculus mRNA for serine/threonine kinase protein, long-form III 
*L02526 Protein kinase, mitogen activated, kinase 1/p45 I 
U43585 Mus musculus kinase  suppressor of ras-1 (KSR1) I 
 AF043326 Mus musculus N-myristoyltransferase 1 (Nmt1) I 
AF033663 PRP4 pre-mRNA processing factor 4 homolog B (yeast)/pre-mRNA protein kinase (Prpf4b) I 
U34973 Phosphoserine/threonine/tyrosine interaction protein (Styx) I 
U02313 MAST205  protein  kinase/microtubule associated serine/threonine kinase 2 (Mast2) I 
AI180687 Phosphodiesterase 4B, cAMP specific (Pde4b) I 
AV336804 Mus musculus cDNA/3' end of protein kinase C, theta (Prkcq) II 
AI838337 Mus musculus cDNA/polynucleotide kinase 3'- phosphatase (Pnkp) I 
U65986 Annexin  XI (Anxa11) I 
 L21671 Epidermal growth factor receptor pathway substrate 8 (Eps8) I 
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Table A.4 continued   
AV007820 Mus musculus cDNA/S100 calcium binding protein A13 (S100a13) IV 
NIH/3T3-specific non-rhythmic genes (N=13) 
D17433 Prostaglandin F receptor (Ptgfr) 
AF059029 Calcium/calmodulin-dependent protein kinase II delta (Camk2d) 
M63801 Connexin 43 (Gja1) 
M80739 Protein tyrosine phosphatase, non-receptor type 2 (Ptpn2) 
X82288 Protein-tyrosine-phosphatase (Ptprs) 
AF099988 Ste-20 related kinase SPAK (Stk39) 
AB012393 Inositol 1,4,5 trisphosphate receptor type2 (Itpr2) 
X84896 ATP receptor (P2rx1) 
AJ009823 P2X7 receptor subunit (P2rx7) 
X77731 Deoxycytidine kinase (Dck) 
AF000236 RDC1 orphan chemokine receptor (Cmkor1) 
X70764 Serine/threonine protein kinase (Emk) 
AF039601 Betaglycan transforming growth factor, beta receptor III (Tgfbr3) 
  
Cluster 5 - Nuclear factors  
E-box and immediate early factors  
Rhythmic (N=8) 
*U10325 Aryl hydrocarbon receptor nuclear translocator (Arnt) I 
X61800 CCAAT/enhancer binding protein (C/EBP-delta) I 
M60285 CAMP responsive element modulator  I 
†U16322 Transcription factor 4 (Tcf4) I 
M94087 Activating  transcription  factor  4 (Atf4) I 
X67644 Cyclic AMP inducible gene 3/immediate early response 3 (Ier3)  I, I-IV 
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Table A.4 continued   
AF036893 Mus musculus circadian clock protein period homolog 2 (Drosophila) (Per2) I 
†M28845 Early growth response 1 (Egr-1) I 
NIH/3T3-specific non-rhythmic genes (N=3) 
AF017128 Fos-related antigen 1 (fra-1) 
X12761 Jun oncogene (Jun) 
M61007 CCAAT/enhancer binding protein (C/EBP), beta (Cebpb) 
  
Other nuclear factors  
Rhythmic (N=14) 
AB000777 Cryptochrome 1 (photolyase-like) (Cry1) I 
X95504 Mus musculus mRNA for zinc finger protein  I 
AB023485 Mus musculus mRNA for transcription factor CA150b I 
M36146 Zinc finger protein 35 I 
U46186 Zinc finger protein 93  III 
AB000490 Nuclear receptor subfamily 5, group A, member 1 (Nr5a1) III 
U53228 RAR-related orphan receptor alpha (Rora / sg, ROR1, ROR2, ROR3, Nr1f1) I 
X17459 Recombining binding protein suppressor of hairless (Drosophila) (Rbpsuh-rs3) I 
M34476 Retinoic acid receptor, gamma (Rarg) I 
AF050182 Mus musculus Period 3 (Per3) I 
 X74040 Forkhead box C2 (Foxc2) I 
Y12293 Mus musculus lun gene, exon 1/forkhead box F2 (Foxf2) I 
U20282 Transcription factor 20 (Tcf20) III 
AA794509 Mus musculus cDNA/reduced expression 2 (Rex2) I 
NIH/3T3-specific non-rhythmic genes (N=10) 
L13204 HNF-3/fork-head homolog-4 (Foxj1) 
  
186
 
 
 
Table A.4 continued  
Z23066 Mi protein (Mitf) 
X66223 Retinoid X receptor-alpha (Rxra) 
M60909 Retinoic acid receptor-alpha (Rara) 
M57966 HNF-3/fork-head homolog-1 (Tcf1) 
X60136 Trans-acting transcription factor 1 (Sp1) 
AB013097 Brain finger protein (Zfp179) 
D90174 Nuclear factor I/A (Nfia) 
L00039 Myelocytomatosis oncogene (c-myc) 
X16995 Nuclear receptor subfamily 4, group A, member 1 (Nr4a1) 
 
Category 3 - Protein dynamics 
Cluster 1 - Degradation and synthesis  
Rhythmic (N=15) 
X54327 Mus musculus mRNA for glutamyl-prolyl-tRNA synthetase (Eprs) I 
U39473 Mus musculus histidyl-tRNA synthetase  mRNA (Hars) I 
U20619 Mus musculus serine-rich RNA polymerase suppressor protein1 (SRP1) I 
X91656 Splicing factor, arginine/serine-rich 3 (SRp20) I 
J04761 
Ubiquitin-like 4 (Ubl4)/solute carrier family 10 (sodium/bile acid cotransporter family) 
(Slc10a3) I 
Y13071 Proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 (Psmd14) I 
U11274 Heterogeneous nuclear ribonucleoprotein D (Hnrpd) I 
X98511 Splicing factor, arginine/serine-rich 2 (SC-35) (Sfrs2) I 
L00993 Sjogren syndrome antigen B (Ssb) IV 
AF061503 Bop1 protein (Bop1) and heat shock transcription factor I (Hsf1) I 
AB007139 Proteaseome (prosome, macropain) 28 subunit, 3 (Psme3 ) I 
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Table A.4 continued   
AA690583 
Splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) 
(Sfpq) I 
AF060490 
TLS-associated  protein TASR-2/FUS interacting protein (serine-arginine rich) 
1(Fusip1) I 
AW121031 Mus musculus cDNA/nucleolar protein family A, member 2 (Nola2) I 
J04620 Primase p49 subunit/(Prim1) I 
NIH/3T3-specific non-rhythmic genes (N=4) 
U58280 Second largest subunit of RNA polymerase I (Rpo1-2) 
U12620 Dipeptidyl peptidase IV (CD26) 
AF091998 Calpain Lp82 (Capn3) 
M27347 Elastase 1 (Ela1) 
 
Cluster 2 - Protein sorting and trafficking  
Rhythmic (N=7) 
D17577 Kinesin heavy chain member 1B (Kif1b) I 
AF020771 Mus musculus importin alpha Q1 mRNA/karyopherin alpha 4 I 
 X14971 Adaptor protein complex AP-2, alpha 1 subunit (Ap2a1) I 
AW123408 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2 (Kdelr2) I 
U91933 Adaptor-related protein complex 3, sigma 2 subunit (Ap3s2) II 
U78315 Hermansky-Pudlak syndrome 1 homolog (human) (Hps1) II 
AF043120 Coatomer protein complex, subunit beta 2 (beta prime) (Copb2) I 
NIH/3T3-specific non-rhythmic genes (N=2) 
AF003999 Golgi SNARE GS15 (Bet1l) 
AF076681 Eukaryotic translation initiation factor 2 alpha kinase 3 (Eif2ak3) 
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Table A.4 continued 
Cluster 3 - Protein modification and folding  
Rhythmic (N=4) 
U08215 Mus  musculus Hsp70-related NST-1 (hsr.1) I 
AA919208 &   
D85904 Heat shock protein 4 (Hspa4/Hsp70) I 
D50264 Phosphatidylinositol glycan, class F (Pigf) III 
*U73820 
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 
(Galnt1) IV 
NIH/3T3-specific non-rhythmic genes (N=2) 
M60320 Protein-L-isoaspartate (D-aspartate) O-methyltransferase1/protein carboxyl methyltransferase (Pcmt1) 
U35646 Puromycin-sensitive aminopeptidase (Psa) 
 
Category 4 - Cellular Development  
Cluster 1 - Cell Cycle 
Rhythmic (N=5) 
AA791962 
Mus musculus cDNA/ similar to D-type G1 cyclin catalytic subunit/ cyclin-dependent kinase 
4 (Cdk4) II 
AJ223087 Mus musculus mRNA  for  Cdc6-related  protein I 
AF016583 Mus musculus checkpoint  kinase 1 homolog (Chk1/Chek1)  I 
U42385 SMC2 structural maintenance of chromosomes 2-like 1 (yeast) (Smc2l1) I 
D83745 B-cell translocation gene 3 (Btg3) I 
NIH/3T3-specific non-rhythmic genes (N=1) 
U09968 Cyclin-dependent kinase inhibitor (p27kip1) 
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Table A.4 continued 
Cluster 2 - Maintenance of DNA and chromatin  
Rhythmic (N=10) 
AF006602 Mus musculus histone deacetylase (mHDA1) I 
AF012710 Mus musculus centromere protein A (Cenp-a) gene,  promoter region and partial cds III 
L32751 Lipopolysaccharide  response/Ran, member RAS oncogene family I 
D87973 Imprinted  and  ancient (Impact) I 
X12944 HMG-17 chromosomal protein/binding domain 2 (Hmgn2) II 
U62673 Mus musculus  histone  H2a(A)-613, histone H2a(B)-613, and histone H2b-613 (H2b) genes IV 
X67668 High mobility group box 2 (Hmgb2) I 
U25691 Helicase, lymphoid  specific (Hells) I 
D26089 Mini chromosome maintenance deficient  4 homolog (S. cerevisiae) (Mcm4) I 
AB028920 A kinase anchor protein 8 I 
NIH/3T3-specific non-rhythmic genes (N=1) 
X12521 Transition protein 1 (Tnp1) 
 
Cluster 3 - Growth and differentiation  
Rhythmic (N=9) 
Y00208 Homeo box A5 (Hoxa5) I 
 X55318 Homeo box C9 (Hoxc9) II 
L06864 Epidermal growth factor receptor (EGFR) III 
X96639 Exostoses (multiple) 1 (Ext1) I 
U88327 Suppressor of cytokine  signalling-2  (SOCS-2) I 
M12379 Mouse Thy-1.2  glycoprotein/thymus cell antigen 1, theta (Thy1) I 
K02245 Proliferin (Plf) I-II 
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Table A.4 continued   
D31967 Jumonji, AT rich interactive domain 2 (Jarid2) I 
AF014117 
GDNF  receptor/glial cell line derived neurotrophic factor family receptor alpha 1 
(Gfra1) I 
NIH/3T3-specific non-rhythmic genes (N=13) 
AB010557 Pax4 (Pax4) 
D49921 Glial cell line-derived neurotrophic factor (Gdnf) 
L35049 Bcl2-like (Bcl2l) 
D85028 Semaphorin 3A (Sema3a) 
AB018194 BIT/Signal-regulatory protein alpha (Sirpa/Ptpns1) 
U59746 Bcl-w (Bcl2l2) 
AF017255 Persyn Synuclein, gamma (Sncg) 
Z21858 pS2m/trefoil factor 1 (Tff1) 
AB010152 p73H/transformation related protein 63 (Trp63) 
U94331 Osteoprotegerin (Tnfrsf11b) 
AF047389 Dominant megacolon mutant Sox-10 protein (Sox10) 
Z12171 Putative homeotic protein/Dlk1-like protein (Dlk1) 
L12447 Insulin-like growth factor binding protein 5 (Igfbp5) 
 
Category 5 - Defense and Detoxification  
Rhythmic (N=21) 
 M57999 Nuclear factor of  kappa light chain gene enhancer in B-cells (Nfkb1) I 
*U92565 Small inducible cytokine subfamily D, 1  I 
AF100927 Mus musculus apoptosis-inducing factor AIF (Aif) I 
V00835 Metallothionein 1 (Mt1) IV 
Y13090 Mus musculus mRNA for caspase-12 IV 
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    Table A.4 continued 
D89613 Cytokine inducible SH2-containing  protein (Cish) I 
*AF029215 Antigen identified by monoclonal antibody MRC OX-2 (Mox2) IV 
D64162 Retinoic acid early transcript gamma (Rae-123) cell surface  protein (Raet1c) II 
 M63695 CD1d1 antigen (Cd1d1) I-II 
*U27267 
Small inducible cytokine B subfamily, member 5/chemokine (C-X-C motif) ligand 5 
(Cxcl5) I 
D63679 Decay accelerating factor 1 (Daf1) I 
U10094 Killer cell lectin-like receptor, subfamily A, member  7 IV 
X00246 
Set 1 repetitive element for a class I MHC complex/histocompatibility 2, D region locus 
1 (H2-D1) II 
*U81052 Defender against cell death 1 (Dad1) I 
*J04596 GRO1 oncogene/chemokine (C-X-C motif) ligand 1 (Cxcl1) I 
U35623 Myeloid cell leukemia sequence 1 (Mcl1) I 
U44088 Pleckstrin homology-like domain, family A, member 1 (Phlda1) I 
M18237 Mouse  Ig  kappa  chain  V-region/similar to immunoglobulin light chain variable region III 
AF071179 Formyl peptide receptor, related sequence 1 (Fpr-rs1) I 
AW045202 Thioredoxin domain containing 7 I 
*AB027565 Thioredoxin reductase 1 (Txnrd1) I 
NIH/3T3-specific non-rhythmic genes (N=7) 
M20658 Interleukin 1 receptor, type I (Il1r1) 
U38261 Extracellular superoxide dismutase (Sod3) 
M27960 Interleukin 4 receptor, alpha (Il4ra) 
AF036907 Linker for activation of T cells (Lat)  
AF027707 Apoptosis activator (Mtd/Bok) 
X81627 Lipocalin 2 (Lcn2) 
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Table A.4 continued  
AJ009840 Cathepsin E protein, exon 1 
 
Category 6 - Cytoskeletal elements and Adhesion 
Rhythmic (N=14) 
X52046 Procollagen, type III, alpha 1 (Col3a1) III 
U20365 Actin, gamma 2, smooth muscle, enteric (Actg2) I 
X66084 Hyaluronic acid receptor/CD44 antigen (Cd44) I 
*U12884 
Mus musculus C57BL/6 vascular cell adhesion molecule-1 truncated form T-VCAM-1 
(Vcam-1) I 
L07921 Iduronate 2-sulfatase (Ids) III 
U14135 Integrin alpha V (Cd51/Itgav) IV 
J04181 & M12481 Actin, beta, cytoplasmic (Actb) I 
L18880 Vinculin (Vcl) I 
Z19543 h2-Calponin 2 (Cnn2) I 
J03520 Plasminogen activator, tissue (Plat) III 
M32490 Insulin-like growth factor binding protein 10/cysteine rich protein 61 (Cyr61) III 
D88793 Cysteine rich protein/cysteine and glycine-rich protein 1 (Csrp1) I 
M62470 Thrombospondin 1 (Thbs1) I 
AW123707 Mus  musculus  cDNA/par-3 (partitioning defective 3) homolog (C. elegans) (Pard3) I 
NIH/3T3-specific non-rhythmic genes (N=7) 
X72795 Gelatinase b (Mmp9) 
D78265 Pancortin-4 (Olfm1) 
U07890 Epidermal surface antigen (Flot2) 
U90435 Flotillin (Flot1) 
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Table A.4 continued  
AB020886 Ssecks A kinase anchor protein (Gravin) 12 (Akap12) 
X83506 Utrophin (Utrn) 
L31397 Dynamin (Dnm) 
 
Category 7 - Unknown and ESTs 
Rhythmic (N=166) 
 L36829 Mus Musculus alpha A-crystallin-binding  protein I (alphaA-CRYBP1) gene I-IV 
AW046227 UI-M-BH1-ala-a-08-0-UI.s1  Mus musculus cDNA III 
AI643885 Mus musculus cDNA IV 
AI838853 Mus musculus cDNA I 
AI131982 Mus musculus cDNA II 
 Z31360 Mus musculus (Balb/C) P/L01 mRNA  IV 
Z83956 Similar to spermidine synthase/Mus musculus spermidine synthase pseudogene I 
U95783 Mus musculus endogenous provirus Imposon1 envelope gene III 
U17961 Similar to SRC associated in mitosis, 68 kDa IV 
AW046194 Mus musculus cDNA I 
AI854432 Mus musculus cDNA I 
X14206 Poly (ADP-ribose) polymerase/model, pseudogene, not transcribed IV 
AA871791 Abhydrolase domain containing 5 (Abhd5) I 
AW046850 Mus musculus cDNA III 
AW048189 Mus musculus cDNA I 
AI843655 Mus musculus cDNA I 
AI788543 Mus musculus cDNA I 
AI197507 Mus musculus cDNA I 
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Table A.4 continued   
D73368 
Musculus domesticus adult thymus Mer  protein/enhancer of rudimentary homolog 
(Drosophila) (Erh) I 
U88588 Cerebellar degeneration-related 2 (Cdr2) I 
U70210 TR2L/amyloid beta (A4) precursor protein-binding, family B, member 2 (Apbb2) I 
AF034580 Mus musculus TSG118.1 (Tsg118) II 
AW046579 Mus musculus cDNA I 
AA738776 Mus musculus cDNA/paraspeckle protein 1 (Pspc1) I 
AW124334 Mus musculus cDNA I 
AW122523 Mus musculus cDNA I 
AI837786 Mus musculus cDNA I 
AW123286 Mus musculus cDNA III 
AA388099 
Mus musculus cDNA/DNA segment, Chr 7, Wayne State University 128, expressed 
(D7Wsu128e) I 
AW123729 Mus musculus cDNA I 
AW050153 Mus musculus cDNA I 
AA110657 Mus musculus cDNA I 
AI850624 Mus musculus cDNA I 
AI507524 Mus musculus cDNA I 
AI645050 Mus musculus cDNA IV 
AW046694 Mus musculus cDNA IV 
AI852578 Mus musculus cDNA IV 
AA863742 Mus musculus cDNA IV 
AI563623 Mus musculus cDNA I 
AW121972 Mus musculus cDNA I 
AW046889 Mus musculus cDNA I 
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Table A.4 continued   
AI551347 Mus musculus cDNA II 
AI851421 Mus musculus cDNA I 
AI837625 Mus musculus cDNA I 
*AI852641 Mus musculus cDNA I 
AI850638 Mus musculus cDNA I 
AW122811 Mus musculus cDNA I 
AI846961 Mus musculus cDNA I 
AI838249 Mus musculus cDNA I 
AI839901 Mus musculus cDNA I 
AI845987 Mus musculus cDNA IV 
AW121695 Mus musculus cDNA I 
AI839417 Mus musculus cDNA I 
AI839803 Mus musculus cDNA I 
AA646966 Mus musculus cDNA I 
*AI846851 Mus musculus cDNA I 
AA645537 Mus musculus cDNA I 
AA667100 Mus musculus cDNA III 
AW123347 Mus musculus cDNA I 
AW060526 Mus musculus cDNA IV 
AW061073 Mus musculus cDNA I 
AA796214 Mus musculus cDNA/spindlin (Spin) I 
AW123983 Mus musculus cDNA I 
AW124904 Mus musculus cDNA II 
AI853347 Mus musculus cDNA I 
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Table A.4 continued   
AA709728 Mus musculus cDNA I 
AW121924 Mus musculus cDNA I 
AV171460 Mus musculus cDNA IV 
AV229143 Mus musculus cDNA IV 
AV232133 Mus musculus cDNA II 
AV025111 Mus musculus cDNA IV 
AV295044 Mus musculus cDNA III 
AV322550 Mus musculus cDNA IV 
AV305832 Mus musculus cDNA IV 
AV374868 Mus musculus cDNA I 
AV334573 Mus musculus cDNA I 
AV290470 Mus musculus cDNA I 
AA867778 Mus musculus cDNA I 
*AW123542 Mus musculus cDNA I 
AI891475 Mus musculus cDNA I 
AI842259 Mus musculus cDNA I 
AW045233 Mus musculus cDNA I 
AI847564 Mus musculus cDNA I 
*AI845584 Mus musculus cDNA I 
*AW122310 Mus musculus cDNA I 
AW122897 Mus musculus cDNA IV 
AI840579 Mus musculus cDNA/expressed sequence AW550801 I 
AW107884 Mus musculus cDNA I 
AA763918 Mus musculus cDNA I 
AI837493 Mus musculus cDNA III 
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Table A.4 continued   
AW060546 Mus musculus cDNA I 
AW045204 Mus musculus cDNA I 
AW123852 Mus musculus cDNA II 
AI661370 Mus musculus cDNA I 
AW046443 Mus musculus cDNA II 
AW125190 Mus musculus cDNA III 
AI837311 Mus musculus cDNA I 
AI845886 Mus musculus cDNA I 
AW122551 Mus musculus cDNA I 
AI849615 Mus musculus cDNA I 
AW123801 Mus musculus cDNA I 
AA666464 Mus musculus cDNA I 
AW122851 Mus musculus cDNA I 
*AW046181 Mus musculus cDNA I 
AI843119 Mus musculus cDNA I 
AI847879 Mus musculus cDNA I 
AW122860 Mus musculus cDNA I 
AW124520 Mus musculus cDNA I 
AI852534 Mus musculus cDNA I 
AW120683 Mus musculus cDNA I 
AI850113 Mus musculus cDNA I 
AA959180 Mus musculus cDNA II 
AI849067 Mus musculus cDNA I 
AW124224 Mus musculus cDNA I 
AI843709 Mus musculus cDNA I 
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Table A.4 continued   
AW124044 Mus musculus cDNA I 
AI836083 Mus musculus cDNA I 
AI850362 Mus musculus cDNA I 
AW045974 Mus musculus cDNA I 
AI835784 Mus musculus cDNA I 
AI853476 Mus musculus cDNA I 
AI850546 Mus musculus cDNA I 
AI843210 Mus musculus cDNA I 
AI848453 Mus musculus cDNA I 
AI843417 Mus musculus cDNA I 
AI851104 Mus musculus cDNA I 
AW121624 BC018507: cDNA sequence BC018507 I 
AW046661 Mus musculus  cDNA I 
AI838452 Mus musculus cDNA I 
AI847050 Mus musculus cDNA I 
AA623426 Mus musculus cDNA IV 
AI844374 Mus musculus cDNA I 
AI843046 Mus musculus cDNA I 
AJ130975 
Mus musculus cDNA/similar to Ariadne-2 protein homolog (ARI-2) (Triad1 protein) 
(HT005) I 
AF093821 Synaptotagmin binding, cytoplasmic RNA interacting  I 
AA869927 Mus musculus cDNA I 
AW050287 Mus musculus cDNA I 
AW120722 Mus musculus cDNA I 
AW124889 Mus musculus cDNA I 
AW061228 Mus musculus cDNA II 
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Table A.4 continued   
AI846519 Mus musculus cDNA I 
AW046449 Mus musculus cDNA I 
AI854281 Mus musculus cDNA I 
AA716963 Mus musculus cDNA I 
AI648831 Mus musculus cDNA I 
AI854020 Mus musculus cDNA I 
AA153773 Mus musculus cDNA I 
AV381276 Mus musculus cDNA IV 
AI835630 Mus musculus cDNA I-II 
AI849453 Mus musculus cDNA I 
AI835520 Mus musculus cDNA I-II 
AI851081 Mus musculus cDNA I 
AI844751 Mus musculus cDNA I 
AA638002 Mus musculus cDNA I 
AW046160 Mus musculus cDNA I 
AI838293 Mus musculus cDNA I 
AI842649 Mus musculus cDNA I 
AW123507 Mus musculus cDNA I 
AI841320 Mus musculus cDNA IV 
AI451564 Mus musculus cDNA IV 
AI854285 Mus musculus cDNA I 
AW124318 Mus musculus cDNA III 
AA881294 Mus musculus cDNA I 
AI849333 Mus musculus cDNA I-II 
AI840458 Mus musculus cDNA II 
AI848623 Mus musculus cDNA I 
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    Table A.4 continued  
8 
     Functional categorization of rhythmic (bold) genes in NIH/3T3 fibroblasts and of NIH/3T3-specific non-rhythmic (regular) 
genes. Listed are the GenBank ID, gene descriptor and functional category/cluster assignment for annotated genes and ESTs or 
genes of unknown function that surpassed expression criteria in NIH/3T3 fibroblasts. Rhythmic genes only expressed in 
NIH/3T3 cells are denoted by * whereas genes with rhythmic patterns in NIH/3T3 cells, SCN2.2 cells, and the rat SCN are 
indicated by †.   
NIH/3T3-specific non-rhythmic genes (N=19) 
AW122331 Mus musculus cDNA 
AI847619 Mus musculus cDNA (also AI846570) 
AI849354 Mus musculus cDNA 
AI841159 Mus musculus cDNA, (Lcn2) 
AI117848 Mus musculus cDNA 
AW121844 Mus musculus cDNA, (Itm2b) 
AA711915 Mus musculus cDNA, 9130211I03Rik 
AV345565 Mus musculus cDNA,  3'  end (Adarb1) 
AI839886 Mus musculus cDNA, (Apbb1) 
AI851821 G protein beta subunit-like (Gbl-pending) 
Y18298 CUG triplet repeat, RNA binding protein 2 (Cugbp2) 
X73580 Secretin (Sct) 
U55060 Beta-galactoside binding lectin (Lgals9) 
AF087695 Veli 3/Lin-7 homolog C (C. elegans) (Veli3-pending) 
U36384 Twist-related bHLH protein Dermo-1, (Twist2) 
AW047343 Mus musculus cDNA (Dbp) 
AA007891 Mus musculus cDNA 
AF039563 Retinoblastoma binding protein (Rbbp9) 
M77497 Cytochrome P-450 naphthalene hydroxylase (Cyp2f2) 
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